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Abstract
c-diGMP (bis-(3→5)-cyclic di-guanosine monophosphate) is used extensively
in bacteria to control biofilm formation and is lately postulated as a novel
secondary messenger. Little is known about the signalling process, nor the
control, of this dinucleotide. It is clear, however, that its synthesis is catal-
ysed by the DGC (diguanylate cyclase) domain that contains a conserved
GG(D/E)EF sequence motif. Despite its high abundance in bacteria, the
structure was until now unknown.
The PleD protein from Caulobacter crescentus contains a C-terminal
DGC domain, preceded by the input domain D1 and the adaptor domain
D2. PleD is a response regulator from the two-component signalling system.
The output DGC response relies phosphorylation at the N-terminal D1 input
domain. Therefore, the control of c-diGMP signal can be revealed in this
multi-domain protein.
The objectives of my PhD work are to (1) reveal the structure of DGC
domain, (2) understand the catalytic mechanism of DGC, and (3) under-
stand the regulation of the DGC response through the structure of PleD.
The crystal structure of PleD has been solved in complex with c-diGMP
to 2.7 A˚. The fold of the DGC domain is similar to adenylate cyclase, but
the proposed nucleotide binding mode is substantially different. The crystal
packing has suggested that two DGC domains align in a two-fold symmetric
way to catalyse c-diGMP synthesis. Hence, PleD is active as a dimer using
D1 and D2 domains for dimerisation. The dimer formation is probably
caused by phosphorylation at the D1 domain. In addition, the structure
shows that two intercalated products bind at the D2-DGC domain interface.
Such binding is thought to serve an allosteric purpose by immobilising DGC
domain movements and prevent them from forming the active site.
This thesis reports the crystal structure of PleD in complex with c-
diGMP, and discusses the implications of the structure on DGC catalysis
and on activation and inhibition regulation of DGC activity in PleD. In
addition, the thesis describes the preparative investigations and characteri-
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sation that have led to structure determination of PleD. These include the
design and screening of PleD constructs, the establishment and optimisa-
tion of expression and purification, protein characterisation, crystallisation
optimisation, and diffraction data collection.
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Chapter 1
Introduction
c-diGMP as a novel secondary messenger
Cyclic nucleotides like cyclic adenosine monophosphate (cAMP) or cyclic
guanosine monophosphate (cGMP) (Figure 1.1) have been recognised as im-
portant low molecular weight signalling molecules. While bacterial pathogens
can interfere with cGMP signalling of their eukaryotic host cells [65], prokary-
otes in general do not seem to use cGMP for signalling. This suggests an
alternative signalling molecule. In fact, the cyclic bis-3→5-dinucleotide c-
diGMP has been shown to regulate cell surface associated traits in bacteria
including Caulobacter crescentus [1, 23], Escherichia coli, and the pathogenic
bacteria Pseudomonas aeroginosa and Salmonella typhimurium [56], and
community behaviour like biofilm formation in pathogenic bacteria includ-
ing Pseudomonas fluorescens [57] and Vibrio cholerae [64]. The recent sug-
gestion that c-diGMP might be a novel secondary messenger [10, 18, 26] has
led to mounting interest in the regulation of this cyclic di-nucleotide.
The structure of c-diGMP
The structure of c-diGMP is known [16, 39]. In the crystal structure, two c-
diGMP molecules intercalate to form a dimer that is stabilised by a hydrated
Mg2+ ionon the pseudo two-fold symmetry axis (Figure 1.2). The dimer
structure is further stabilised by the alternate stacking of guanines from
each monomer. In addition, there is also a set of parallel hydrogen bonds
between the guanine and the phosphate of the other monomer.
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Figure 1.1: Cyclic mono-nucleotides like cAMP and cGMP have an intramolecular phos-
phodiester linkage, whereas cyclic di-nucleotides like c-diGMP contain two intermolecular
phosphodiester linkages to form a large 12-membered cyclic structure.
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Figure 1.2: Crystal structure of c-diGMP showing two intercalated c-diGMP molecules
[16, 39]. A, Front view shows the alternate stacking of the guanine bases coordinated by
the hydrated Mg2+ ion (purple). Water molecules are in red. B, Side view shows the
cyclic structure with the two phosphodiester linkages. All diagrams of the organic and
protein molecules in this report are produced in the programme DINO [48].
DGC catalyses c-diGMP synthesis
c-diGMP is a cyclic molecule composed of two guanosine monophosphates
that are connected by two intermolecular 3’→5’-phosphodiester bonds (Fig-
ure 1.1). It is synthesised by the enzyme diguanylate cyclase (DGC) accord-
ing to the following reaction [54]:
2 GTP → c-diGMP+ 2 PPi (1.1)
Two guanosine 5’-triphosphate (GTP) substrate molecules are converted
by DGC in a condensation reaction to form a c-diGMP molecule and two
pyrophosphates (PPi). The ribosyl 3’-hydroxyl group is first deprotonated
to allow for a nucleophilic attack on the α-phosphate of the second GTP
molecule. A 3’→5’-phosphodiester bond is formed, and β- and γ-phosphates
subsequently leave as pyrophosphate. The c-diGMP synthesis requires mu-
tual attack of the two GTP molecules to give a cyclic di-nucleotide plus two
pyrophosphates.
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Figure 1.3: c-diGMP synthesis. The letter ‘G’ denotes guanine. A, Deprotonation of
the ribosyl 3’ hydroxyl groups of the two GTP substrate molecules. B, Mutual attack of
the α-phosphates from the ribosy’ 3’ oxygens. C, c-diGMP and two pyrophosphates (not
shown) as products.
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High abundance of DGC domain in bacteria yet
lack of structural information
DGC activity was recently ascribed to a domain family hitherto known as
‘GGDEF’ or ‘DUF1’ domain [45]. The annotation of ‘GGDEF’ and ‘DUF1’
was used because this domain family possesses a very conserved GG(D/E)EF
sequence motif and was one of the ‘domains of unknown function’ at the time
of domain classification. Now that it is proven to confer diguanylate cyclase
activity, we have decided to renew the annotation to ‘DGC domain’, and I
will use this for the rest of this report.
The general importance of the DGC domain is marked by its abundance
in the bacterial genomes. A search for DGC in the the SMART domain
database [37] showed 1152 hits in September 2004. As shown in Figure 1.4,
DGC is mostly found in bacteria and occurs in various combinations with
other sensory and/or regulatory modules [18, 19].
Despite the wide distribution and obvious regulatory relevance of DGC
domains, in vitro functional characterisation of this domain family was only
recently carried out [45]. No structural information about this domain family
was available, although it was predicted to be homologous to the adenylate
cyclase (AC) catalytic domain [61] and the DNA polymerase I (DNAP) palm
domain [13] in a threading study [46]. Interestingly, both AC and DNAP I
catalyse a very similar chemical reaction as the DGC domain, as the reaction
involves a nucleophilic attack from a ribosyl 3’ oxygen to a 5’ phosphate on
a nucleoside triphosphate [62]. However, unlike the intermolecular attack in
the DGC catalysis, the attack carried out in the AC reaction is intramolec-
ular, so that the product is a cyclic mono-nucleotide. This is different in the
DNAP reaction in which an intermolecular attack is involved in extending
the replicating DNA strand with a incoming nucleotide.
PleD from C. crescentus as a model for DGC study
We were interested in understanding the catalytic mechanism of the DGC
domain. Unravelling the structure of this significant signalling domain would
yield information at the molecular level. We have chosen the signalling pro-
tein PleD from Caulobacter crescentus, which has a DGC domain, as a model
system. The asymmetric cell cycle of C. crescentus involves a cell differen-
tiation step in which the motile, flagellum-containing swarmer cell loses its
flagellum, before a stalk can be produced at the same cell pole to allow the
cell to transform into a stalked cell. The transition of the swarmer cell to
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Figure 1.4: A non-exhaustive list of DGC domain containing proteins shown in terms of their
domain architecture. The domain symbols were taken from the SMART database, i.e. DGC
domain is denoted DUF1 domain. The identity of the protein is listed on the right of the protein
representation. PleD from Caulobacter crescentus is labelled CC2462 and consists of two REC
(CheY homologous receiver) domains and a C-terminal DGC / DUF1 domain. Domain abbrevia-
tions include: CACHE, Ca2+ channels and chemotaxis receptors; CBS, Cystathionine β-synthase,
prototype for a family of repeats; CHASE, cyclases/histidine kinases associated sensory extracel-
lular; cNMP, cNMP binding domain; DUF2 (EAL), presumable cyclic diguanylate phosphodi-
esterases; FHA, Forkhead-associated domain; GAF, cGMP-specific and -stimulated phosphodi-
esterases/ adenylate cyclases (Anabaena)/ FhlA (E. coli); HAMP, Histidine kinases, adenylyl
cyclases, methyl-accepting proteins, phosphatases; HD-GYP, metal-dependent phosphohydrolase;
Hemerythrin, oxygen binding protein; MASE, membrane associated sensor (MASE1 and MASE2);
MHYT, integral membrane sensor domain; PAC, PAS C-terminal motif; PAS, Drosophila period
clock, aryl hydrocarbon receptor, and single-minded proteins; PBPb, high affinity periplasmic
solute-binding protein of ABC-type amino acid transport system; Pfam, protein family (Pfam
database of alignments and HMMs, http : //www.sanger.ac.uk/Software/Pfam/); Rec, re-
ceiver domain of response regulators; SPBbac3, bacterial extracellular solute-binding proteins,
family 3; TRP, tetratricopeptide repeat, involved in proteinprotein interaction. The blue vertical
bars symbolise membrane-spanning domains. This figure is adapted from [26].
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the stalked cell is regulated by PleD as proved by the observed supermotility
of the swarmer cell and the inability of the cell to grow proper stalk in a
pleD− mutant [1, 23].
swarmer
cell
stalked
cell
flagellum stalk
PleD-PPleC
DivJ
PleD
Figure 1.5: PleD temporally and spatially controls the cell differentiation from swarmer
cell to stalked cell in the cell cycle of C. crescentus. PleD is in coloured in light blue
and is distributed throughout the cell. Phosphorylated PleD is coloured in blue and is
localised to the stalk pole. Its cognate histidine kinase DivJ is coloured in yellow, and its
phosphatase PleC in pink.
Unphosphorylated PleD is inactive and widely distributed over the cell.
Upon phosphorylation by its sensor histidine kinase partner DivJ, it becomes
activated, sequesters to the differentiating pole of the cell and catalyses the
conversion of two GTP molecules to c-diGMP [45]. Thus, PleD activity is
temporally and spatially controlled through the coupling of activity and its
cellular localisation.
PleD belongs to the two-component signal trans-
duction pathway
PleD belongs to the two-component signal transduction pathway prevalently
used in bacteria [50]. In a typical two-component system, information is
transferred from the first component, a histidine kinase, to a second compo-
nent, a response regulator, through a phosphoryl group (Figure 1.6). Upon
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receiving an input signal at the N-terminal sensory domain, the C-terminal
kinase domain of histidine kinase autophosphorylates on a conserved histi-
dine. The response regulator catalyses the transfer of this phosphoryl group
to a conserved aspartate on its N-terminal receiver domain, which subse-
quently leads to an output signal from its C-terminal effector domain.
Sensory Kinase Receiver Effector
P
H D
ATP
ADPInput signal Output responseP
Histidine kinase Response regulator
Figure 1.6: Typical domains utilised in phosphotransfer in the two-component signal
transduction pathway. This involves the transfer of a phosphoryl group (circled ‘P’) from
a conserved histidine (circled ‘H’) in the kinase domain to a conserved aspartate (circled
‘D’ in the receiver domain in the response regulator.)
PleD is an unorthodox response regulator
The response regulators constitute a large protein family. They typically
contain a conserved CheY-like receiver domain [35, 58] and a DNA-binding
effector domain that functions as a transcription factor [4, 41, 51]. All struc-
turally characterised receiver domains share the structural features of the
chemotaxis protein, CheY, from E. coli that comprises a doubly-wound,
five-stranded parallel sheet structure (Figure 1.8). PleD is an unorthodox
response regulator in that it consists of three domains instead of two (Figure
1.7). The N-terminal domain D1 is CheY-like and carries the phosphoac-
cepting aspartate D53. The middle domain D2 is also CheY-like but it lacks
the phosphoacceptor aspartate. The C-terminal effector domain is the do-
main of interest, DGC. Apart from the methylesterase CheB structure [12],
PleD represents the second structure of a multidomain response regulator
with proven enzymatic activity.
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D1 DGC
D53
D2
GGEEF
1 454
Receiver 2Receiver 1 Effector
Figure 1.7: Unusual domain arrangement in the multidomain protein PleD. It consists
of two receiver domains named D1 and D2, and an effector domain which catalyses c-
diGMP formation. The D1 domain carries the phosphoaccepting aspartate D53. The
DGC domain carries the conserved sequence motif GGEEF. The starting and the finishing
residue numbers are marked.
Figure 1.8: Typical response regulator receiver domains adopt the (β/α)5 fold as the
CheY protein (PDB code 2CHE [59]). Secondary structures are labelled. All helices are
annotated as α and all strands as β in this study.
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Communication between receiver and effector do-
mains is not well understood
In response regulators, the conformational changes invoked by phosphory-
lation of the receiver domain have been thoroughly studied on the single-
domain CheY protein [35] and other receiver domains like FixJN [4], N-
Spo0A [38] and NtrCr [29]. A common mechanism seems to be employed
to propagate structural changes from the phosphorylation site to a large
surface covering mainly the C-terminal portion of the domain, involving he-
lices α3, α4 and α5, and β-strands β4 and β5. Interestingly, subsets of
this surface in different response regulators are identified to be involved in
protein-protein or domain-domain interactions, some of which might help
regulate the function of the effector domain.
For example, the α4-β5-α5 surface represents the interaction surface be-
tween activated CheY and the N-terminal peptide of its effector protein
FliM [36]. The same surface represents the dimerisation interface in the
phosphorylated FixJN [4]. As for the few known structures of intact mul-
tidomain response regulators, subsets of the α4-β5-α5 surface provides the
domain interface in CheB [12], DrrB [51] and in NarL [2]. In unphospho-
rylated CheB, this α4-β5-α5 surface obstructs the methylesterase catalytic
triad in the effector domain, and thus, suggests an activation mechanism by
the relief of active site obstruction [12]. It is, however, less clear in DrrB
how this surface might be related to a possible dimerisation mechanism of
the C-terminal DNA-binding domain as suggested by the complex structure
of a dimeric PhoB effector domain bound with its target DNA [5]. In NarL,
the receiver domain uses this surface to block the DNA recognition helix
of the effector domain [2], hence preventing it from binding to the target
DNA. Phosphorylation of its receiver domain leads to the disruption of this
domain interface [17] in a comparative study using NMR. This is to allow
the C-terminal effector domain to dimerise to bind to the target DNA [41].
Despite the distinct mechanisms that have been proposed to activate
some of the response regulators, molecular details that describe such mech-
anisms are missing. There is a need for structures of a multidomain response
regulator in both its active and inactive forms.
Objectives of this project
Based on our interest in the role of DGC domain on the regulation of c-
diGMP signalling, we asked the following questions:
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• What is the structure of DGC?
• What is the catalytic mechanism of DGC?
• How does the domain architecture in PleD help in translating a phos-
phorylation signal into a DGC response?
The main aim of this project was to address these questions by determin-
ing the 3-D structure of the DGC domain or the intact response regulator
PleD using X-ray crystallography. The method of X-ray crystallography has
been chosen due to its strength in dealing with medium-size proteins like
PleD (predicted MW of about 50 kDa) or larger complexes, which are oth-
erwise too big for nuclear magnetic resonance, a method that is generally
limited to proteins under 30 kDa. To this end, the prerequisite was to obtain
a PleD or DGC domain construct that can be over-expressed, purified to
high purity while being soluble and stable in solution, and is amenable to
crystallisation to give diffraction-quality crystals. Previous constructs made
in the laboratory of our collaborators suffered from poor expression and high
aggregation. I have, therefore, set the following objectives:
• Design PleD constructs that enable studies on both the full-length
protein and the DGC domain.
• Screen PleD constructs for their level of expression and solubility.
• Establish the purification procedures to obtain PleD/DGC of high
purity for characterisation studies and crystallisation.
• Characterise PleD constructs to obtain physicochemical information
on PleD that might provide clues useful for crystallisation.
• Carry out limited proteolysis study on the full-length PleD constructs
to define the domain boundaries, which might be useful for designing
new constructs for certain domains.
• Screen for optimal crystallisation conditions to obtain well diffracting
crystals of PleD / DGC.
• Solve the structure using X-ray crystallography.
Many of these objectives were met at the end of the project. The high-
light is our structure of the full-length PleD in complex with its enzymatic
product c-diGMP. The complex structure provides detailed information on
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the product-enzyme interactions, hence offering insight into the catalytic
mechanism of DGC. The full-length structure of the multidomain protein
sheds light on the mechanism of activation and product inhibition of PleD.
Detailed information regarding the structure is described in our manuscript
(attached at the end of this report) which has been accepted by the Pro-
ceedings of the National Academy of Sciences, USA.
This report details my attempts in meeting the objectives and evaluates
which objectives were achieved. I have divided the chapter of ‘Results’ into
three sections. In the section of ‘Selection of PleD constructs’, I will describe
the basis of the design of constructs, their selection basing on their expres-
sion level and solubility, the development of the purification procedures and
some characterisation of the constructs. The second section of ‘Structural
determination of PleD by X-ray crystallography’ focusses on crystallisation
screens of the constructs, procedures involved in structural elucidation, and
analysis of crystal packing. The final section of ‘Structural analysis’ pro-
vides structural information about the complex structure of the full-length
PleD. I will explain in the chapter of ‘Discussion’ our model of the activa-
tion mechanism of PleD and the allosteric inhibition of the enzyme by its
product.
Chapter 2
Materials and Methods
Bioinformatics analysis
Analysis of the primary protein sequences, including pI, molecular weight,
extinction coefficient calculations / predictions, were carried out using the
Proteomics and Sequence Analysis Tools at the ExPASy Proteomics Server
[20]. The secondary structure of PleD was predicted using the PredictPro-
tein Server, also from ExPASy. Analysis of the domain arrangement in PleD
was carried out using SMART [37] and InterPro linked to ExPASy.
The protein sequences of PleD homologues were searched using the EM-
Bnet server (www.ch.embnet.org). Multiple sequence alignment was carried
out using the default settings in ClustalW [63] and the results were presented
using ESPript [22].
The overall and residue-by-residue geometry of the PleD structure was
analysed using the programme PROCHECK [32].
Subcloning
Full length hexahistidine fusions of wildtype pleD were subcloned using the
plasmid pRP45 [45], which bears a silent G489T mutation in the pleD gene
it carries, as template. Full length hexahistidine fusions of pleD* [45] were
subcloned using the plasmid pRP60 [45] as template. Truncated His6 fusions
were subcloned from the full length constructs.
DNA encoding PleD (TrEMBL code: Q9A5I5) was amplified by PCR
using the plasmid pRP45 as template with PleD specific primers containing
an NdeI restriction site at the 5’ end and an EcoRI restriction site at the
3’ end. Hexahistidine codons were inserted in the PCR primer after the
13
14 CHAPTER 2. MATERIALS AND METHODS
NdeI restriction site for the production of an N-terminal hexahistidine fu-
sion, or before the EcoRI restriction site for the production of a C-terminal
hexahistine fusion. The PCR fragments were digested with NdeI and EcoRI
and subcloned independently into NdeI-EcoRI cut pRUN expression vectors
that were derived from the pBR322 vector. The hexahistidine fusion pro-
teins were overexpressed in the Escherichia coli strain BL21 (DE3) pLysS.
Overexpression
Cell cultures were grown in LB medium with the addition of 0.1 mg / mL
ampicillin at 30 ◦C until they reached an OD600 of 0.5. They were induced
with 0.4 mM IPTG and were left to grow for a further three hours. The
cells were then harvested and washed in 1/25 culture volume of TNCP pH
8.0 buffer (20 mM TrisHCl, pH 8.0, 500 mM NaCl, ‘Complete’, EDTA-free
protease inhibitor cocktail tablet used according to manufacturer’s instruc-
tion (Roche Diagnostics AG, Rotkreuz, Switzerland), 0.01 % phenylmethyl-
sulphonyl fluoride (PMSF)) before finally resuspended in the same amount of
the same buffer. The cell resuspension was immediately frozen for overnight
storage at -80 ◦C.
Purification
Cells were thawed in a water bath and lysed using a small probe sonicator
(Misonix Inc, New York, USA) with pulses for 6 x 30 sec at 50 % output.
The cell lysate was clarified by centrifugation in a TFT 70.38 rotor at
50 000 rpm at 4 ◦C for 30 min (Kontron Instruments, Switzerland). The su-
pernatant was then loaded onto a HiTrap chelating HP column (Amersham
Biosciences, Freiburg, Germany) charged with 0.1 mM NiSO4C and pre-
equilibrated with TNMI pH 8.0 buffer (20 mM TrisHCl, pH 8.0, 500 mM
NaCl, 5 mM β-mercaptoethanol, 50 mM imidazole). PleD was eluted on
the A˚KTA Purifier at approximately 200 mM imidazole using an gradient
of 50-500 mM. The fractions referring to the 200 mM elution were pooled
and dialysed against TND pH 8.0 buffer (20 mM TrisHCl, pH 8.0, 100 mM
NaCl, 1 mM DTT) using Spectra-Por 7 dialysis membrane of cut-off 25
kDa at 4 ◦C overnight. The protein solution was concentrated to no more
than 40 mg/ mL using an Amicon Ultra device with a cut-off of 10 kDa
(Millipore AG, Volketswil, Switzerland). After clarification in a Beckman
TLA 100.2 rotor (Beckman Coulter GmbH, Krefeld, Germany) at 50 000
rpm for 15 min, the sample was loaded on a Superdex 200 HR 10/30 gel
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filtration column (Amersham Biosciences Europe, Freiburg, Germany) pre-
equilibrated with the same buffer. PleD appeared as monomer and fractions
contributing to this peak were pooled. The protein was concentrated in the
same way as before for crystallisation.
Selenomethionine-substituted protein preparation
Selenomethionine-substituted PleD was expressed using the metabolic inhi-
bition pathway as described previously [14]. Briefly, cell culture was grown
in M9 medium with the addition of 0.1 mg / mL ampicillin at 30 ◦C.
At 15 minutes before the OD600 reached 0.5, amino acid supplements
were added to the culture which included: L-Lysine, L-Phenylalanine and
L-Threonine to 100 mg / mL, L-isoleucine, L-Leucine, L-Valine and L-
Selenomethionine to 50 mg / mL. The cells were allowed to grow for 15
min before induction as for the native material. The purification procedures
were the same as for native PleD.
Protein concentration determination
Based on the Beer-Lambert relation [15], the concentration of purified PleD
and its co-purified c-diGMP molecules were calculated from the UV absorp-
tion measurements at 280 and 253 nm using the equations 3.4 and cp. The
derivation of the equations is explained on page 31.
Polyacrylamide gel electrophoresis and Western blot
SDS-PAGE on 12-20 % gradient gels was performed according to the method
of Laemmli [31]. Protein bands were visualised with Coomassie Brilliant
Blue staining and the molecular weights they referred to were compared
to the LMW-SDS Marker (Amersham Biosciences, Freiburg, Germany).
Native-PAGE was performed on 12-20 % gradient gels using the same buffer
as for SDS-PAGE but omitting SDS and β-mercaptoethanol.
For western blot analysis, protein samples were electroblotted onto nitro-
cellulose membranes (BA85, Schleicher & Schuell, Dassel, Germany) using
the Bio-Rad Mini-PROTEAN 2 Electrophoresis / Mini Trans-Blot Mod-
ule. The immunoanalysis was carried out according to the manufacturer’s
protocol of ECL Western Blotting Analysis System (Amersham Biosciences,
Freiburg, Germany). Briefly, non-specific binding sites on the blotting mem-
brane were blocked with Tris-buffered saline (TBS) (20 mM Tris-HCl pH7.6,
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137 mM NaCl) containing 5 % skimmed milk powder and 0.1 % Tween. The
blot was washed twice for 10 min in TBS-Tween before incubating in TBS
containing the primary antibody, monoclonal anti-polyHistidine antibody in
mouse (Sigma Chemie, Buchs, Switzerland), at 1:3000 dilution for 1 hour
at room temp. The blot was washed twice in TBS-Tween, each time for 10
min, and then incubated in TBS containing the secondary antibody, anti-
mouse IgG (Fc specific) peroxidase conjugate (Sigma), at 1:5000 dilution.
The blot was twice washed as before and incubated in ECL Western Blotting
Detection Reagents (Amersham Biosciences, Freiburg, Germany) mixed at
the ratio of 1:1 for 1 min. The blot was subsequently exposed on Kodak
X-OMAT XAR-5 radiography film for 15 s to 15 min until protein bands
appeared.
Limited proteolysis by trypsin
Purified CF at 5 mg/ mL in the storage buffer was proteolysed by trypsin
at the w/w ratio of 5000:1 on ice. Aliquots of 22 μL were removed from the
reaction mixture at 10, 30, 60 and 90 min and added to 2.4 μL 1 % PMSF
(final concentration 0.1 %) to stop the reaction. The stopped reaction mix-
tures were then subjected to SDS-PAGE and Western blot analysis aganist
the His-tag.
Mass spectrometry
Liquid chromatography (LC) / Mass spectrometric (MS) analysis of the CF
protein and its digests were carried out on 100 mm i.d. capillary columns
packed with C18 material (5 mm particle size, MONITOR, Column Engi-
neering, Ontario, USA). Bound peptides were eluted with a linear 30 min
gradient from 0.05 % TFA to 60 % acetonitrile containing 0.05 % TFA at
a flow rate of 1.5 ml / min into a micro ion source of a TSQ7000 instru-
ment (Thermo Finnigan, San Jose, USA). A voltage of 1300 V was applied
to initiate spraying. The instrument was scanned between 200 to 2000 Da
m/z in 3 s at unit resolution. All mass spectrometric measurements were
performed by the group of Dr Paul Jenoe, Biozentrum, Basel.
Mass fingerprinting
Trypsinsed fragments of CF were separated using SDS-PAGE. Fragments in
gel representing proteolysis intermediates were further trypsinised. Trypsinised
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fragments belonging to each intermediate were subsequently subjected to
matrix-assisted laser desorption ionisation-time of flight (MALDI-TOF) mass
spectrometric analysis. MALDI-TOF mass spectra were acquired on a
Bruker Reflex III instrument (Bruker Daltonik, Bremen, Germany). Pep-
tides were analysed either in linear or in reflector mode by using a-cyano-
4-hydroxycinnamic acid (1 mg / ml in 80 % acetonitrile / 0.1% TFA) as
matrix. Samples were prepared by mixing 1 ml peptide solution with 1
ml matrix solution and 300 nl were deposited onto anchor spots of a Scout
400 mm / 36 sample support (Bruker Daltonic, Bremen, Germany). The
droplet was left to dry at room temperature. The instrument was cali-
brated with angiotensin II, substance P, bombesin, and ACTH-18-39. For
each proteolysis intermediate, the molecular weights of the ejected species
were measured and searched in the sequence library of the theoretically
trypsinised CF using the programme MASCOT [47]. These fragments were
used to map the boundary of the proteolysis intermediate in the protein.
The mass fingerprinting analysis was carried out by the group of Dr Paul
Jenoe, Biozentrum, Basel.
N-terminal peptide sequencing
For protein identification with N-terminal sequencing , protein samples were
blotted from SDS-PAGE onto polyvinylidene difluoride membranes. Bands
corresponding to the protein of interest were cut and sent to Analytical
Research and Services, University of Bern, for N-terminal sequencing.
Absorption spectroscopy
Protein concentrations were determined with absorption spectroscopy at
280 nm. The extinction coefficients  of the constructs were calculated from
the amino acid sequence [21] and listed in Table 3.1. The extinction coeffi-
cient of c-diGMP was experimentally determined to be 16 000 M−1 at 254
nm by Dietrich Samoray, Biozentrum, University of Basel.
Isoelectric focussing
Isoelectric focussing (IEF) of CF was performed during the EMBO PEPC
workshop, EMBL Hamburg, 2002. A Bio-Rad mini, pre-cast IEF gel of the
pH range 3-10 was run using the Bio-Rad Mini-PROTEAN 2 system.
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Circular dichroism
Circular dichroism (CD) measurements were carried out using a Cary 61
spectropolarimeter equipped with a thermostatted quartz cell (Hellma, Muell-
heim, Germany). Spectra were recorded at 20 ◦C in a quartz cell with a path
length of 1 mm with 400 μL protein of 0.1 mg / mL in 20 mM NaPi, pH 8.0,
100 mM NaCl. Scans were recorded over the range of 200-259 nm at the
rate of 0.15 nm / s.
For the thermal stability experiment, CD was measured at the fixed
wavelength of 221 nm while changing the temperature at the rate of 1 ◦C /
min using a water bath (Lauda RC3) together with a temperature program-
mer. The temperature was raised from 4 to 90 ◦C and lowered to 4 ◦C. The
dead time of the cell was 5 s.
Analytical ultracentrifugation
Analytical ultracentrifugation analysis was performed on NF and CF sam-
ples in the protein storage buffer. Sedimentation velocity (SV) and sedimen-
tation equilibrium (SE) runs were carried out in a Beckman XLA analytical
ultracentrifuge equipped with absorption optics. The SV runs were per-
formed at 54 000 rpm at 20 ◦C using a 12 mm double sector cell. The SE
runs were performed at 12 000 and 18 000 rpm at at 20 ◦C. The SE results
were analysed using a floating baseline computer programme that adjusts
the baseline absorbance to obtain ln A versus r2, where A is the absorbance
and r the radial distance. A specific volume of 0.73 cm3 g−1 and a solution
density of ρ=1.003 g cm−3 was assumed. All analytical ultracentrifuga-
tion experiments were performed by Ariel Lustig, Biozentrum, University of
Basel.
Dynamic light scattering
Dynamic light scattering of CF was performed using a Protein Solutions
device in the EMBO PEPC workshop, EMBL Hamburg, 2002. Measurement
of 50 μL of CF at 1 mg / mL sample in the storage buffer was recorded.
Chemical synthesis of c-diGMP
c-diGMP was chemically synthesised by Dr Nicolas C. Amiot, Department
of Organic Chemistry, Basel, according to the procedures described by Ross
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and co-workers [53]. c-di-GMP was purified by semi-preparative reversed
phase HPLC on a Merck LiChrospher 100 RP18 endcapped (10 μm) column
(Merck KgaA, Darmstadt, Germany) at 37 ◦C. 0.1 M triethyl ammonium
carbonate buffer (TEAC) pH 7.0 containing 7.5 % methanol (isocratic con-
ditions) was used as mobile phase at a flow rate of 7.5 mL / min. The
separation was achieved on an HP1050 Series and detected at 252 nm.
Reversed phase high pressure liquid chromatrogra-
phy
Purified CF samples were analysed using 80 μL aliquots loaded onto a Merck
LiChrospher 100 RP18 endcapped (5 μm) HPLC column at 37 ◦C. 0.1 M
TEAC pH 7.0 containing 7.5 % methanol (isocratic conditions) was used as
mobile phase at 1 mL / min on a Waters Alliance 2690 Separative Module.
A Waters 2487 ultraviolet detector was used at 252 nm as detection device
(Waters AG, Rupperswil, Switzerland).
Crystallisation
Crystals were obtained at room temperature by vapour diffusion using the
hanging drop method. PleD at a nominal concentration of 200 μM (assuming
an 280 of 9200 M−1cm−1 equivalent to 10 mg/mL ) in 20 mM Tris-HCl pH
8.0, 100 mM NaCl, 1 mM DTT, 2 mM MgCl2 and 0.8 mM c-diGMP was
mixed with the reservoir (1.0 M glycine pH 9.2, 2 % dioxane and 14.5 %
polyethylene glycol 20 000 (PEG 20 k)) at a ratio of 1:1. SeMet-substituted
crystals were obtained in the same manner, but using a reservoir solution
containing 1.0 M TAPS pH 9.0, 2 % dioxane and 11 % PEG 20 k.
For the native protein crystallisation, clover-leaf like crystals obtained
by direct vapour diffusion were crushed on the drop. They were picked up
as seeds by streaking with piece of hair and were seeded into a clear drop
that was already equilibrated.
Data collection
Cryoprotectants contained the mother liquor with an additional 2-5 % PEG
20 k and 5-15 % ethylene glycol. The crystal was soaked successively in cry-
oprotectants containing 5 %, 10 % and 15 % ethylene glycol. Each soaking
20 CHAPTER 2. MATERIALS AND METHODS
lasted for 5-10 s. After the last soaking the crystal was flash frozen in liquid
nitrogen.
Diffraction data were collected from a single native crystal (about 0.015
mm in diameter) and a single SeMet-substituted crystal (0.060 mm) at the
beamline X06SA (PX) at Swiss Light Source, Villigen, Switzerland using
cryo-conditions. Before collecting data on the native crystal, the crystal
was allowed to anneal by blocking the liquid nitrogen stream for 3 s.
Structural elucidation
Diffraction data were processed with MOSFLM/SCALA [44]. 18 selenium
positions were identified using SHELXD [55]. Phase refinement was per-
formed by SHARP/SOLOMON [11] and was followed by two-fold averaging
and phase extension using DM [8]. The model was built using interactive
graphics in the programme ‘O’ and refined by using REFMAC5 [44] imposing
strict non-crystallographic symmetry (NCS) constraints for the two copies
in the asymmetric unit except residues 117, 164, 168, and 404. The en-
tire mainchain was defined by final electron density except residues 137-146,
282-288, and the C-terminal His-tag. The scheme of structural elucidation
is summarised in Figure 3.18. The structure was elucidated under the close
supervision by Prof Tilman Schirmer, Biozentrum, University of Basel.
Chapter 3
Results
Design of PleD constructs
Recombinant method
For the study of the bacterial PleD protein and its DGC domain, we have
applied the recombinant method. Recombinant method allows tailoring of
the protein according to the researcher’s desire and is, thus, well suited for
the study of domains. It offers the possibility of attaching purification tags
to the protein which facilitates the purification procedures. Hexahistidine-
tag (His-tag) was chosen for easy affinity chromatography [24]. Compared
to other affinity tags like glutathione-S-transferase which is a protein on
its own, the small size of a hexahistidine tag, which consists of only six
amino acids, does not interfere with function and crystallisation ability of
many recombinant proteins, and hence, might shorten the protein prepara-
tion procedures of having to cleave the tag. In our study, two His-tagged
constructs were made for each protein sequence of interest, one of them was
tagged at the N-terminus and the other at the C-terminus.
Another advantage of using recombinant proteins is that their production
can be boosted by the use of an efficient expression system, which is normally
a better alternative to protein extraction from the native source, if the goal
is to produce proteins in a large quantity to meet the need of crystallisation.
In the case of bacterial PleD, the expression system of choice was E .coli .
PleD constructs
All constructs produced in this study are summarised in Table 3.1. They
were divided into three categories: constructs covering the full-length PleD,
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the DGC domain, and D2-DGC domains. The nomenclature of these con-
structs are as follows. They were annotated as Nx or Cx, where ‘N’ anno-
tated N-terminal His-tagged fusion and C annotated C-terminal His-tagged
fusion. The ‘x’ represents the type of protein sequence–‘F’ represents the
full-length protein, and a number signifies the starting amino acid position
of that construct. For example, the construct N137 refers to the N-terminal
His-tagged domain construct starting at residue 137 and finishing at the last
residue 454.
Table 3.1: A summary of the physical properties of the various full-length and do-
main constructs of PleD. MW refers to the theoretic molecular weight calculated us-
ing PeptideMass at the ExPASy Proteomics Server [20] whereas  refers to the theoreti-
cal extinction coefficient at 280 nm calculated using the Peptide Property Calculator at
www.basic.nwu.edu/biotools/proteincalc.html.
Category Construct His6-tag Residue range No of aa MW (Da) pI 
Full-length wt PleD - 1-454 454 49593.04 5.68 9200
NF N
CF C
1-454 460 50415.39 6.04 9200
PleD* - 1-454 454 49607.05 5.87 10480
NF* N
CF* C
1-454 460 50429.40 6.18 10480
DGC N287 N
C287 C
287-454 175 19021.77 6.18 3960
N319 N
C319 C
319-454 143 15526.93 5.95 2680
D2-DGC N137 N
C137 C
137-454 325 35538.60 6.65 6520
N150 N
C150 C
150-454 312 34215.83 6.19 6520
N153 N
C153 C
153-454 309 33930.70 6.32 6520
Full-length constructs
The first category belongs to the full-length PleD, which includes the wild-
type and the constitutively active mutant PleD* [45]. The wild-type PleD
sequence has the Q9A5I5 entry in the SwissProt/TrEMBL database [6].
The constitutively active mutant PleD* contains the following mutations–
T120N, T214A, E220A, P234H and N357Y. It leads to elongated stalks [1],
has a dominant negative effect on motility of the cell, and localises to the cell
pole in the absence of its kinase DivJ and phosphatase PleC [45]. It shows
a higher DGC activity than the wild-type regardless of the disruption of
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the phosphorylation site at D53 in the PleD*D53N mutant, thereby proving
that PleD* mimicks the activated state of the wild-type PleD. Nevertheless,
initial investigation on PleD* showed that it suffered from very poor expres-
sion and high aggregation in solution, and was, therefore, shelved. In this
report, I only focus on wild-type PleD.
DGC constructs
The second category belongs to DGC constructs which include the N237 / C237
and N319 / C319 constructs. The N319 / C319 constructs were designed
based on sequence alignment and threading experiments by Pei and Grishin
[46]. They observed a weak structural homology between the GGDEF-motif
containing sequences and the adenylate cyclase (AC) catalytic domain after
an extensive iterative search in the protein sequence database. From the
result of a multiple sequence alignment they concluded that GGDEF-motif
containing sequences share the same fold as AC catalytic domain. Accord-
ingly, the DGC domain of PleD would start at residue 319.
Beside the N319 / C319 constructs, we have designed other DGC con-
structs starting from residue 287 with the following considerations. The
integrated domain database InterPro assigned the domain arrangement of
‘response regulator receiver’–’response regulator receiver’–’GGDEF’ to PleD
(’GGDEF’ domain is equivalent to ‘DGC’ domain as explained before). The
prediction of the domain boundaries was as follows: The first response regu-
lator receiver (RRR) domain ranges from residue 1 to residue 120 or 130; the
second RRR domain ranges from residue 160 to residue 280 or 290; the DGC
domain ranges from residue 280, 290 or 330 to residue 454. The prediction
of the DGC domain was particularly unclear.
A search using the programme METAMOTIF from the EMBnet server
(www.ch.embnet.org) for protein sequences with the arrangement of two
‘RRR’ domains and a ‘DGC’ domain resulted in seven hits. As the structure
of CheY was known, we wanted to use the CheY sequence as a ruler to phase
the RRR and the DGC domains. Considering CheY proteins contain around
120 residues, we arbitrarily assigned residues 1- 150 in each homologous
sequence as the first putative RRR domain and residues 130-300 as the
second putative RRR domain. Four of these putative RRR sequences were
randomly selected and then multiply aligned (Figure 3.1).
It was found that the second putative RRR sequences could be aligned
with the first RRR sequences starting from residue 150. This suggested
the second RRR domain started at around residue 150. The second finding
was that the C-terminal helix of CheY could be mapped to a helix pre-
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sp|Q8FGP6|CHEY_ECOL6
1 10 20 30
1 sp|Q8FGP6|CHEY_ECOL6 L LVVDD V V DG................................ADKELKF FSTMRRI RNL KELGFNN EEAE
2 tr_Q9A5I5 RRR 1 L LI VVDD N L V DG..................................MSAR IEA VRL EAK TAEYY.E STAM
tr_Q9ZDT8 RRR 1 L LI VVDD N L V G..................................MTT. IET IKL TAK LKEYY.T LTANS
tr_Q92QM5 RRR 1 L LI VVDD N L V DG..................................MTAR VPA VKL EAR VAEYF.D LTAG
tr_Q9X575 RRR 1 L LI VVDD N L V DG..................................MTAR IPA VKL EAR LAEYF.D MTAA
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Figure 3.1: Prediction of DGC domain boundary in PleD by multiple sequence alignment
and secondary structure prediction. CheY from E .coli (sequence group 1) was aligned with the
CheY-like domains of PleD (SwissProt/TrEMBL: Q9A5I5) and other PleD homologues (Swis-
sProt/TrEMBL: Q9ZDT8, Q92QM5, Q9X575). The sequences aligned fall into three groups:
group 1, CheY; group 2, the first putative RRR domain, or RRR 1, of the PleD and PleD
homologous sequences; and group 3, the second putative RRR domain, RRR 2. The num-
bering of the sequence and the secondary structures shown at the top of the alignment are
from the CheY protein (PDB accession code 1DJM). Secondary structures predicted for PleD
are shown in the background of the PleD sequence: yellow for helix and green for β-strand
(http://cubic.bioc.columbia.edu/predictprotein/). The strictly conserved residues are in red back-
ground and the conserved residues are in red letters. The phosphoacceptor D56 is annotated with
a red arrow and the acidic cluster, including M59 whose mainchain amide is used for phosphory-
lation, is annotated with a black arrow at the bottom of the alignment. The figure was produced
by ESPript [22].
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dicted in PredictProtein (http://cubic.bioc.columbia.edu/predictprotein/),
ranging from residues 274 to 280 in the PleD sequence. We concluded that
D2 domain would finish at residue 280 and that DGC domain would start
at the next predicted secondary structure, which was a β-strand at residue
289. There were two polar residues, D282 and E287, in the putative D2-DGC
domain linker. We designed the DGC constructs to start at E287.
D2-DGC constructs
The third category belongs to the D2-DGC constructs. Characterisation of
the full-length PleD protein using limited proteolysis found two fragments
that were resistant to proteolysis. The combination of mass fingerprinting
and N-terminal sequencing identified the two fragments to be the D1 domain
and a C-terminal fragment starting at residue 156 and thus comprising the
D2 and DGC domains. The linker connecting these two experimentally
defined domains ranged from residue 130 to 156. We designed constructs
that started at the polar residues E137 and D150 and the flexible glycine
G153 on this linker for an experimental screen on expression and solubility.
More details about the design of these constructs follow in the next section.
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Overexpression, purification and characterisation of
PleD
Expression and solubility test of full-length PleD
A trial was carried out to test the expression level and the soluble yield of
the full-length NF and CF constructs as a function of growth temperature,
time of induction and duration of expression. The bacteria were grown at
30 ◦C and 37 ◦C, induced at an optical density at 600 nm (OD600) of 0.4, 0.7
and 1.0 for 1, 2, 3 and 4 hours. The cells were lysed and pelleted to estimate
the amount of inclusion bodies and the yield of the soluble fraction.
Higher growth temperature, induction at higher OD, and longer expres-
sion time led to more protein going into inclusion bodies. NF and CF were
found to give the best soluble yield when grown at 30 ◦C and induced at
OD600 of 0.5 for 3 hr.
Purification of full-length PleD
NF and CF were purified in two chromatography steps using nickel affinity
chromatography and gel filtration. The supernatant of cell lysate was first
purified on a nickel affinity column. For CF purification, the protein was
eluted with an imidazole gradient from 50 to 500 mM. Two elution peaks
were observed. Peak A was eluted with 120 mM imidazole and appeared to
be 80 % pure by estimation from the SDS gel (Figure 3.2A). Peak B was
eluted at an imidazole concentration of 250 mM and was smaller and less
pure as seen from the contaminants of various sizes shown on the SDS gel.
This peak also had a tendency to aggregate during the subsequent overnight
dialysis process.
In the second chromatography step of gel filtration, both elution peaks
were run individually on a Superdex 200 gel filtration column. This column
has a fractionation range from 10 to 600 kDa, and is thus, well suited for
resolving full-length PleD which has a calculated monomeric MW of 49.6
kDa. For the run of Peak A from the nickel affinity column, two peaks were
eluted. The first peak was eluted at the void volume and showed a major
band of CF with contaminants, suggesting this peak was due to protein
aggregates (Figure 3.2B). The second peak was eluted at the monomer MW,
was bigger than the first peak, and showed a clean band on the gel.
As for the run of Peak B, two peaks were also eluted at similar elution
time as observed from the run of peak A. For this run, however, the first peak
corresponding to the protein aggregates was much more intense than the
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Figure 3.2: SDS-PAGE analysis of CF expression and purification. A, CF was over-
expressed in the cells (C) which were spun down to remove the pellet (P) and give the
supernatant (S). B, CF lysate supernatant was purified on a nickel affinity column which
gave two elution peaks. C, Gel filtration showed that peak A consisted of more monomer
proteins than aggregates. Peak B was the reverse.
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second monomeric peak. The gel filtration chromatography thus confirmed
the difference between the two elution peaks from nickel affinity column. In
conclusion, CF existed as a monomer in solution and only Peak A, the peak
eluted at 120 mM imidazole, corresponded to monomeric CF in solution.
It was observed that the protein concentration process before gel filtra-
tion was crucial in alleviating aggregation. By keeping the protein concen-
tration below 40 mg / mL the elution in the gel filtration run could be
shifted towards the monomer peak. Figure 3.3 shows the elution profile of
the optimised gel filtration run.
Figure 3.3: Elution profile of the optimised run of CF (peak A from nickel affinity
column) on Superdex 200 gel filtration column with an overlaid chromatogram of the
calibration run. Elution peaks are labelled according to their respective protein masses of
26, 44, 66, 150 and 200 kDa. The 200 kDa elution peak gives the void of the column. A
trapped bubble has contributed to the first elution peak at 0 mL.
For the purification of NF on a nickel affinity column, the elution started
already at 100 mM imidazole. Nevertheless, the elution pattern it displayed
was very similar to CF (Figure 3.4).
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Figure 3.4: SDS-PAGE analysis of NF expression and purification.
30 CHAPTER 3. RESULTS
Verification of the identity of CF construct
Purified CF was confirmed using mass spectrometric analysis and N-terminal
peptide sequencing. Using LC-MS, the molecular weight (MW) of CF was
determined to be 50 276 Da, which is 139 Da smaller than the theoreti-
cal value. N-terminal sequencing confirmed the N-terminal sequence of CF
but found the first methionine missing. This explains the difference in the
calculated and experimental values of MW, which is close to the mass of a
methionine which is 149 Da. In addition, the identity of CF was also in-
directly proven by the positive signal on the Western blot probed with an
anti-histidine antibody (Figure 3.5A).
Figure 3.5: Characterisation of the CF construct. A, Western blot of purified monomeric
CF showed positive signal when probed with anti-histidine antibody. B, CF gave a single
band on the native gel. C, CF showed an experimental pI of 6.3 using isoelectric focussing.
Identification of c-diGMP bound to CF
The UV absorption spectrum of purified CF showed a peak around 260 nm
in addition to the peak at 280 nm which is expected for proteins due to
absorption contribution by aromatic residues (Figure 3.6B). Because PleD
is a di-nucleotide cyclase, we thought the absorption peak at 260 nm might
be due to the presence of bound nucleotides, most probably being GTP,
c-diGMP or the linear reaction intermediate, diguanosine tetraphosphate
(pppG3’p5’G), in the DGC reaction [54]. These nucleotides can be identified
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according to their polarities using RP-HPLC. To identify the ligand co-
purifying with CF, the CF sample was analysed using RP-HPLC and the
chromatogram was compared to the reference chromatograms.
Purified CF gave two elution peaks from the HPLC column (Figure 3.7).
The first peak corresponded to that given by c-diGMP, with a retention
time of 7.3 min. This indicated that CF carried c-diGMP throughout the
purification procedures. The second peak appeared at a later time at 12.4
min. The possibility of the substrate GTP or the linearised dinucleotide
intermediate were ruled out since they were probably more polar and could
only be eluted at an earlier time. So the peak might correspond to the CF
protein itself.
Figure 3.6: UV absorption spectra of purified CF before (red) and after (blue) dialysis
at 4◦C. The buffer baseline is in green.
Quantification of amount of bound c-diGMP on CF
The concentration of purified PleD was determined using the Beer-Lambert
relation [15] by measuring UV absorption.
An = n ∗ c ∗ l (3.1)
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Figure 3.7: Elution profiles on HPLC measured at 252 nm. A, c-diGMP. B, Purified
CF sample. The same elution peak at around 7.4 min was obtained.
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where An = absorbance at n nm
n = molar extinction coefficient at n nm
l = pathlength
Both PleD and its co-purified c-diGMP contribute to UV absorption.
Therefore, the total absorption of the purified PleD sample is given by the
sum of the absorption of both protein and ligand. Since the absorption max-
ima of PleD and c-diGMP are at 280 and 253 nm respectively, we measure
A280 and A253:
A280 = 280p ∗ cp ∗ l + 280l ∗ cl ∗ l (3.2)
A253 = 253p ∗ cp ∗ l + 253l ∗ cl ∗ l (3.3)
where A280 = measured absorbance at 280 nm
A253 = measured absorbance at 253 nm
280p = 9200 M−1cm−1 theoretical value for PleD at 280 nm
253p = 5878 M−1cm−1 theoretical value for PleD at 253 nm
280l = 9600 M−1cm−1 for c-diGMP at 280 nm
253l = 16160 M−1cm−1 for c-diGMP at 253 nm
l = 1 for this experiment
Let the molar ratio of ligand : protein be x, i.e. cl/cp = x, and the
measured absorption ratio of A253 / A280 be R. By dividing equation 3.3 by
equation 3.3, x is expressed in function of R, which is measured experimen-
tally, and the extinction coefficients, which are known values.
x =
R ∗ 280p − 253p
253l −R ∗ 280l (3.4)
For a purified CF sample, x is around 1. As shown by the complex
structure of PleD with c-diGMP which was solved later, two ligand molecules
probably co-purify with PleD, hence, the occupancy of bound c-diGMP is
x/2. The concentration of the protein can then be deduced by substituting
x into equation 3.3, as shown in equation 3.5. The concentration of the
ligand is cp ∗ x.
cp =
A280
280p + 280l ∗ x (3.5)
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Hydrodynamic characterisation of CF
CF protein was shown to be a monomer in solution from the purification
step of gel filtration chromatography (Figure 3.3). This was confirmed by
the following measurements including dynamic light scattering (DLS) and
analytical ultracentrifugation (AU).
DLS observes the fluctuations in the intensity of light scattered by par-
ticles in solution [9]. The fluctuations reflect translational diffusion that
is dependent on the shape, MW and concentration of the particles in the
sample. DLS is a useful tool to investigate the physical homogeneity of a
purified protein sample. For the measurement of CF sample, a monomodal
distribution was observed which indicated the presence of a single species.
The measured diffusion coefficient of the species was 630 x10−9 cm / s2,
which corresponded to a spherical protein of 61 kDa. This observation was
consistent with a monomeric PleD of MW 50 kDa that had a molecular
shape deviating from a perfect sphere.
Sedimentation measurements were carried out using AU [33, 49]. Sed-
imentation velocity run of CF showed a sedimentation coefficient of 3.9 S.
Sedimentation equilibrium runs at 18 000 rpm of a sample with the concen-
tration of 0.45 mg / mL gave an estimated MW of 53 kDa.
Conformation and thermal stability of CF
Native-PAGE separates proteins in their native state according to their net
charge, mass and shape. The CF protein ran as one band on the native gel
(Figure 3.5A). Together with the gel filtration result, this suggested that CF
was a monomer in solution.
In circular dichroism (CD) spectra of proteins, peptide bonds dominate
the far-UV region, and are useful for characterisation of secondary struc-
ture [9]. Figure 3.8A shows the CD spectrum of CF in the far-UV region.
The characteristic minimum at 221 nm was found, which was indicative of
a structure with considerable α-helical content. Upon heating, the molar el-
lipticity at 221 nm showed a monophasic transition from -1400 to -800 with
a sharp increase of ellipticity around 49 ◦C. On cooling down, the molar
ellipticity remained stable at the value observed at 90 ◦C. This suggested
that the CF structure was irreversibly unfolded, or melted, at around 49 ◦C.
Isoelectric point determinaton
Isoelectric focussing (IEF) allows the separation of proteins according to
their isoelectric point, pI, in the presence of a continuous pH gradient. The
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Figure 3.8: Conformation characterisation of CF using CD. A, CF showed the charac-
teristic trough of α-helix at 221nm at 22 ◦C (blue) which collapsed at 90 ◦C (pink). The
buffer baseline is in green. B, CF showed monophasic transition at around 49◦C upon
heating (pink). Once melted, it could not renature by cooling (blue).
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pI of CF was experimentally determined to be 6.3 (Figure 3.5 B), compared
to the theoretical value of 6.0 calculated using the programme PeptideMass
on the ExPASy website.
Domain boundaries delineation of PleD
CF was subjected to limited trypsinolysis which yielded two groups of protease-
resistant fragments. The larger fragments were around 32 kDa (pointed with
blue arrow in Figure 3.9A) and the smaller about 15 kDa (red arrow) as
shown in the SDS-PAGE. Each group of intermediates contained two visi-
bly distinctive bands. The bands were isolated and further trypsinised to
allow for mass fingerprinting. In this technique, the trypsinised fragments
of each band, being small enough for MALDI, were analysed by mass spec-
trometry. The molecular weights of these fragments were then searched in
the sequence library of the theoretically trypsinised CF using the programme
MASCOT [47]. The two bands of MW around 15 kDa resulted in tryptic
fragments that were mapped to the N-terminal region between residues 5
and 130 on CF (red segments in Fig 3.9 C). On the other hand, the bands
belonging to the larger intermediate of around 30 kDa resulted in tryptic
fragments that covered the C-terminal region of CF (blue segments in Fig
3.9 C). The lower band was mapped to residues 138-393, whereas the upper
band was mapped to residues 156-393. N-terminal sequencing of the upper
band confirmed the starting residue to be residue 156.
Western blot of the same SDS gel followed by immunological detec-
tion using anti-histidine antibodies showed positive signal for the bands
belonging to the larger intermediates, showing that they both carried the C-
terminal His-tag from the C-terminal His-tagged CF construct (Fig 3.9 B).
This agreed with the finding from electrospray-mass spectrometry analysis
of the solution sample of the trypsinised mixture. Two masses of 15 218 Da
and 35 117 Da were measured, which were similar to those of the protease-
resistant fragments estimated from the gel. The smaller mass of 15 218
Da was closest to the mass of a tryptic fragment of residues 1-138 whereas
the larger mass of 35 117 Da was closest to a tryptic fragment of residues
138-460 covering the C-terminal His-tag.
According to above findings, there exists two possible stable fragments
(Fig 3.9 D). A conservative prediction was that the first fragment encom-
passed residues 1-130, covering the D1 domain, and the second fragment
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Figure 3.9: Domain delineation by limited proteolysis and mass fingerprinting. A,
SDS-PAGE showing a time-controlled proteolysis of CF from the intact protein (sin-
gle band) to two stable intermediates (arrows). B, The corresponding western blot
showed that only the larger intermediates (blue) were recognised by anti-histidine
antibody. C, The location of the tryptic fragments that were identified by mass
fingerprinting on CF. D, The inferred domain arrangement of CF consisted of two
domains separated by a linker that contained the tryptic cleavage sites R132, R137,
R138, R148 and R155.
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would start at any position between residues 130 and 156 and finally end at
residue 460 to cover the D2 and DGC domains. The stretch of amino acids
connecting these two putative domains is rather hydrophobic. We have de-
signed three domain constructs starting at R137, D150 and G153. R137 and
D150 were chosen since they are polar and would probably favour exposure
to the solvent environment. G153 was chosen due to its flexibility.
A follow-up experiment was carried out on one of these domain con-
structs to check if smaller protease-resistant fragments existed. However,
limited proteolysis of the N137 construct did not show any detectable stable
intermediates (Figure 3.10).
Figure 3.10: SDS-PAGE analysis of the limited proteolysis of N137. Limited proteolysis
of the N137 construct using different amounts of trypsin did not show any stable fragments.
Expression and solubility test of D2-DGC constructs
A small-scale expression and solubility screen was performed on the domain
constructs N/C137, N/C150 and N/C153. All constructs were expressed
in the same way and purified on a nickel affinity column to assess their
solubility. Under the tested conditions, all constructs but C153 expressed to
yield soluble proteins that could be purified (Figure 3.11). Apart from the
153 constructs, the N-terminal constructs gave 2-3x higher yield than their
C-terminal counterparts.
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Due to the general positive results of the expression and solubility of the
D2-DGC constructs, there was a plan to perform crystallisation using these
constructs, particularly N/C137 and N/C150. However, diffraction of the
CF protein was obtained at that time, and thus the plan was shelved.
Figure 3.11: Expression and solubility test of D2-DGC constructs. S denotes super-
natant, P denotes pellet, and E denotes elution from nickel affinity column. The arrow
shows the expected size of the construct on the gel. A, N-terminal His-tagged constructs.
B, C-terminal His-tagged constructs.
Expression and solubility test of DGC constructs
The C287 construct was purified in a similar way as for the full-length PleD
constructs using both nickel affinity and gel filtration chromatography. As
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in the CF preparation, the cell lysate was passed through a nickel affinity
column. Gradient elution with imidazole showed elution peaks at 200 mM
and 500 mM. The 500 mM elution was highly aggregated and the aggrega-
tion could be observed by eye straight after elution. The 200 mM elution
was 50 % pure (Figure 3.12B) and tended to precipitate during the protein
concentration step (Figure 3.12C). Approximately 20 % of the soluble frac-
tion was recovered and further purified on Superdex 200. Out of this minute
fraction of proteins, the majority eluted as void or as contaminants of vari-
able sizes. Only a very minute fraction corresponded to the monomer MW
of C287 and could only barely be seen on a silver-stained gel (not shown).
Figure 3.12: Expression and Purification procedures of C287. A, C287 showed moderate
level of expression. 50 % was soluble as seen from the lysate supernatant. B, Lysate
supernatant was purified on a nickel affinity column which gave an elution at 200 mM
imidazole that contained plenty of contaminants. C, Concentrating this peak resulted in
the majority going into pellet.
The other DGC constructs, N319 / C319, inferred from the Pei and
Grishin study [46] also suffered from poor solubility and could not be purified
on the nickel column (Figure 3.13).
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Figure 3.13: Expression and solubility test of N319 / C319 constructs. S denotes su-
pernatant, P denotes pellet, and E denotes elution from nickel affinity column. Both
constructs tended to form inclusion bodies and could not be purified to the amount ob-
servable by SDS-PAGE.
Structural determination of PleD by X-ray crystal-
lography
Verification of SeMet substitution in CF
The substitution of Met by SeMet in the CF protein was verified by mass
spectrometry and absorption spectrometry. SeMet-substituted CF has a
mass of 50852 Da as determined by mass spectrometry. It is 575 Da bigger
than the native CF protein (Figure 3.14A). Considering the replacement of a
sulphur atom (mass = 32.965) with a selenium atom (mass = 78.96) leads to
a mass increase of 46.895 Da, this MW difference in the proteins accounts
for SeMet substitution at 12.3 out of 13 sites per PleD monomer. Thus,
the occupancy of SeMet is 95 %. The characteristic absorption edge of Se
displayed by the SeMet CF crystal quantitatively verified this substitution
in the protein (Figure 3.14B).
CF-product crystal
The type of constructs and ligands used in crystallisation, and crystal ma-
nipulation affected the quality of PleD crystals. The crystals that were
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Figure 3.14: Verification of SeMet substitution in CF using mass spectrometry and
absorption spectroscopy. A, Overlaid mass spectra of native and SeMet CF show a mass
increase of 575.2 Da in the SeMet CF. This is equivalent to the replacement of 12.3 Met
with SeMet. B, Absorption spectrum of the SeMet CF crystal showed the characteristic
absorption edge of Se at 12.6582keV.
Δ Mass = 575.2
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50276.8
SeMet CF
50852.0
A
B
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used in structure determination were the CF crystals co-crystallised with
c-diGMP. These CF-(c-diGMP) crystals were cloverleaf-like when directly
obtained from vapour diffusion. They belonged to the space group of P42212
and diffracted to 3.5 A˚. Microseeding was required to produce needle-like
crystals that gave an improved diffraction to 2.7 A˚ (Figure 3.15A, C).
They belonged to the same space group. Assuming two molecules in
the asymmetric unit, the Matthews coefficient Vm was determined to be
3.88 A˚3 / Da using equation 3.7, which lies within the common range of
1.66-4.0 A˚3 / Da for soluble proteins [42].
Vm =
cell volume
total weight of protein in unit cell
=
abc
mnZ
(3.6)
= 3.88 A˚3 / Da
where a = b = 135.9 A˚, c = 169.2 A˚; m is the molecular weight of CF,
50278 Da; n is the number of molecules in the asymmetric unit, 2 in this
case; and Z is the number of asymmetric units in the unit cell, 8 for P41212.
The solvent content was derived from the following equation:
% solvent = 1− 1.23
Vm
= 68.3 %
SeMet CF protein was also crystallised in complex with c-diGMP. But
when complexed with c-diGMP, crystals in the form of cloverleaf and needles
appeared in the same crystallisation drop directly from vapour diffusion.
Only the needle form was measured and it diffracted to 3.0-3.2 A˚ in the
multiwavelength anomalous diffraction (MAD) experiment (Figure 3.15B).
The SeMet CF-(c-diGMP) crystal belonged to the same tetragonal space
group as the native crystal but with slightly smaller cell constants.
Other PleD crystals
Two other PleD crystal forms were also obtained. Co-crystallisation of CF
with GMP-PNP formed cloverleaf-like crystals (Figure 3.16). These crystals
belonged to the space group of P41212 and had a very long cell constant
along the c*-axis (a = b = 86.3 A˚, c = 295.8 A˚). There were two molecules
in the asymmetric unit. The diffraction was only up to 6.6 A˚. On the other
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Figure 3.15: CF-c-diGMP crystals and diffraction. A, The native needle crystal of
width 15 μm. B, SeMet CF-c-diGMP crystal in needle form. C, Integrated and scaled
reflections from the native crystal. Reflections with high intensities are shown as big spots.
The diffraction is isotropic and reaches 2.7 A˚.
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hand, co-crystallisation with GTPγS did not give crystals at all, and that
co-crystallisation with PPi gave only salt crystals.
The other PleD crystal form was obtained from the apo-NF crystals. It is
interesting that CF did not crystallise in its apo form. The NF crystals were
bipyramidal (Figure 3.17). They belonged to the hexagonal space group of
P6222 with a unit cell of the dimensons a = b = 94.2 A˚, c = 187.4 A˚. They
diffracted to 4.5 A˚. In contrast to the CF-ligand crystals, the apo-NF crystal
form contained only 1 molecule per asymmetric unit.
Data collection
The method of anomalous scattering exploits the anomalous difference in
Friedel-related reflection intensities when heavy atoms are excited close to
their absorption edge. The sites of the heavy atoms can be located and the
phases for the structure factors calculated [60]. We have used the MAD
method in which multiple datasets were collected at several wavelengths
to maximise the anomalous signal. These datasets were collected from the
same crystal to avoid non-isomorphism.
A native dataset from a native CF crystal and three MAD datasets from
a SeMet-substituted CF crystal were collected at the synchrotron facility at
Swiss Light Source in Villigen, Switzerland. Cryo-conditions were used to
prevent ordered ice formation and to reduce the radiation damage to crys-
tals, which is a major concern when using the synchrotron source. Flash
freezing was achieved with CF crystals pre-soaked in a mother liquor that
was cryoprotected with ethylene glycol. This resulted in a clear drop in the
mounting loop and diffraction patterns that were free of ice rings. A com-
plete dataset was collected from a small, single native crystal of 0.015 mm by
width by shifting the X-ray beam along the length of the crystal. Likewise,
the three MAD datasets were all collected from a single SeMet-substituted
crystal by scanning along the length of the crystal.
Overall scheme in structural elucidation of CF
The overall scheme in determining the CF structure is represented as a
flowchart in Figure 3.18. Significant results at intermediate steps of structure
determination are stated in the corresponding stage in the flowchart for quick
reference. Statistics obtained from data collection, phasing and refinement
are summarised in Figure 3.19.
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Figure 3.16: Diffraction and statistics of CF-GMP-PMP crystals. A, Integrated and
scaled reflections of the cloverleaf-like crystal (top right) to 6.6 A˚. B, Statistics of data
collection.
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Figure 3.17: Diffraction and statistics of the apo-NF crystals. A, Integrated and scaled
reflections of the bypyramid crystal (top right) to 4.5 A˚. B, Statistics of data collection.
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Figure 3.18: Scheme detailing the procedures in structure determination of PleD.
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Figure 3.19: Crystallographic data of CF crystal, and statistics of phasing and refine-
ment.
Experimental data
Data collection Native SeMet
Peak Inflection Remote
Wavelength (Å) 0.97950 0.97950 0.97970 0.97700
Resolution (Å)
Highest shell
2.7
2.85 – 2.70
3.2
3.27 – 3.20
3.0
3.16 – 3.00
3.0
3.16 – 3.00
Space group P42221
a = b (Å)
c (Å)
135.9
169.2
134.9
168.1
Unique reflections 42707 26249 32080 32140
Average redundancya 5.7 (5.5) 4.1 (3.9) 4.8 (4.9) 4.6 (3.6)
I /   a 7.2 (1.9) 6.2 (2.1) 7.2 (1.8) 7.3 (1.1)
Completenessa (%) 99.3 (98.7) 99.9 (100) 99.9 (100) 99.6 (97.6)
Anom complete (%) - 99.7 99.9 97.5
Rmerge
a,b (%) 8.3 (36) 10.5 (33) 9.4 (39) 11.0 (63)
Phasing
Resolution shell 13.1
2
7.69 5.98 5.06 4.47 3.72 3.46 3.16
Figure of merit 0.74 0.67 0.62 0.55 0.50 0.34 0.27 0.13
Mean figure of merit 0.39
Refinement
No of molecules in AU 2 Protein atoms 688
3
Resolution (Å) 50.0 – 2.7 Water molecules 15
Rc / Rfree
d (%) 21.0 / 23.9 Ligand atoms 233
R.m.s.d. e
            bond lengths e (Å)
            bond angles e (o)
0.008
1.2
Residues in
Ramachandran core (%)
92.8
R.m.s.d.e B bonded atoms (Å2) Residues in 0.0
Main chain 1.13 disallowed region (%)
Side chain 2.42 Average B (Å2) 25.6
aThe numbers in parentheses refer to the highest shell.
bRmerge = | I – <I> | /  I, where I is the scaled intensity of a given reflection.
cR = | Fo – <Fc> | /  Fo, where Fo and Fc are the observed and calculated structure
factor amplitudes for reflection.
dRfree refers to the R value of 5 % of randomly selected reflections excluded from the
refinement.
er.m.s.d. from ideal stereochemistry
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Phasing
Considering 2 molecules per asymmetric unit (Vm = 3.88) and 12 out of 13
methionines labelled per monomer, there are 24 SeMet sites in the asym-
metric unit. Using the programme SHELXD [55], 25 Patterson peaks were
searched from the peak dataset at 4.5 A˚. The best run with correlation co-
efficients at 28.2 (all) and 11.2 (weak) and a figure of merit (FOM) at 0.64
gave 18 Patterson peaks at > 29 % intensity. Among these peaks, two clus-
ters, each consisting of 4 peaks, were observed to be related by NCS two-fold
symmetry (Figure 3.20).
Peak x y z self cross-vectors
99.9 0.6696 0.4671 0.2179 46.8
3.0
83.5 0.5944 0.5593 0.2901 30.2 20.2
3.2 2.6
75.0 0.6701 0.5499 0.2652 48.0 13.8 11.2
4.5 1.9 2.6
70.3 0.5175 0.8248 0.0977 47.7 51.2 49.6 51.2
1.9 8.5 1.5 7.0
59.7 0.7392 0.4758 0.2501 65.2 11.0 23.6 14.0 46.6
1.1 7.9 0.0 0.0 0.0
56.0 0.6490 0.4865 0.2528 40.5 7.0 13.9 9.3 54.6 12.3
7.2 8.7 0.0 0.0 0.0 0.0
52.7 0.5782 0.5316 0.2540 22.9 16.3 7.5 12.8 48.4 23.1 11.4
1.8 6.0 4.6 0.0 1.4 0.4 0.0
49.3 0.5477 0.7990 0.2634 56.0 44.7 33.4 37.6 28.6 37.6 44.6 36.5
0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0
48.6 0.6010 0.7264 0.2989 67.2 38.9 22.7 26.3 38.3 39.6 34.1 27.6 13.6
0.0 3.4 0.0 6.8 0.0 0.0 1.7 0.0 0.0
48.5 0.3754 0.7743 0.2153 69.1 33.3 43.5 36.8 28.5 37.7 36.0 42.4 25.0 34.3
1.7 0.0 0.0 0.6 5.9 0.0 0.0 0.0 5.6 0.0
44.3 0.5957 0.8545 0.0855 47.2 48.5 52.9 48.5 11.5 39.3 47.6 52.3 31.7 40.1 38.6
0.0 5.6 0.0 2.5 0.0 5.3 3.5 0.0 0.0 0.0 0.0
41.5 0.6168 0.7582 0.3210 66.4 41.0 27.6 30.6 41.1 37.4 38.8 33.2 14.6 6.1 35.8 42.1
0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
40.0 0.4387 0.8277 0.3671 49.6 48.1 44.0 45.9 46.9 42.8 48.3 48.3 23.3 28.4 28.1 40.1 27.1
0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.9 0.0 3.8
35.2 0.3590 0.8587 0.3829 54.1 38.8 47.6 37.9 40.3 35.7 42.2 47.0 33.6 40.0 30.7 34.9 38.9 11.9
0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0
34.7 0.6399 0.5445 0.3148 39.8 19.9 7.7 9.4 55.4 19.7 13.2 13.4 37.7 25.3 40.6 47.2 29.1 47.9 46.6
0.0 4.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
32.3 0.6748 0.5093 0.2060 47.4 6.1 19.2 11.5 51.2 12.3 9.2 15.7 44.0 34.8 39.1 51.5 39.7 43.8 34.2 19.6
0.0 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.0 0.0 0.0
29.5 0.7187 0.4782 0.2042 59.6 7.2 24.8 15.6 53.3 8.3 12.6 22.0 40.3 40.5 36.6 46.7 37.5 41.6 32.7 23.4 7.3
0.0 2.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
29.1 0.5018 0.7345 0.2615 63.6 36.6 27.3 33.9 30.4 43.4 36.3 29.4 10.7 14.9 19.6 36.3 18.8 23.5 32.9 33.1 39.6 42.6
0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3
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Figure 3.20: Crossword table output from a SHELXD run and assignment of sites to
NCS-2-fold related clusters from the peak dataset. The Patterson peaks are sorted in
decreasing order of intensity (first column), and each peak is annotated with fractional
coordinates x,y,z (second to fourth columns). The self-vectors and cross-vectors relating
different Patterson peaks are annotated with distance (in A˚) at the top and Patterson
minimum function at the bottom. Cluster A, consisting of peaks A1-A4, was assigned to
be related to cluster B, consisting of peaks B1-B4, by a local two-fold symmetry.
These eight sites were used as input in a MAD run at 3.2 A˚ in the
programme SHARP [11] to search for other SeMet sites. The newly found
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sites that coincided with the hits from the SHELXD run were incorporated
as input into new rounds of searches. The position, occupancy and thermal
parameters of the SeMet sites were then refined to give a final mean FOM
at 0.39. 18 out of 24 SeMet sites in PleD dimer were found of which 17
were correct (Figure 3.21). Solvent flipping was performed at 60 % with
programme SOLOMON and the first electron density map was calculated
by fast Fourier Transform with the programme FFT. Figure 3.22 panel A
shows the superimposition of this electron density map onto the Cα trace
of the final structure. The central β-sheet was already clearly visible at
this stage and there were even some indications of sidechains albeit serious
ambiguities at the helix and loop region.
Figure 3.21: SeMet sites found in SHELXD and SHARP. The correct sites are high-
lighted in blue and the wrong site in red. The unfound sites, including the two unlabelled
ones, are shown in yellow. The Cα trace of CF is also shown. The two sites in blue that
are away from the Cα trace are in a different asymmetric unit but are crystallographic
symmetry related to the asymmetric unit shown.
Density modification with two-fold averaging
The electron density map was improved by NCS averaging [66]. The oper-
ator describing the NCS symmetry that related the two clusters of heavy
atoms mentioned above was calculated in the programme MODTRAFO. It
obeyed a two-fold symmetry of polar angles (85.7, 274.4, 180.0) with a screw
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Figure 3.22: Comparison of the electron density maps calculated from different stages
in structure elucidation showed improvements in terms of completeness and clarity. A,
Map before two-fold NCS averaging in DM. B, Map after NCS averaging; C, the final
map. Cα trace of the final structure is shown in yellow.
component of -0.03 A˚. Using the NCSMASK option in the programme DM
[8], an NCS averaging mask comprising the two clusters was computed at
a solvent content of 63 %. NCS operations were applied to this mask and
the densities of the two molecules were averaged. The modified map was
back-transformed to calculate a new set of phases that were used to generate
a new map. These density modification procedure was carried out in cycles
until convergence with phase extension to the diffraction limit of 2.7 A˚ by
merging with the amplitudes of the observed structure factor from the na-
tive dataset. Further cycles of electron density modification yielded a refined
NCS symmetry axis of polar angles (85.9, 273.7, 179.9) with a screw com-
ponent of -0.16 A˚, and an intermediate map (Figure 3.22B), which showed
an improvement in the signal-to-noise ratio especially in the helix and loop
region where ambiguities were resolved. More sidechains were also identified.
Model building
Using the BONES programme in the programme MAPMAN [27, 30], the
electron density was skeletonised and then visualised in the programme O.
Due to the predicted topological homology of the D1 domain, and possibly of
the D2 domain, to the CheY protein [35, 58], the Cα trace of CheY was used
to fit the bones to trace the polypeptide chain. It was possible to fit two Cα
traces of CheY to the bones proving that D2 domain has the same fold as
CheY. Using the SeMet sites as sequence markers, the orientation of D1 and
D2 domains was determined as a result. On the other hand, the building of
the DGC domain was achieved by manual rectification. After the bones were
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edited, the positions of the Cα atoms were assigned by placing consecutive
Cα atoms at a distance of around 3.8 A˚ along the skeleton. The mainchain
was then placed on the Cα trace followed by addition of sidechains using
rotameric conformations that fitted the electron density. Subsequently, the
built polypeptide was regularised to restore the proper bond lengths, bond
angles and dihedral angles. The first manually built model gave an R-factor
of 46.9 % and Rfree of 47.4 %.
Refinement
Successive rounds of TLS / REFMAC5 refinement [44] with strict NCS
restraints and model building lowered the R-factor to 25.5 % and Rfree to
27.3 %. As the electron density map improved, we could find three clusters
of electron density that did not belong to the protein. They were all in
the shape of a horse-shoe (Figure 3.23), to which c-diGMP could be fitted.
One of them was located on the DGC domain while the other two were
intercalated and were situated between the D2 and DGC domains.
Figure 3.23: The Fo-Fc map, contoured at 4 σ and shown in magenta, shows electron
density that does not belong to the protein in two regions of the asymmetric unit. A,
Density in the shape of a horse-shoe is located between two crystallographic symmetry
related molecules (green and dark green) at the border of an asymmetric unit. B, Two
of these horse-shoe shaped electron density masses are located at the domain interface
between D2 (yellow) and DGC (green).
In order to include a ligand molecule in structural refinement, its internal
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geometry has to be specified for REFMAC5. This is often described in the
monomer library in CCP4 [44] if the ligand occurs commonly. Due to the
absence of a c-diGMP molecule entry in both the monomer library and the
Protein Data Bank (PDB) [3], a library file for c-diGMP was created using
the internal geometry of a GMP molecule described in a monomer library
file. In addition to the specified geometry requirements, connectivity was
built between the ribosyl O3* and the Pα of the second GMP molecule while
restraining their interatomic distance to 1.59 A˚, the usual bond length. The
new bond angles at Pα between the ribosyl O3* and the non-ester oxygens
O1A and O2A were set to the usual bond angle of 109◦.
The two GMP molecules were then set in an anti-parallel fashion and
fit into the electron density map. Care was taken to place the ribosyl 3’
oxygen of one molecule to the 5’ phosphorus of the other molecule close to
the bond distance and bond angle to facilitate proper stereochemistry in the
refinement process.
Another issue was to address was the packing in this protein crystal.
Two c-diGMP molecules are situated in the strategic locations that crosslink
two crystallographically related CF dimers. In other words, there is half a
c-diGMP molecule per PleD monomer. However, refinement of the PleD
monomers with two halves of c-diGMP in an asymmetric unit would lead
to individual refinement of the two GMP molecules, with the daunting re-
sult that the proper stereochemistry of an intact c-diGMP molecule at this
crystal contact might be lost.
This problem was circumvented by re-defining the asymmetric unit. In-
stead of assigning two halves of the c-diGMP molecule to the dimer, one
intact c-diGMP molecule was assigned to a monomer chain. The conse-
quence was that the two GMP molecules were subjected to the restraint
measures required to bring them to the right stereochemistry of a c-diGMP
molecule.
In the subsequent rounds of refinement, we searched for peaks in the Fo-
Fc map that had a σ-value above 3. We assigned them to 15 water molecules
and 3 metal ions including two Mg2+ ions and one Zn2+ ion. The two Mg2+
ions are located in the acidic clusters on chain A and B, whereas the Zn2+
ion is located at the end of the disordered His-tag on chain A (Figure 3.24).
As the R-factors finally converged, the electron density map revealed
that four sidechains did not adopt the same conformation in the NCS dimer.
They were R117, R164, R168 and H404. R117 of chain A might pack against
F113 whereas its counterpart on chain B does not interact with any residues.
R164 and R168 are both involved in non-isologous intra-layer crystal con-
tacts and will be explained later. H404 is located very close to the disordered
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Figure 3.24: Evidence of Zn2+ ion in CF crystal. A, Absorption spectrum of CF
crystal shows characteristic absorption edge of Zn2+ at 9.6586 keV. B, The map (pink)
showing the anomalous difference of zinc is contoured at 2.5 σ and shows a Zn2+ ion (cyan)
bound to the disordered C-terminus at H455 (carbons in grey). The electron density on
this sidechain is absent in the 2Fo-Fc map (black) of the native dataset. The last five
histidines of the His-tag are disordered as reflected by the proximal arrangement of the
C-terminal end of another molecule (carbons in khaki).
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D1-D2 domain linker on the same chain of the crosslinked dimer. It might
be due to the disorder in this region that caused the difference in the con-
formation of H404 on the two chains. NCS restraints were only relieved for
these sidechains.
The final R-factor is 21.0 % and Rfree is 23.9 %, and the electron density
map is shown in panel C of Figure 3.22. In comparison to the initial and
intermediate maps (Figure 3.22A, B), the final map is complete including a
whole loop which did not show electron density before. It also shows details
of most sidechains.
Evaluation of structure quality
The stereochemical quality of the crystal structure was continuously eval-
uated throughout the refinement steps using the programme PROCHECK
[32]. In the final structure, 92.8 % residues are found in the most favourable
region on the Ramachandran plot (Figure 3.25) and none in the disallowed
region. The mainchains and sidechains obey good stereochemistry (Figure
3.26 and 3.27). The structure was deposited in PDB under the accession
code 1W25.
STRUCTURAL DETERMINATION OF PLED 57
1w25_01.ps
PROCHECK
B
A
L
b
a
l
p
~p
~b
~a
~l
b
~b
b
~b
~b
-180 -135 -90 -45 0 45 90 135 180
-135
-90
-45
0
45
90
135
180
Ramachandran Plot
1w25
Phi (degrees)
Ps
i(
de
gr
ee
s)
ALA 13 (A)
ASN 280 (A)
VAL 402 (A)
HIS 404 (A)
ARG 446 (A)
B
ARG 446 (B)
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Residues in most favoured regions [A,B,L] 705 92.8%
Residues in additional allowed regions [a,b,l,p] 48 6.3%
Residues in generously allowed regions [~a,~b,~l,~p] 7 0.9%
Residues in disallowed regions 0 0.0%
---- ------
Number of non-glycine and non-proline residues 760 100.0%
Number of end-residues (excl. Gly and Pro) 10
Number of glycine residues (shown as triangles) 66
Number of proline residues 36
----
Total number of residues 872
Based on an analysis of 118 structures of resolution of at least 2.0 Angstroms
and R-factor no greater than 20%, a good quality model would be expected
to have over 90% in the most favoured regions.
Figure 3.25: Ramachandran plot of the final CF structure.
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Figure 3.26: PROCHECK assessment of the overall geometry of the mainchains in CF.
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Figure 3.27: PROCHECK assessment of the overall geometry of the sidechains in CF.
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Structural analysis of PleD
PleD architecture
The final electron density map was of good quality and allowed the building
of most of the PleD molecule. PleD comprises three domains, D1 (aa 2-
136), D2 (aa 147-281) and DGC (aa 289-455) (Figure 3.28). D1 and D2
domains have the same (β/α)5 topology as CheY, whereas DGC shares a
similar fold as the AC catalytic domain that consists of a mixed topology
βααββαβ (Figure 3.29). The domain linkers (aa 137-146 and 288-454) and
the C-terminal His-tag (aa 456-460) show poor electron density quality and
could not be modelled.
Secondary structures were assigned using the programme DSSP [28, 32]
with additional manual rectification. In particular, we have made the ex-
tra assignment of strands β0 and β0’ in DGC domain after observing an
extension of the hydrogen bond pattern of the central anti-parallel β-sheet
(inset of Figure 3.29). The final assignment is shown in Figure 3.30. In each
monomer, there are 15 α-helices, 8 β-strands, and 2 short 310 helices com-
prising residues 221-223 and 403-405. In addition, two cis-prolines, P106
and P255, are observed.
Crystal packing
The unit cell of CF crystal consists of 8 asymmetric units. Each of the asym-
metric units contains a dimer of NCS-related CF molecules, the interactions
of which will be discussed in more detail on page 77. The asymmetric units
are arranged in layers that are almost parallel to the xy-plane (Figure 3.31).
These layers stack on top of each other along the z-direction to build up
the 3D lattice. Crystal packing is therefore provided by contacts within the
layer, i.e. intra-layer, and across the layers, i.e. inter-layer.
The intra-layer contacts involve only protein residues (Figure 3.32). They
include contacts 1 and 2 which are responsible for lattice expansion in the
y- and x-directions respectively. The contacts are held by non-isologous D1-
D1 and D2-D2 interactions from chain A of one dimer, and chain B of the
neighbouring dimer.
Contact 1 involves the α1-α1 helix-helix interactions of the D2 domains.
Whereas Arg168 of chain B forms a hydrogen bond with the mainchain
carbonyl of Ala171 on chain A, its counterpart in chain A forms hydrogen
bonds to the mainchains of Gln167 and Ala170 on chain B. In addition,
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Figure 3.28: PleD monomer structure. A, The Cα-trace of PleD monomer, numbered
at every ten residues, shows the modular arrangement of three domains, D1 (red), D2
(yellow), and DGC (green). The domain linkers (grey) are disordered and are modelled
here. The last five residues of the His-tag, H456-H460, are disordered and not shown. B,
Ribbon representation of the monomer. D1 domain carries the phosphoacceptor (in sticks),
the acidic cluster (in sticks) and the Mg2+ ion (purple) required for phosphorylation. D2
domain does not have a phosphorylation site. DGC domain has a conserved β-hairpin
(blue) that bears the conserved GGEEF sequence motif. PleD is bound with c-diGMP
molecules at the catalytic active site, A-site, located on the conserved β-hairpin, and the
product inhibition site, I-site, located at the domain interface of D2 and DGC.
62 CHAPTER 3. RESULTS
α
5
N
α
1 β 2
β5
β 4
β 3
β 1
β 0
β1
β 3
β 2
β 0'
β5
β 4
β
3'
β
3''
C
α
2
a1α0
α
4
α
3
α
2
α
3
α
4
β2
β 5
α
5
α
1
α
2
α
4
β 1
α
3
β 3
β 4
P
-lo
o
p
G
G
E
E
F
seq
u
en
ce
m
o
tif
acid
ic
clu
ster
fo
r
p
h
o
sp
h
o
rylatio
n
Leu
297
:C
=
O
A
rg
366
:N
-H
Pro
364
:C
=
O
H
-N
:H
is298
A
sn
299
:N
-H
O
=
C
:H
is298
H
-N
:A
sp
292
O
=
C
:Val290
β
0'
β
0
β
2
F
igure
3.29:
T
o
p
o
lo
g
ica
l
d
ia
g
ra
m
o
f
P
leD
co
lo
u
red
a
cco
rd
in
g
to
in
d
iv
id
u
a
l
d
o
m
a
in
s.
A
rrow
s
d
en
o
te
β
-stra
n
d
s
a
n
d
cy
lin
d
ers
d
en
o
te
α
-h
elices.
D
1
(red
)
a
n
d
D
2
(y
ellow
)
d
o
m
a
in
s
sh
a
re
th
e
sa
m
e
(β
/
α
)
5
fo
ld
.
D
G
C
(g
reen
)
d
o
m
a
in
co
n
sists
o
f
a
cen
tra
l
m
ix
ed
β
-sh
eet
o
f
sev
en
β
-stra
n
d
s
in
th
e
o
rd
er
0
,0
’,2
,3
,1
,4
,5
th
a
t
is
fl
a
n
k
ed
b
y
fi
v
e
α
-h
elices
o
n
b
o
th
sid
es.
It
a
lso
h
a
s
a
sm
a
ll
sh
eet
o
f
th
e
a
n
ti-p
a
ra
llel
stra
n
d
s
3
’
a
n
d
3
”
.
T
h
e
seco
n
d
a
ry
stru
ctu
res
w
ere
d
eterm
in
ed
u
sin
g
th
e
p
ro
g
ra
m
m
e
D
S
S
P
[2
8
,
3
2
].
T
h
e
ex
tra
a
ssig
n
m
en
t
o
f
stra
n
d
s
β
0
a
n
d
β
0
’
in
D
G
C
d
o
m
a
in
w
a
s
d
u
e
to
th
e
ex
ten
sio
n
o
f
th
e
cen
tra
l
a
n
ti-p
a
ra
llel
β
-sh
eet
v
ia
β
2
(in
set).
T
h
e
tw
o
sh
o
rt
3
1
0
h
elices
co
m
p
risin
g
resid
u
es
2
2
1
-2
2
3
a
n
d
4
0
3
-4
0
5
a
re
n
o
t
sh
ow
n
h
ere.
S
p
ecia
l
seq
u
en
tia
l,
stru
ctu
ra
l
a
n
d
fu
n
ctio
n
a
l
fea
tu
res
a
re
la
b
elled
in
ita
lics.
N
-
a
n
d
C
-term
in
i
o
f
th
e
p
ep
tid
e
a
re
la
b
elled
a
cco
rd
in
g
ly.
STRUCTURAL ANALYSIS OF PLED 63
Figure 3.30: Multiple sequence alignment of PleD homologues containing the modular arrange-
ment of two CheY domains and a DGC domain. PleD sequence (top) is shown with six homologues
found by the programme METAMOTIF from the EMBnet server (www.ch.embnet.org). The sec-
ondary structure of PleD is shown according to the domain colour scheme above the alignment.
Arrows represent β-strands, coils represent α-helices and the letter ‘T’ represents turns. Strictly
conserved residues are shown on a red background. Functional residues are indicated by symbols
below the alignment: black triangle, Mg2-binding in acidic pocket of phosphorylation; blue trian-
gle, phosphoacceptor; red triangle, residues expected to undergo big conformational change led by
phosphorylation; red star, nucleotide-binding at A-site; red circle, intra-domain salt bridge that
might ensure formation of complete two-fold symmetric active site; blue star, nucleotide-binding
at S-site; red square, dimer interface; blue circle, ionic pairs at D1-D2 domain interface; posi-
tions that are mutated in the constitutively active PleD are highlighted in green. The consensus
sequence is calculated using the Blossum 62 algorithm and is shown below the alignment. The
figure was produced by ESPript [22].
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Figure 3.31: Packing of the CF crystal. A, The unit cell of CF crystal viewed along the
xy-diagonal direction. It consists of 8 dimers which can be grouped into two layers (cyan
and yellow) related by the crystallographic two-fold axis. B, Intra-layer packing as viewed
along the x-direction. The crystal contacts are highlighted in cpk. Our reference molecule
is in yellow. C, Inter-layer packing in CF crystal. Two molecules, each from a crystal layer
in panel A, are shown here. The NCS axis that relates the two monomers in our reference
molecule is shown as a white line. It intersects at right angle with the crystallographic
two-fold axis that goes along the xy-direction. Crystal contacts are highlighted in cpk.
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Figure 3.32: Intra-layer packing in CF crystal. A, Topview of the xy-plane shows the
two types of crystal contacts within the crystal layer. Contact 1 is responsible for the
expansion of the crystal in the y-direction and contact 2 in the x-direction. Residues
involved in the contacts are highlighted in cpk as before. The reference dimer molecule is
shown in yellow. Chains A and B of all four dimers on this plane are labelled. B, Enlarged
view of crystal contact 1 shows non-isologous interactions between the two asymmetric
units. Arg168 from chain B (yellow) makes a hydrogen bond with Ala171 from chain A
(cyan) whereas its counterpart in chain A interacts with two other residues. C, Non-
isologous interactions at crystal contact 2. Asp34 from each chain interacts with different
residues from the other chain.
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Arg164 of chain B forms a hydrogen bond with c-diGMP of chain A while
its counterpart on chain A does not make contacts of any sorts. These
non-isologous interactions are also found in Contact 2 that involves D1-D1
domain interactions. Asp34 of chain A makes a hydrogen bond to Lys67
of chain B and Asp34 of chain B makes two hydrogen bonds to Arg44 on
chain A.
The inter-layer contacts do not involve direct protein-protein interactions
but are provided instead by the ligand that was co-crystallised. C-diGMP
crosslinks the crystal layers via the DGC domain of chain A and the DGC
domain of chain B from the neighbouring dimer (Figure 3.33). Due to NCS
symmetry, there are two such contacts per pair of symmetry-related dimers.
The interactions are isologous, and both hydrogen bonding and hydrophobic
interactions are involved. More details, including the biological relevance,
will be discussed later on page 80.
Possibility of DGC domain swapping
Weak electron density between the end of D2 domain and the beginning of
the DGC domain of the other subunit of the dimer has been observed (Figure
3.34). The gap between the D2 and DGC domains from different monomers
is 10.2 A˚, which can probably allow the five residues in the linker to adopt
a coiled or a somewhat helical conformation, considering the pitch of an
α-helix is 5.4 A˚ for 3.6 residues. Thus, the possibility of domain swapping
exists but has to be proven.
Domain structures
D1 and D2 domains adopt the typical fold of response regulator
receiver domain
D1 domain ranges from residues 2 to 136. It adopts the typical (β/α)5
fold found in CheY and many other response regulator receiver domains
including FixJN. Superimposition of the D1 domain with CheY (PDB code
2CHE [59]) gave an rmsd of 1.3 A˚ (Table 3.2). The central β-sheet of D1
domain consists of five parallel β-strands in the order 2,1,3,4,5 and is flanked
by five α-helices (Figure 3.29 and 3.35). This domain carries all the residues
required for activation of a response regulator. In the acidic cluster for
phosphorylation, the carboxyl groups of Asp9, Asp10, and phosphoacceptor
Asp53, and the mainchain carbonyl of Met55 coordinate a Mg2+ ion (Figure
3.35B). The carboxyl group of Asp53 is additionally hydrogen bonded to
Lys105. In addition, the D1 domain carries the residues Thr83, Phe102
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Figure 3.33: Inter-layer packing in CF crystal. A, Ligands (shown in cpk) mediate the
packing of crystal layers in the unit cell, as viewed along the diagonal axis from the origin
to xy. B, Closed-up view of the inter-layer crystal packing. The ligand, c-diGMP, mediates
the contacts of DGC domains by hydrogen bonding and hydrophobic interactions.
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Figure 3.34: Possibility of DGC domain swapping. Topview down the NCS two-fold
axis reveals that the ends of the domains are very close. Helix α5 of D1, helix α5 of
D2, and strand β0 of DGC line the dimer interface. The 2Fo-Fc map contoured at 1 σ
shows the poor electron density of the linkers but possible connectivities (red broken line)
between helix α5 of D2 domain and strand β0 of the DGC domain of the other monomer.
STRUCTURAL ANALYSIS OF PLED 69
Table 3.2: Structural comparison of domains at a glance. Cα atoms of molecule 2 have
been superimposed on that of molecule 1 using the programme TOPP [40].
Molecule 1 Molecule 2 Cα matched rms (A˚) PDB file
D1 D2 123 1.2 -
D1 CheY 107 1.3 2CHE
D2 CheY 91 1.2 2CHE
DGC AC catalytic 92 1.5 1CJK
DGC DNAP I palm 63 1.7 1NK4
and Lys105 in the characteristic positions at which large structural changes
induced by activation have been shown [7, 36, 35] (Figure 3.35C).
The D2 domain ranges from residues 147 to 280. It also shares the
CheY fold (Figure 3.29) with an rmsd of 1.2 A˚ when superimposed onto
the structure of CheY (Table 3.2). However, it lacks the phosphoacceptor
and the conserved residues necessary for conformational changes induced
by phosphorylation. D1 and D2 domains are related by a quasi-two-fold
symmetry and shows an rmsd of 1.2 A˚ . In both domains, the helix α5 is
significantly longer than that in CheY homologues and protrudes from the
globular domain. For example, the D1 and D2 domains are 1.7 x and 1.5 x,
respectively, longer than that in CheY.
D1 domain is in the inactive form
The characteristics of the inactive response regulator receiver domains in-
clude outward orientations of the β4-α4 loop and the relevant residues, like
T87 and Y106 in CheY, with respect to the acidic pocket [50]. The β4-α4
loop and the sidechains of T83, F102 and K105, which typically bring about
conformational changes driven by phosphorylation [7, 36, 35], also adopt
similar conformations as that in the inactivated CheY, much in contrast to
the conformations found in the activated form of CheY.
In the D1 domain, the sidechains of T83 and F102, as well as the β4-
α4 loop, are in outward conformations as the corresponding sidechains and
the β4-α4 loop in the inactivated CheY (Figure 3.35C-D). The sidechain
of K105, however, forms a hydrogen bond with the phosphoacceptor D53,
which is not found in the inactivated CheY. In CheY that is activated using
the phosphate mimicry BeF3− (PDB code 1FQW; [36]), the T87 sidechain
swings towards the acidic cluster to form a hydrogen bond with the fluoride
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Figure 3.35: D1 domain structure. A, Ribbon representation of D1 shows that it has
the typical CheY fold. Secondary structures are labelled accordingly. B, Superimposition
of the Cα trace of D1 on that of inactivated CheY [59] reveals similar overall structures,
including the acidic cluster for phosphorylation (in sticks; sidechain of M55 not shown).
The β4-α4 loop that carries out the landmark conformational change upon activation is
shown in red. The relevant residues are labelled according to that in D1 domain. C,
Close-up view of the conformation of the residues in the acidic cluster, residues showing
characteristic conformational changes upon domain activation (carbon atoms in yellow),
and the β4-α4 loop in the D1 domain. D, The same in inactivated CheY. E, The same in
BeF3
−-activated CheY [7, 36, 35].
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atom of BeF3− which also coordinates the mainchain amide of N59 and G88,
the sidechain of K104, and a Mn2+ ion in the acidic pocket via hydrogen
bonds. This brings the β4-α4 loop inwards to open up a pocket between helix
α4 and the β-sheet that allows Y106 to swing in to form a hydrogen bond
with mainchain carbonyl of E89 (Figure 3.35E). Such open conformations
of the sidechains and the β4-α4 loop, and such hydrogen network are absent
in the D1 domain. We conclude that D1 is in the inactive form.
DGC resembles the AC catalytic domain
The DGC domain ranges from residues 288 to 455. Its structure comprises
an open β-sheet composed of seven β-strands in the order 0,0’,2,3,1,4,5, all
of them anti-parallel except the last strand (Figure 3.36). The β-sheet is
packed by five α-helices on both sides of the central sheet. There is also a
small sheet of two anti-parallel β-strands separate from the main sheet.
The βααββαβα fold of the core of the DGC domain resembles that of
the AC catalytic domain [61] and of the DNAP I palm domain [13] (Figure
3.29 and 3.37). This common core structure comprises an anti-parallel β-
sheet of four strands in the order 2,3,1,4. The DGC domain and the AC
catalytic domain have an additional β5 strand parallel to the β4 strand to
finish the sheet. The sheet is packed by four α-helices in all three structures.
The highlight of the fold is the β-hairpin connecting the strands β2 and
β3, and it has been shown to form part of the catalytic site of AC and DNAP.
In the DGC domain, the GGEEF sequence motif that is highly conserved
in the DGC domain family but not in AC or DNAP is located on this β-
hairpin (Figure 3.30). Unlike in the AC catalytic domain or the DNAP I
palm domain, the β-hairpin in DGC domain is preceded by a bend, located
between the residues R366 and G368, that apparently stabilises it using an
elaborate hydrogen bonding network that involves mainchain atoms from
the strands β0 ad β0’ (Figure 3.38A). Specifically, the mainchain carbonyl
group of G369 receives a hydrogen bond from the N1 amino group of R366
on the bend (Figure 3.38B), whose orientation is stabilised by a hydrogen
bond between its Nζ amine group and the sidechain carboxyl group of D292
from the β0 strand. The orientation of the sidechain carboxyl of D292 is in
turn stabilised by hydrogen bond interactions with the sidechain hydroxyl
and mainchain amide of T295, and the mainchain amide of L297 from β0’.
The bend also seems to be further stabilised by the hydrogen bond between
the mainchain amide group of Y367 and the carbonyl oxygen of E371. The
bend, together with the β0 ad β0’ strands, are absent in AC and DNAP
(Figure 3.38C,D).
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Figure 3.36: Ribbon representation of the DGC domain structure. The β-strands in
blue and the α-helices in red refer to the core structure common in the DGC domain, AC
catalytic domain and DNAP palm domain. The β-strand in purple is found in both the
DGC domain and the AC catalytic domain. The secondary structures coloured in yellow
are found only in the DGC domain. Secondary structures are labelled accordingly.
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Figure 3.38: Differences in the conserved β-hairpins. A, Stereodiagram of the sideview
of the superimposition of the β2 and β3 strands including the β-hairpin from DGC (green),
AC catalytic domain (cyan) and DNAP palm domain (dark blue). Residues located at
the bend preceding the hairpin, as well as the conserved sequence motif, in the DGC
domain are labelled. B, Frontview of the hydrogen bonding network (yellow broken lines)
that stabilises the hairpin. Only the mainchain backbone is shown except the sidechains
of relevant residues. This hydrogen bonding network involves the mainchain of G369
from the β-hairpin, the sidechain of R366 from the bend, D292 from the β0 strand and
other residues from the β0’ strand, and the mainchain carbonyls of E371 and Y367. The
usual hydrogen bonds found within the β-hairpins and the two β-strands are shown in
red broken lines. Note that the carbonyl oxygen of G368 adopts an unusal conformation
that prevents it from making a hydrogen bond with the amide group of E371. B, The
same view of the hairpin for the AC catatytic domain. C, The same for the DNAP I palm
domain.
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Other structural features unique in DGC domain include the helix α0
that is N-terminal to the beginning of the core fold, and the small anti-
parallel β-sheet of β3’ and β3” that replaces the α3-β4 loop (Figure 3.36).
Domain interfaces
D1-D2 domain interface is stabilised by quasi-isologous salt bridges
A surface of 1038.2 A˚2 is buried at the interface between D1 and D2 domains
in the PleD monomer (Table 4.2). These two domains are related by a quasi-
two-fold axis (Figure 3.39) and are stabilised by quasi-isologous salt bridges
(Table 3.3) that involve helix α4 and strand β5 from one domain and helix
α5 from the other domain. Interestingly, these secondary structure elements
have been shown in other response regulator receiver domains to carry out
phosphorylation-induced conformational changes. It will be discussed in
the next chapter how the D1-D2 domain interface might be affected by
phosphorylation of the D1 domain through these conformational changes.
Table 3.3: Quasi-isologous salt bridges stabilising the D1-D2 domain interface connect
residues from helix α4 on one domain to helix α5 on the other domain, and strand β5 on
one domain to helix α5 on the other domain. The domain that the residue belong to is
provided in bracket.
α4-α5 salt bridges β5-α5 salt bridges
α4 α5 β5 α5
R91 (D1) D257 (D2) R115 (D1) D250 (D2)
R237 (D2) D108 (D1) R264 (D2) D101 (D1)
D2-DGC domain interface is smaller than D1-D2 domain interface
The domain interface of D2-DGC is smaller than that of D1-D2 and covers
an area of 686.6 A˚2. The two domains interact mainly through two salt
bridges between R155 of strand β1 in D2 domain and D378 of strand β3 in
DGC domain, and E182 of strand β2 of D2 domain and R313 of helix α0 of
DGC domain. There is also a hydrogen bond between R222 in D2 domain
and the mainchain amide of G305 of helix α0 in the DGC domain (Figure
3.40). In addition, the domain interface is further stabilised by hydrophobic
interactions between the helix α2 and the α2-α3 loop of D2, and between
the helix α0 and the α2-α3 loop of DGC.
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Figure 3.39: D1-D2 domain interface. A, D1 (red) and D2 (yellow) domains are related
by a quasi-two-fold axis that goes into the paper. Their interface is stabilised by quasi-
isologous salt bridges (in sticks) contributing by residues on the helices α4, α5 and the
strand β5. The sidechains of the residues involved in the acidic cluster for phosphoryla-
tion (in sticks) and the bound Mg2+ ion (purple) are also shown. B, Stereoview at the
arrangement of the salt bridges at the D1-D2 domain interface. The salt bridges are in
close vicinity to T83, F102 and K105 that are involved in conformational changes resulting
from phosphorylation. The Cα trace of the phosphorylated FixJN (pink) and the relevant
sidechains (carbons in pink) that are affected by phosphorylation are shown for reference
but not labelled.
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Figure 3.40: D2-DGC domain interface. Two ion pairs and a hydrogen bond that
involves a mainchain atom are important in stabilising this interface.
PleD has a small dimer interface
PleD is a dimer in the asymmetric unit (Figure 3.41). The dimer arrange-
ment is mainly stabilised by isologous interactions between residues from
the D1 and D2 domains. The dimer interface covers an area of 815.7 A˚2 per
monomer (Table 4.2). A central pore of the width of 9 A˚ and the length of
20 A˚ extends along the symmetry axis.
The dimeric contacts involve isologous D1-D2 interactions (Figure 3.41A-
B). The first interaction consists of a hydrogen bond between Gln131 and
Glu221 of which Glu221 is mildly conserved among the PleD homologues
but only in terms of charge (Figure 3.41C). The second interaction consists
of hydrophobic packing between Leu124 and the Cζ atom of Arg224, a
residue that is also conserved. Both sets of interactions involve helix α5 of
D1 and the 310-helix between α3 and β4 of D2. The third interaction seems
to be the most significant. A strictly conserved residue Tyr26 among the
PleD homologues from helix α1 forms a hydrogen bond with Arg239 and
serves as a ridge that fits into the well-defined pocket formed by a number of
residues, Arg212, Asp209, Ala215, Leu211, Lys242, Ile246 and Arg239, from
the other monomer (Figure 3.41D). All these residues come from the helices
α3 or α4 of D2, and hence, confer rigidity to the pocket. Asp209 and Leu211
are strictly conserved among PleD homologues whereas Arg212, Lys242 and
Ile246 are charge- or type-conserved.
It is worth noting that the N-terminus of the peptide is in the close
vicinity (Figure 3.42), suggesting that an N-terminal His-tag might cause
steric clashes at the dimer interface.
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Figure 3.41: Packing of the NCS dimer. A, Surface representation of the CF dimer
viewed along the NCS axis. DGC domains are at the top and D1 and D2 domains are at
the bottom. Chain A is coloured in grey and chain B in light blue. The points of dimer
contacts are coloured in purple on chain A and blue on chain B. The c-diGMP ligands
are shown in sticks. B, Sideview of the NCS-related dimer reveals three points of contacts
(arrows) on one side of the dimer, which are enlarged in panel C and D. C, Hydrogen
bonding between Q131 and E221 and hydrophobic interaction between L124 and R224.
Protein surface is set to semi-transparent for clarity. D, Hydrogen bonding between Y26
and R239 situated in a well-defined pocket.
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Figure 3.42: Overview of the arrangement of D1 (red) and D2 (yellow) domains in the
PleD dimer viewed from the D1-D2 dimer stem. D1 and D2 domains interact using dis-
tinctive surfaces for domain packing within the PleD monomer and for PleD dimerisation.
The overall shape of PleD is shown as a semi-transparent surface with the surface of one
monomer coloured in grey and that of the other in blue. The DGC domains are located
at the back of the dimer base but are omitted with the disordered linkers for clarity.
Secondary structures involved in the two types of D1-D2 interfaces are lablled.
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Ligand binding
PleD monomer has two c-diGMP binding sites (Figure 3.28B). The first
one is annotated as the catalytic active site, A-site, which is located in the
conserved β-hairpin region in the DGC domain. The second binding site is
unexpected. It is named the product inhibition site, I-site, and is located
at the D2 / DGC domain interface. The annotations of these nucleotide
binding sites will be explained later.
Crystal packing suggests that the active site is two-fold symmet-
rical
The catalytic active site is suggested by the crosslinking of two DGC domains
from adjacent symmetry-related PleD molecules by a c-diGMP molecule
(Figure 3.43). The two DGC domains, as well as the product molecule, are
related by local two-fold symmetry. This local axis is a direct result of the
orthogonal intersection of the NCS and crystallographic axes, both of which
being two-fold. Although this is an artefact of crystallisation specific to our
case, we believe that this reflects the situation in solution in which DGC
domains from the same PleD dimer can be bridged by the product molecule
for the following reasons. Firstly, the active site is located on the β2-β3-
hairpin not only found in the DGC domain, but also in AC and DNAP.
Secondly, this β2-β3-hairpin carries the GGDEF sequence motif which is
highly conserved in the DGC domain family. Thirdly, the presence of the
highly specific guanine binding pocket suggests this nucleotide binding site is
biologically relevant. In addition, the possible salt bridges between R300 and
D336 that connect the two DGC domain lends support to the significance of
such an arrangement of two DGC domains as shown in the crystal structure
(Figure 3.44). All these will be discussed in more detail in the following
sections.
GGEEF motif containing β-hairpin binds the nucleotide
As in the AC catalytic domain and the DNAP palm domain, the β2-β3-
hairpin in DGC domain forms part of the nucleotide binding site (Figure
3.44). In particular, it carries the conserved GGEEF sequence motif. The
ribosyl and the α-phosphate of the c-diGMP molecule extend over the β2-
β3-hairpin and completely cover G369 which probably explains the conser-
vation of a glycine at this position. The mainchain amide of G369 donates
a hydrogen bond to a non-ester oxygen of the α-phosphate. The carboxyl
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Figure 3.43: Two-fold related active site as implied by crystal packing. A, PleD dimer
in the asymmetric unit. Colour scheme is the same as in Figure 3.28. NCS axis is coloured
in black, crystallography axis in blue, and the local two-fold axis in red. B, The same
view showing the monomers that are related by the local two-fold axis (red) interacting
across the crystal layers. The top monomer is crystallographic symmetry related to the
NCS partner (shown in panel A but not here) of the monomer below. C, Head-on view of
this inter-layer monomer-monomer interaction along the local two-fold axis. The product
molecule also obeys this two-fold symmetry. Another inter-layer interaction is given by
the NCS partners (grey) of these monomers towards the back of the molecules. Their
crosslinking product molecule is removed for clarity.
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Figure 3.44: Stereodiagram of product binding at the A-site viewed along the local two-
fold axis. Crystal packing suggests that the DGC active site requires two DGC domains
arranged in a two-fold related fashion. The β-hairpin carrying the conserved GGEEF
sequence motif is coloured in blue. The relevant residues are labelled in full on one DGC
and in abbreviation with a ‘prime’ sign on the other DGC domain. Residues lining the
specific guanine pocket are coloured in yellow. The Fo-Fc map is contoured at 4 σ. The
sidechains of R300, K332, D336, E370 and E371 are partially disordered.
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group of E370 is partially disordered but the position of its β-carbon indi-
cates that the sidechain may point towards the ribosyl 3’ oxygen direction
in an enzyme-substrate complex. Together with K332 which is conserved
in the DGC domain family, E370 probably serves a catalytic function that
will be discussed later. The carboxyl group of E371 is also disordered but
may point towards the α-phosphate as indicated by the β-carbon position.
The possible role of E371 in nucleotide binding will be discussed in the next
chapter. The final residue in the sequence motif, F372, is situated in a
hydrophobic core in which the guanine is located.
c-diGMP binding at the active site involves specific guanine recog-
nition
The guanine base is inserted in a pocket formed mainly by helices α1 and
α2 of DGC (Figure 3.45). The strength and specificity of the binding is
provided by hydrogen bonding interactions. The carboxyl group of Asp344
receives a hydrogen bond from the NH group at position N1 of the guanyl
group. Moreover, Asn335 forms a bidentate hydrogen bond with the guanyl
group. Whereas its carbonyl Oδ receives a hydrogen bond from the exocyclic
amine group at position N2 of the guanyl base, its amine group donates a
hydrogen bond to the N3 atom of the guanine. The hydrogen bond between
the exocyclic N2 amine and Asn355 particularly explains the specificity of
DGC domain towards guanine over adenine [45] because asparagine cannot
interact with the carbon atom C2 in the adenine base. The location of the
G343, which is invariant in the DGC domain family, also seems to make
room for this exocyclic amino group in the guanine. Only the oxygen atom
O6 of guanine, which is replaced by an amino group in adenine, does not
make interactions with any protein residues.
In addition to the hydrogen bonding interactions, guanine also makes
hydrophobic contacts with the apolar sidechains of L294, F331, and L347
(Figure 3.45A,C), which, together with F372 from the signature motif, are
part of the hydrophobic core.
Apart from guanine recognition, the correct orientation of the ribosyl
group might be ensured by a hydrogen bond between the ribosyl 2’ oxy-
gen and the amine group of Asn335. The hydrogen bond between an α-
phosphate non-ester oxygen and the mainchain amide of G369 might also
help in keeping the position of the phosphate group close to the β-hairpin.
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Figure 3.45: c-diGMP binding to the A-site viewed directly into the guanine binding
site. A, Only half of the c-diGMP molecule is shown for clarity. All relevant sidechains
and the atoms of the nucleotide involved in the protein-ligand interactions are shown and
labelled. The β-hairpin is coloured in blue as before. B and C, Chemical properties of the
c-diGMP binding surface. Acidic surface is coloured in red, basic in blue, hydrophobic in
yellow, and the rest in grey.
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Two intercalated c-diGMP molecules bind to the inhibition site
at D2-DGC domain interface
The PleD structure shows an unexpected second c-diGMP binding site at the
D2-DGC domain interface, known as the inhibition site. At this I-site, two c-
diGMP molecules with mutually intercalated purine bases are bound (Figure
3.46A,B). Intercalation of this di-nucleotide has been reported previously
[16, 39] and might also exist in solution. In our structure, the intercalation
is provided by the stacking of the guanine bases and the intermolecular
hydrogen bonds between the central guanines and the phosphate groups
(Figure 3.46D, E). Unlike in the previous structure (Figure 1.2), however,
no Mg2+ ion is found in PleD to coordinate the two central guanines.
The product ligand is bound to both D2 and DGC domains through
a strong hydrogen bonding network (Figure 3.46C-F). The predominant
guanyl base-arginine pairing occurs three times involving both intercalated
molecules. Two of these pairing interactions are bidentate, in particular,
and involve the N7 and O6 atoms of the guanyl base (Figure 3.46C,E). The
binding of one of the product molecule to PleD seems to be tighter than the
other molecule. In this tightly bound molecule, the binding of one of the
guanyl groups is stabilised by a bidentate base-arginine pairing interaction
with R390 and another bidentate interaction with D362 via its N1 and N2
amine groups (Figure 3.46C). The other guanyl group in this molecule is
hydrogen bonded to R178 via its N7 atom (Figure 3.46D). As for the other
product molecule, only one guanyl base-arginine pairing is involved (Fig-
ure 3.46E). The second guanyl group in this molecule is hydrogen bonded
via its N2 amine group to the mainchain amide groups of G174 and H177
(Figure 3.46F). The tight binding of the c-diGMP molecules observed here
is consistent with the observed co-purification of c-diGMP during protein
preparation (Figure 3.6 and 3.7).
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Figure 3.46: c-diGMP binding to the allosteric I-site. A, Two intercalcated c-diGMP
molecules bind at the D2 (yellow)-DGC (green) domain interface. Guanyl groups from the
two product molecules (carbons in grey and khaki) alternately stack on top of each other.
The Fo-Fc map is contoured at 4 σ. B, Strong hydrogen bonding network connecting the
ligand and D2, the ligand and DGC, and the two product molecules. C-D, Interactions of
individual guanyl groups of one c-diGMP molecule (khaki) with PleD. The oxygen atoms
of the α-phosphate groups that are hydrogen bonded to the guanyl groups are shown
together with the entire α-phosphate group. E-F, Interactions of individual guanyl groups
of the other c-diGMP molecule (grey) with PleD. The sidechain of H177 is not shown.
Chapter 4
Discussion
The signalling PleD protein is important for an asymmetric cell differenti-
ation step in C. crescentus [1, 23]. It is a multidomain response regulator
that belongs to the two-component signal transduction pathway prevalently
used in bacteria [50]. Unlike the typical response regulators, PleD contains
three domains. The N-terminal D1 domain serves as the phosphorylatable
receiver domain like the CheY protein [35, 58], while the middle D2 do-
main only shares the CheY topology. The C-terminal DGC domain shows
the proven diguanylate cyclase activity to synthesise the putative secondary
messenger molecule, c-diGMP [45]. The high abundance of the DGC do-
main in diverse bacterial genomes and its role in producing c-diGMP has
pointed to a novel signalling pathway [18]. No downstream components of
this pathway have yet been characterised. The PleD protein, thus, provides
the best starting point to understand c-diGMP signalling.
Evaluation of PleD crystallisation
Based on the PleD structure, it is now evident why the selected construct
and ligand were useful for crystallisation. The selected construct makes
room for crystal contact and the selected ligand provides a crucial crystal
contacts.
The present crystal form of the CF protein crystal shows that the N-
terminus of the peptide is located at the dimer interface, suggesting an
N-terminal His-tag might prevent the formation of a PleD dimer. In fact,
the activity assay conducted in Prof Urs Jenal’s Group has shown that the
N-terminal tagged NF is inactive (personal communication). These might
explain why the NF protein only gave crystals of inferior quality (Figure
87
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3.17). The C-terminal tagged CF protein, on the other hand, has the His-
tag away from the dimer interface, thus allowing PleD dimer formation.
The crystal form of the CF protein also presents a special scenario in
which the two-fold symmetrical ligand, c-diGMP, crosslinks adjacent crystal
layers by inserting into a substrate binding site on each layer. Attempts in
co-crystallisating CF protein with substrate analogues like GMP-PNP and
GTPγS failed to give crystals diffracting better than 3 A˚ (Figure ??). It is
very likely that they fullfil the stereochemical requirements of the nucleotide
binding site due to their structural similarities to the c-diGMP molecule.
However, they are unable to physically bridge the two nucleotide binding
sites together to maintain the active site, simply due to the lack of covalent
bridges between the two bound molecules. This implies that we have to
screen for a new crystallisation condition if we were to obtain a substrate-
enzyme complex structure.
Evaluation of domain delineation results
The knowledge of the full-length structure of PleD also allows the evaluation
of the three methods used to determine the boundaries of different domains
prior to structure determination (Table 4.1).
Construct Predicted Approach Correct domain Correct boundary
domain(s) definition prediction
Full-length All N/A N/A N/A
137 D2, DGC Limited Proteolysis - +
150 D2, DGC Limited Proteolysis - +
153 D2, DGC Limited Proteolysis - +
287 DGC Sequence alignment + +
319 DGC Threading + -
Table 4.1: Performance of the three approaches on domain prediction and determination.
‘+’ symbolises positive, ‘-’ negative, and ‘N/A’ not applicable.
Published information was used in the first instance. The entry of PleD
(Q9A5I5) in the SwissProt database [6] automatically defined a ‘GGDEF’
domain in the PleD sequence. I searched for ‘GGDEF’ domain homologues
in the SwissProt database, carried out multiple sequence alignments and
secondary structure prediction to map the domain boundary (Figure 3.1).
The result was the constructs, N287 and C287, both starting at residue
287. As seen in the structure, this fragment is indeed identical to the do-
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main which we have coined the term ‘DGC’ after the biochemical evidence
of diguanylate cyclase activity. The predicted boundary starts in a small
turn that runs before the first strand of β0 starting at residue 290 in the
DGC domain (Figure 3.30). Despite the correction prediction of the domain
boundary, these constructs were, however, highly insoluble in solution.
In the second approach, the results of the domain analysis by Pei and Gr-
ishin were directly used [46]. Pei and Grishin extensively threaded GGDEF
domain homologues and detected a mild homology of this domain with the
AC catalytic domain. They aligned all these sequences and predicted the
domain boundary. According to their alignment, the DGC domain should
start at residue 319 in PleD. As in the first approach, they successfully pre-
dicted the GGDEF domain as a single domain. However, they failed to
determine the correct domain boundary by missing the N-terminal strands
of β0, β0’ and helix of α0 (Figure 3.30 and Table 4.1). The reason is that
the GGDEF domain of PleD has structural features that are additional to
those of the AC catalytic domain (Figure 3.37). When this happens, any
bioinformatic analysis based on structural homologues is prone to fail.
The domain architecture was also analysed by experimental methods.
Limited proteolysis of the full-length PleD protein was carried out in search
for protease-resistant fragments (Figure 3.9). Two stable protease-resistant
fragments were identified. One of them was the D1 domain, the domain
homologue of the CheY protein, while the other comprised the entire length
of the D2 and DGC domains. Three sets of constructs, N/C137, N/C150
and N/C153, were then designed with different starting residues in the linker
between the D1 and D2 domains. All constructs show the right boundary
(Figure 3.30 and Table 4.1), and all performed well in terms of expression,
purity and solubility in the first screen (Figure 3.11). However, our structure
reveals that D2 and DGC domains exist as two individual domains.
What makes the D1-D2 domain linker more accessible to the protease
than the D2-DGC domain linker? The reason is that there is actually no
trypsin cleavage site on the domain linker connecting the D2 and DGC
domains (Figure 3.30). A possible cleavage site is located before the last
residue of the helix α5 of D2 domain but was protected from cleavage.
As a summary, only the combined approach of sequence alignment of ho-
mologues and secondary structure prediction gave the right domain bound-
ary. Nevertheless, the resulting constructs did not overexpress and were not
stable in solution. It seems that nature has selected the optimal domain ar-
chitecture present in PleD, as the full-length constructs performed the best
in all experimental aspects (Figure 3.2 and 3.4).
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Model of substrate binding to DGC
Based on the observed product-enzyme complex structure (Figure 3.44) and
our knowledge of the DGC reaction (Figure 1.3), we propose a model for
the binding of the GTP substrate to the A-site (Figure 4.1).
Figure 4.1: Modelled GTP substrate binding to A-site of DGC. The two GTP molecules
are arranged in an anti-parallel fashion to allow β- and γ-phosphates to extend along the
glycine side of the β-hairpin. The ribosyl and guanyl groups bind in a very similar way
as they do in the enzyme-product complex structure.
Considering the specific interactions with the protein, the guanyl group
of the GTP substrate probably binds in the same way as that of the product
molecule, assuming that it remains stationary during catalysis. The ribosyl
group and the α-phosphate probably also bind very similarly. The β- and γ-
phosphate groups would extend from the α-phosphate alongside the highly
conserved G368 of the β-hairpin, and bind via a Mg2+ ion to E371 from
the conserved sequence motif. R300 would probably confer stabilisation
of the negative charges of the phosphate groups. Applying the same rules
to the GTP molecule on the other DGC domain, the result is two GTP
molecules arranged in an anti-parallel fashion and well juxtaposed to allow
for mutual intermolecular nucleophilic attack of the ribosyl 3’ oxygen onto
the α-phosphate.
Interestingly, a comparison of substrate binding in DGC domain, the AC
catalytic domain and the DNAP palm domain reveals substantial differences,
in spite of their common core structure (Figure 4.2). In both AC and DNAP,
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the phosphate-binding site is located on the short P-loop between strand β1
and helix α1. The binding is stabilised by two basic residues such as R484
and K1065 in AC and H506 and R518 in DNAP, which apart from R484,
come from the other subunit of the heterodimer in AC and from another
domain in DNAP (Figure 4.2B,C). Although DGC domain contains this P-
loop and the basic K442 and R446 that are at similar positions, juxtaposition
of the phosphate groups in this location would forfeit the specific guanine-
protein interactions and create a distance between the α-phosphate and the
ribosyl 3’ oxygen that is too long for an intermolecular attack (Figure 4.2A).
On the other hand, an attempt to simultaneously fix the guanyl group to
the guanine binding pocket and the phosphate groups to the P-loop would
be sterically unfeasible.
In the DGC domain, the guanyl group in GTP is modelled to bind
specifically as that in the product molecule to a guanine binding pocket
formed between the helices α1 and α2 (Figure 3.45). For AC and DNAP,
the base group is not bound at all to the catalytic domain or to the palm
domain. Instead, it is recognised by the other subunit of the heterodimer
in AC and by another domain in DNAP (Figure 4.2B,C). Specifically, the
adenine base of the ATPγS substrate analogue in the AC catalytic domain
is recognised by R938 and D1018 from the other subunit in the heterodimer
(Figure 4.2B) [62]. As for DNAP I palm domain, the base of the incoming
nucleotide for polymerisation with the primer DNA strand is stabilised by
the stacking of Y526 from another domain in the protein that promotes the
base-pairing of the nucleotide base with the template DNA strand (Figure
4.2C) [13].
Only the basic residue K332 in DGC (K1029 in AC and K522 in DNAP)
is modelled to stabilise the α-phosphate during its pentavalent intermediate
state and seems to play a similar role in the catalysis of the three enzymes.
Proposed catalytic mechanism
Based on the suggested mode of substrate binding in DGC domain, the fol-
lowing catalytic mechanism of DGC domain is proposed (Figure 4.3). For
catalysis to occur, two substrate-loaded DGC domains have to arrange them-
selves very similarly as observed in the crystal. This might be facilitated
by charge complementarity between D336 and R300 (Figure 3.44). Subse-
quently, the 3’-OH group of the GTP substrate has to be deprotonated to
allow for an intermolecular nucleophilic attack onto the α-phosphate (Fig-
ure 4.3A, B). E370 from the sequence motif appears to be well positioned
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Figure 4.2: Stereoview of the different substrate binding modes in DGC domain, AC catalytic
domain and DNAP I palm domain. The carbons of the substrates are shown in khaki. The
core fold common in all three structures, except α2 helix that is removed for clarity, is shown in
green. The backbone and the sidechain of the second subunit that are also required for nucleotide
binding are shown in cyan. Parts of the peptides are clipped off for clarity. A, In DGC domain,
the nucleotide is modelled to bind with the phosphate groups alongside the β-hairpin via a Mg2+
ion to E371. The sidechains of E370 and E371 are also modelled to adopt a plausible conformation
that favours catalysis and nucleotide phosphate binding respectively. The arrows from the ribosyl
3’ oxygen to the α-phosphate symbolise the intermolecular attacks. B and C, In AC and DNAP,
the nucleotide binds across the β-hairpin with the phosphate groups resting on the P-loop. In
DNAP, the template and the replicating DNA strands are shown in thin sticks.
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for acting directly as a general base, whereas K332, a conserved residue in
the DGC domain family, would stabilise the charge of the developing penta-
coordinated transition state and the leaving pyrophosphate (Figure 4.3C,
D). Water molecule(s) might be involved in the coordination with Mg2+
ion throughout the process, and might assist in deprotonating the catalytic
E370 in the final step to reset the whole process.
The proposed catalytic mechanism in DGC domain makes use of the
single catalytic acidic residue of E370 (Figure 4.2A). The suggested role of
the modelled Mg2+ ion is to mediate the binding of the nucleotide phosphate
groups to the other acidic residue of E371, which is conserved in the DGC
domain family. This mechanism is significantly different from the two-metal
ion catalysis in AC and DNAP, in which two invariant aspartates are used
with the assistance of a bound Mg2+ ion in the deprotonation of the ribosyl
3’ hydroxyl group [61]. In AC, the two conserved aspartates are D396 from
the β-hairpin and D440 from the strand β1 (Figure 4.2B). Although PleD
also exhibits two invariant acidic residues in very similar positions, namely
E370 from the β-hairpin and D327 from the strand β1, there is no indication
of a bound metal ion in the close vicinity. It is also unlikely that a Mg2+ ion
coordinated by these residues would be able to reach the ribosyl 3’ hydroxyl
group.
The proposed mode of substrate binding in the DGC domain and the
accompanying proposed catalytic mechanism favour the PleD reaction, in
which two identical substrates are arranged in an anti-parallel manner to
form a symmetrical cyclic di-nucleotide. The mechanism involved to com-
plete this bimolecular reaction could be significantly different from that to
complete a reaction such as the AC reaction, that uses only one substrate
molecule to form a cyclic mono-nucleotide.
Allosteric product inhibition of DGC domain in
PleD
The tight binding of c-diGMP at the I-site (Figure 3.46) offers the explana-
tion for the observed co-purification of c-diGMP during protein preparation
(Figure 3.6 and 3.7). In fact, kinetic experiments performed in the group
of Urs Jenal revealed that PleD was significantly inhibited by the product
c-diGMP, with an inhibition constant Ki of 0.5 μM (Figure 4.4). This value
is lower than the estimated cellular concentration of c-diGMP [52] by about
an order of magnitude. The product inhibition was also shown to be inde-
pendent on the substrate concentration, suggesting that the inhibition was
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Figure 4.3: Proposed DGC catalytic mechanism. A Mg2+ ion and a water molecule
are included in the model. A, The two GTP substrates align themselves in a symmetrical
arrangement at the two-fold symmetrical active site formed by two DGC domains. The
carboxyl group of E371 deprotonates the ribosyl 3’ hydroxyl group. B, The ribosyl 3’
oxygen initiates an intermolecular nucleophilic attack onto the α-phosphate of the other
GTP molecule. C, α-phosphate is in the penta-coordinated state which is stabilised by
K332. D, Pyrophosphates leave. c-diGMP is formed. A water molecule might deprotonate
E370 to reset the whole process.
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non-competitive. This finding suggests an allosteric regulation of the DGC
activity in the PleD protein.
Figure 4.4: Product inhibition of PleD at varying GTP concentrations. Roughly 5
μM of c-diGMP concentration is required to attain 50 % inhibition at all tested GTP
concentrations. Considering the enzyme concentration is 5 μM and the molar ratio of
PleD to I-site bound c-diGMP is 1:2, the Ki is estimated to be 0.5 μM, assuming c-
diGMP is a dimer in solution. The kinetic data were measured by Ralf Paul, Uni. Basel,
in an assay using thin layer chromatography [45].
Mechanism of PleD regulation
PleD catalyses a condensation reaction of two identical substrates to yield
a symmetrical product molecule. The crystal structure of PleD suggests
that each PleD monomer forms a binding site for one substrate molecule.
Although the non-activated PleD is monomeric in solution as determined by
analytical ultracentrifugation and gel filtration (Figure 3.3) dimerisation of
PleD appears necessary to promote effective active site formation by raising
the local concentration of the DGC domains. Based on this reasoning, a
simple mechanistic model of activation and product inhibition is proposed
(Figure 4.5).
Phosphorylation at Asp53 of D1 would induce rotameric switches in
Thr83 and Phe102 that would affect the C-terminal region of D1 domain,
especially helix α4 and the α4-β5 loop, as in the studied examples of phos-
phorylated response regulator receiver domains [4, 35]. Since the residues in
D1 domain that contribute to the salt bridges at the D1-D2 domain interface
are also located in this region, a conformational change here might cause a
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Figure 4.5: Mechanistic model of PleD regulation. The catalytic DGC domain (green)
is tethered via a flexible linker to the D1-D2 stem (orange). It is postulated to be mobile
with respect to the stem as indicated by the curved broken arrow. Top row: PleD is
activated by phosphorylation at the D1 domain, which induces dimerisation mediated by
the D1-D2 stem and allows the two substrate binding sites, bound with GTP substrates
(yellow), to approach each other to undergo c-diGMP synthesis. Bottom row: Allosteric
product inhibition occurs by the binding of the intercalated c-diGMP molecules to the
I-site at the stem-DGC domain interface. DGC domain is immobilised with respect to the
stem and barred from approaching its counterpart in the dimer. The schematic diagram
of the crystal structure is shown in a box at the bottom, right hand corner for reference.
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reshuffling of the salt bridges and a reorientation of the D1 and D2 domains
(Figure 3.39,3.42). In effect, a reorientation of the domains might create an
optimal interface that favours PleD dimerisation through isologous D1-D2
domain interactions.
The dimeric structure of non-activated PleD in the crystal might resem-
ble that of an active dimer, though with a suboptimal interface. This view is
supported by the lack of activity of the N-terminal His-tagged PleD protein
(data not shown) that was probably due to the interference of the His-tag
with the dimer interface (Figure 3.42). The basal activity observed for PleD
protein in vitro [45] might actually be due to the presence of a small amount
of non-optimal dimers.
Considering the small D2-DGC domain interface (Table 4.2), and as-
suming flexibility in the D2-DGC domain linker, a ‘closed’ conformation of
the PleD dimer is conceivable (Figure 4.6) in which the two DGC domains
within the dimer can associate to form the two-fold symmetrical active site
as observed in the crystal packing.
Table 4.2: Solvent accessible area per monomer buried as a result of molecular assembly
at different interfaces. Solvent accessible area of the molecules is calculated using a 1.4-
A˚ probe rolling around the van der Waals surface of the molecule in the programme
NACCESS [25, 34]. All disordered linkers were excluded from the structures for surface
calculation.
Molecule / Domain 1 Molecule / Domain 2 Buried surface area(A˚2)
D1 D2 1038.2
D2 DGC 686.6
Chain A Chain B 815.7
A-site ligand DGC 248.4
s S-site ligands Monomer 521.7
S-site ligands D2 192.8
S-site ligands DGC 383.9
However, product binding to the I-site would stabilise the D2-DGC do-
main interface and immobilise the DGC domain relative to the D2 domain,
thereby preventing the formation of the DGC active site.
The full-length structure of PleD shows the unusual domain architecture
in this multidomain response regulator. The presence of a non-receiver D2
domain serves to assist in both the activation and the allosteric regulation
of the enzyme.
The tight feedback regulation of PleD by product inhibition may indicate
98 CHAPTER 4. DISCUSSION
Figure 4.6: Proposed open and closed conformations of PleD. NCS axis is coloured
in black, crystallographic axis in blue, and the local axis holding the A-site in two-fold
symmetry is in red. All pictures here are shown from the same perspective. A, The crystal
structure shows the PleD dimer in the ‘open’ conformation. The two c-diGMP molecules
‘half-bound’ to each PleD monomer are shown. B, Crystal packing shows that two DGC
domains can arrange themselves to form a product binding site. Part of the upper PleD
monomer is clipped off to maintain the same view and same molecule size as in panel A.
C, To model the observed DGC-product-DGC complex in the context of a dimer requires
bringing the observed complex to an orientation such that the local axis it obeys will
coincide with the vertical NCS axis. The result is the modelled ‘closed’ conformation
of PleD. Here we assume that the DGC domain is free to move with respect to the D2
domain.
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the importance of imposing an upper limit on the cellular concentration of
the secondary messenger c-diGMP. It remains to be shown that inhibition
indeed constitutes, as predicted by the model, an overriding principle, i.e.
that inhibition is independent on the phosphorylation state of the enzyme.
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Chapter 5
Conclusions
Our crystal structure of the multidomain response regulator PleD protein in
complex with its product at 2.7 A˚ has shed light onto the catalytic mecha-
nism of the enzyme and its possible regulation. PleD contains three domains,
D1, D2 and DGC. While the N-terminal D1 is a CheY-like receiver domain,
the D2 domain is only structurally similar to CheY. The DGC domain is
shown to share the fold of the AC catalytic domain. The GGEEF sequence
motif is found at the β2-β3 hairpin that is conserved among all DGC ho-
mologues and is involved in nucleotide binding. It is also predicted that it
participates in the DGC activity. However, the modelled substrate bind-
ing mode in DGC is significantly different from that of AC, suggesting a
different catalyic mechanism.
Useful clues regarding the activation and inhibition of PleD have been
obtained from our crystal structure. Two DGC domains are required to
arrange symmetrically in order to form the catalytic active site. Thus, PleD
is activated by dimerisation to release the putative secondary messenger
molecule. The unexpected binding of the product molecules at the D2-DGC
domain interface has enabled us to postulate an allosteric inhibitory mech-
anism, which is manifested by the product molecules in the immobilisation
of DGC domain to the dimer base. This allosteric control provides a second
layer of regulation of the enzymatic activity in this multidomain response
regulator.
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Chapter 6
Perspectives
Since the A-sites are formed at the crystal contacts by two crosslinked,
symmetry related PleD dimers, the present crystal structure of PleD does
not represent any of the states we have postulated in the mechanistic model
(Figure 4.5). In order to prove this model, further studies are required to
show:
• the active dimer with the optimal dimer interface
• the binding of the GTP substrate to DGC domain
• the active site within the PleD dimer
• the flexibility of DGC domain
The first goal can be achieved by obtaining the structure of activated
PleD. Activation can be achieved using BeF3− modification or phosphoryla-
tion with acetophosphate as it has been achieved in other response regulator
receiver domains [4, 29, 35, 38]. While a crystal structure of the activated
PleD showing an optimal dimer interface would provide direct proof to the
activation model of PleD, a similar structure but with product molecules
bound at the I-site would lend support to an overruling role of allosteric
control over phosphorylation.
Some may argue against our model of DGC catalytic mechanism, espe-
cially regarding the invariant D327 that is required for catalysis in AC and
DNAP but not in DGC. Although we have shown that nucleotide binding to
the usual location at the conserved P-loop is unlikely, our enzyme-product
structure, however, does not give direct evidence as to how the phosphate
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groups of the GTP substrate bind to the DGC domain. A complex struc-
ture of the protein with substrate or substrate analogue would clarify this
ambiguity. Alternatively, a complex structure using a D327 mutant comple-
mented with the activity assay would serve the same goal.
Our model of product inhibition through the DGC domain immobili-
sation is based on the assumption that the DGC domain is flexible with
respect to the D1 / D2 dimer base. To test the influence of c-diGMP bind-
ing on DGC domain flexibility, the techniques of small angle X-ray scattering
(SAXS) and NMR could be performed on the protein with and without al-
losterically bound product. We expect DGC domain attains a well-defined
position, as in the crystal, when the product molecules are bound and car-
ries out large movement when it is free of product molecules. The conforma-
tional change is estimated to be on the scale of tens of A˚, given the maximum
length of the product-bound protein of 80 A˚ and the length of the D1-D2
domains of 50 A˚. It is known that conformational changes in the range of 10
A˚ are detectable by the SAXS technique [43]. On the other hand, when the
conformational changes are studied using NMR, the large movement of the
DGC domain would lead to slower relaxation compared to faster relaxation
of the rest of the protein. We expect a broadening of the peaks that refer
to the DGC domain. In both the SAXS and NMR experiments, we hope
to determine the inhibition constant by titrating the protein with product
molecules until the DGC domain becomes immobilised.
Among the few multidomain response regulators whose full-length struc-
tures are known [2, 12, 51], PleD is the only one that contains an additional
CheY-like [35, 58] receiver domain, that is placed between the receiver do-
main D1 and the effector domain DGC. Such an unusual domain arrange-
ment can now be explained by the involvement of the D2 domain in both the
activation and the allosteric control of the protein. PleD employs an extra
level of regulation, compared to many response regulators which negatively
regulate the activity of the effector domain only by autodephosphorylation.
Owing to the lack of structures of both active and inactive multidomain re-
sponse regulator, the mechanism of the relay of phosphorylation signal from
the receiver domain to an output signal from the effector domain still re-
mains unclear. Biochemical data may provide clues to the problem but may
not provide explanations at the molecular level. To unravel the mystery of
the domain communication in the family of response regulators and to test
our mechanistic model of activation and allosteric control, it is imminent to
obtain the crystal structure of the activated PleD.
Appendix A
Data deposition
The coordinates of the PleD crystal structure are deposited in the PDB
under the accession code 1W25.
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Recent discoveries suggest that a novel second messenger, bis-(3’5’)-cyclic di-guanosine
monophosphate (c-diGMP), is extensively used by bacteria to control multicellular
behavior. Condensation of two GTP to the dinucleotide is catalyzed by the widely
distributed diguanylate cyclase (DGC or GGDEF) domain that occurs in various
combinations with sensory and/or regulatory modules.
The crystal structure of the unorthodox response regulator PleD from Caulobacter
crescentus, which consists of two CheY-like receiver domains and a DGC domain has been
solved in complex with the product c-diGMP. PleD forms a dimer with the CheY-like
domains (the stem) mediating weak monomer - monomer interactions.
The fold of the DGC domain is similar to adenylate cyclase, but the nucleotide binding
mode is substantially different. The guanine base is H-bonded to Asn335 and Asp344,
whereas the ribosyl and -phosphate moieties are extending over the 2-3 - hairpin that
carries the GGEEF signature motif. In the crystal, c-diGMP molecules are cross-linking
active sites of adjacent dimers. It is inferred that, in solution, the two DGC domains of a
dimer align in a 2-fold symmetric way to catalyze c-diGMP synthesis.
Two mutually intercalated c-diGMP molecules are found tightly bound at the stem - DGC
interface.  This allosteric site explains the observed non-competitive product inhibition. We
propose that product inhibition is due to domain immobilization and sets an upper limit for
the concentration of the second messenger in the cell.
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Cyclic nucleotides like cAMP or cGMP have been recognized as important low-molecular-
weight signaling molecules. While bacterial pathogens can interfere with cGMP signaling of
their eukaryotic host cells (1), prokaryotes in general do not seem to use cGMP for signaling. In
contrast, the cyclic bis-3’5’-dinucleotide c-diGMP has been shown to regulate cell surface
associated traits and community behavior like biofilm formation in a number of bacterial species
(2-5). The general importance of c-diGMP is underscored by the omnipresence of the
DGCdomain (hitherto named GGDEF or DUF1) in bacterial genomes, where it occurs in various
combinations with other sensory and/or regulatory modules (6, 7). Despite the wide distribution
and obvious regulatory relevance of DGC proteins, structural and functional information about
this class of regulators is largely missing.
In Caulobacter crescentus, pole remodeling during development is regulated by several polar
sensor histidine kinases, which control the diguanylate cyclase activity of the response regulator
PleD (8, 9). PleD is composed of a CheY-like receiver domain (D1), a CheY-like adapter domain
(D2) and a DGC domain. Upon phosphorylation of D1, activated PleD sequesters to the
differentiating pole, where it catalyzes the conversion of two molecules of GTP to c-diGMP (10).
Thus, by coupling of activity and subcellular localization, the PleD readout is controlled in time
and space. The conformational changes invoked by phosphorylation of response regulator
receiver (RRR) domains have been studied thoroughly on CheY (11) and other single domain
receiver proteins (for a review, see (12)). Little, however,  is known about how these alterations
are transmitted to the effector protein or domain and only few intact multidomain response
regulators have been analyzed structurally. Distinct mechanisms of activation, such as relief of
active site obstruction (CheB (11, 13)), dimerization (DrrB, DrrD (14)), or both (NarL (15)),
have been proposed.
Here, we report the structure of full-length PleD that allows drawing conclusions regarding its
mechanism of activation and product inhibition. Also, by providing a detailed view on the
enzyme - product interactions, our study offers insight into the catalytic mechanism of this
widespread family of regulatory proteins.
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Material and Methods
Overexpression and purification. Full-length PleD with a C-terminal His6 tag was
overexpressed in E. coli strain BL21 (DE3) pLysS. Purification was performed on a NiSO4-
charged HiTrap chelating HP column (Amersham Biosciences, Germany) with elution at
approximately 200 mM imidazole. The pooled fractions were dialyzed overnight in 20 mM Tris-
HCl (pH 8.0), 100 mM NaCl, and 1 mM DTT at 4 oC. The protein solution was concentrated and
after clarification loaded on a Superdex 200 HR 10/30 column(Amersham Biosciences) pre-
equilibrated with the same buffer. PleD appeared as monomer and fractions contributing to the
peak were pooled. Selenomethionine-substituted PleD was expressed using the metabolic
inhibition pathway. The purification procedure was the same as for native PleD.
Enzymatic assays. The assay for the measurement of the initial velocity of c-diGMP has been
described previously (10). In short, GTP containing [-32P]GTP (Amersham Biosciences; 5
nCi/μL) was added  to 50 μL of a solution containing 12.5 μg PleD in 50 mM Tris-HCl pH 7.8,
100 mM NaCl, 10 mM MgCl2, 5 mM -mercaptoethanol.  Aliquots were taken at regular time
intervals and the product was assayed by thin layer chromatography.  For the product inhibition
measurements, PleD was pre-incubated with c-diGMP at 25oC for 5 min. Care was taken to
remove any bound c-diGMP from PleD carried over from the purification by extensive dialysis.
Diguanylate cyclase activity was also assayed indirectly by monitoring the production of PPi
using an enzyme coupled spectrophotometric assay (16). The reaction mixture contained PleD in
20 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM MgCl2, 100 μM GTP and pyrophosphatase (500
mU/ml). The reaction was stopped by transferring 100 μL reaction mixture into the phosphate
assay reagent  (pH  0; 1 mL final volume) containing molybdate and malachite-green. The
phosphate content in commercial GTP products had to be reduced from ca. 5 % to less than 0.5
% by anion exchange chromatography to reduce background absoprtion (17).
Crystallography. Crystals were obtained at room temperature by hanging drop vapor diffusion.
For this, PleD at a nominal concentration of 200 μM = 10 mg/mL (assuming an 	280 of 9200 M-
1cm-1) in 20 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM DTT, 2 mM MgCl2 and 0.8 mM
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synthetic(10) c-diGMP was mixed with the reservoir (1.0 M glycine pH 9.2, 2 % dioxane, 14.5
% polyethylene glycol 20 000) at a ratio of 1:1. Selenomethione-substituted crystals were
obtained in the same manner, but using a reservoir solution containing 1.0 M TAPS pH 9.0, 2 %
dioxane, 11 % polyethylene glycol 20000. Diffraction data were collected from a single native
(about 15 μm in diameter) and a single Se-Met substituted crystal (60 μm) at the Swiss Light
Source, Paul Scherrer Institute, Villigen, Switzerland,  and were processed with
MOSFLM/SCALA (18). 18 selenium positions were identified using SHELXD (19). Phase
refinement was performed by SHARP/SOLOMON (20) and was followed by 2-fold averaging
and phase extension using DM (21). The model was built at the interactive graphics and refined
by using REFMAC (18) imposing strict NCS constraints for the two copies in the asymmetric
unit except for residues 117, 164, 168, and 404. The entire main-chain is defined by electron
density except for residues 137 - 146, 282 - 288, and the C-terminal His-tag.
Results and Discussion
Crystal structure. The crystal structure of non-phosphorylated PleD has been solved by MAD
phasing on Se-Met substituted protein to 2.7 Å (Table 1). The structure shows a linear
arrangement of three structural domains (D1, D2, DGC; Fig. 1a) that are connected by single,
disordered loops. As anticipated, domains D1 and D2 show the typical RRR fold with ()5
topology. However, in both domains, the C-terminal helix 5 is considerably extended and
protrudes from the globular domain, apparently enhancing the D1 - D2 contact. Both domains
closely resemble each other (RMSD = 1.2 Å for 119 C). Quasi-isologous contacts are formed
between helix 5 of one domain and 4, 5, 5 of the other domain. The C-terminal extensions
of the 5 helices form mutual apolar contacts, while their N-terminal parts are involved in
several ionic interactions with 4 and 5 (Fig. 1b).
Only D1 carries all the residues required for RRR activation (11). These are primarily aspartates
D9, D10, and the phosphoacceptor D53 of the 'acidic pocket', but also residues K105, T83, and
F102 that have been shown to undergo large structural changes upon activation (11). Strong
density is bridging the three carboxylates of the ‘acidic pocket’ and main-chain carbonyl 55. In
line with its coordination geometry, this has been modeled as a Mg++ ion. Comparison of D1 with
 Diguanylate cyclase structure and mechanism  6
other known RRR structures confirms that D1 is in the non-activated conformation with the 4-
4 loop in an "outward" orientation. The structural changes accompanying activation in RRRs
are known (22). In Fig. 1b, (non-activated) PleD and activated FixJ (23) are superimposed. From
this, one would predict that the largest conformational change upon PleD activation would occur
in the 4-4 loop with a concomitant shift (1-2 Å) in 4 that participates in the D1 - D2
interaction. Another prominent change would be a rotameric switch of F102. Aromatic residues
in this position have been shown to swing from a half-buried location into a pocket between 4
and the -sheet that opens up upon activation (11, 23). Notably and similar to CheB (24), F102 is
located at a central position of the interface (Fig. 1b). This argues for a repacking of the D1 - D2
interface upon phosphorylation. How this may tie in with a global model of PleD activation is
discussed below.
The DGC (GGDEF) domain consists of a 5-stranded central -sheet surrounded by helices (Fig.
1a). Discounting two additional short -hairpins (0, 0’ and 3’, 3’’) and the N-terminal helix
0, the succession of secondary structure elements is (), for which the topology is
identical and the arrangement closely similar to that of the catalytic core of adenylate cyclase
(AC) (25) as well as to the 'palm' domain of DNA polymerases (26) (Fig. S1). Structural
relatedness with AC has been proposed earlier by sequence threading (27). Obviously, the DGC
domain is functionally related to AC and DNA polymerases in that it also catalyzes 3' - 5'
phosphodiester formation. The GG(D/E)EF signature motif locates to the central -hairpin (Fig.
1a) which, as in AC and DNA polymerases, constitutes part of the active site.
In the crystal, PleD monomers are arranged to local dimers (Fig. 1c). Isologous contacts are
formed, with Y26 of D1 being tucked between helices 3 and 4 of D2 and the N-terminus
contacting 3. The small contact area (2 x 425 Å2) is consistent with the monomeric state of
PleD in solution. Along the direction of their symmetry axis, dimers are associated head-to-head
to form tetramers of 222 symmetry. Intriguingly, this interaction does not involve protein -
protein contacts. Instead, as shown in Fig. 2a, c-diGMP is bound with its two guanine bases in a
2-fold symmetric fashion to the active site formed by the adjacent monomers. This cross-linking
of adjacent dimers represents a serendipitous crystallization artifact, since it provides
comprehensive information about the product - enzyme interactions that appears relevant also for
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the situation in solution where the product would bridge the catalytic domains within a dimer
(see below).
Active site and catalytic mechanism. Figure 2b shows that the guanine base is inserted in a
pocket formed mainly by helices 1 and 2 of DGC. All of its polar atoms except O6 make
specific interactions explaining the observed GTP versus ATP discrimination (10). The N335
side-chain forms H-bonds with N3 and N2, whereas N1 is recognized by the D344 carboxylate.
Both residues are highly conserved amongst DGC domains. Furthermore, the base abuts to the
apolar side-chains of L294, F331, and L347. The ribosyl and the -phosphate are extending over
the turn of the 2-3 - hairpin with G369 being completely covered explaining glycine
conservation at this position. The 2'-hydroxyl is H-bonded to N335 and a phosphate non-ester
oxygen is in the vicinity of the main-chain amide 369.
On the basis of the observed complex structure, extrapolations regarding the binding mode of the
GTP substrate to an individual DGC domain as well as the catalytic mechanism can be proposed
(Fig. 2c). Considering the specific interactions with the protein, it is most likely that the guanyl
base does not change its position during catalysis. Furthermore, we assume that the ribosyl and
phosphate moieties largely keep their position In this case, the - and -phosphates of the
substrate would be easily accommodated close to G368 of the -hairpin and probably be bound
via a Mg2+ ion to E371 with R300 conferring further stabilization. For catalysis to occur two
substrate-loaded DGC domains have to arrange themselves in a similar way like the inter-dimer
cross-link in the crystal (Figs. 2b,c). This might be facilitated by charge complementarity
between D336 and R300 (Fig. 2b). Subsequently, the 3'-OH group of the GTP substrate has to be
deprotonated to allow an intermolecular nucleophilic attack onto the -phosphate. E370 appears
well poised for acting as a general base, whereas K332 would stabilize the charge of the
developing pentacoordinated phosphoryl transition state and the pyrophosphate leaving group.
All the residues proposed to be of functional importance are highly conserved amongst DGC
sequences.
Intriguingly, the proposed nucleotide-binding mode is different from that observed in AC (Fig.
2d) and DNA polymerases. In both enzymes, the phosphate-binding site is provided by the short
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P-loop between 1 and 1. In AC, the base is lying on the -hairpin and is recognized by
residues of the second subunit of the heterodimer, whereas in DNA polymerases the base adopts
even another position, which allows base pairing with the template strand (28). Is it conceivable
that DGC can bind the substrate in a similar way as AC? This appears unlikely, since there
would be no interactions with the base conferring specificity and contributing to binding affinity.
An alternative model with the base bound to the DGC guanine binding pocket and the terminal
phosphates bound to the P-loop appears sterically unfeasible. Thus, there seems to be no
reasonable alternative to the proposed model of the substrate - DGC complex which,
nevertheless, has to be confirmed experimentally. In AC, a magnesium ion coordinated by two
aspartates (D396, D440; Fig. 2d) has been proposed to assist in the nucleophilic attack of the 3’-
OH group onto the -phosphate (25). Conspicuously, the DGC domain exhibits two invariant
acidic residues (D327, E370) at very similar positions, but there is no indication for a bound
metal, which is in line with the disorder of E370. In fact, a magnesium ion coordinated by these
residues would be too distant from the substrate to be effective. E370 is proposed to act as a
general base (see above), but the role of D327, if there is any, remains to be elucidated.
Allosteric site and product inhibition. Unexpectedly, the crystal structure shows two product
molecules bound to the D2/DGC interface (I-site; Figs. 1 and 3). The dimeric ligand is of
compact, roundish shape with mutually intercalated purine bases. Each of the two central guanyl
moieties forms an intermolecular H-bond with a phosphate group. A similar structure has been
observed for several crystal forms of c-diGMP (29, 30) and may be present also in solution. The
ligand is bound to both D2 and DGC by a multitude of specific interactions. Hereby the common
base - arginine pairing motif involving O6 and N7 of the guanyl (31) occurs three times (with
R390, R359 and R178; Fig. 3b). Tight binding is consistent with the observed co-purification of
c-diGMP during protein preparation. Intriguingly, kinetic data reveal strong product inhibition,
with a Ki (0.5 μM; Fig. S2) about an order of magnitude lower than estimated for the cellular
concentration of c-diGMP (32). Clearly, inhibition is non-competitive (Fig. S2) , i.e. independent
of substrate concentration, and can thus be attributed to an allosteric effect of I-site binding.
Mechanistic model of regulation. PleD catalyzes a condensation reaction of two identical
substrates (that are bound to two identical DGC domains) to yield a C2-symmetric product
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molecule. In solution, non-activated PleD appears to be monomeric as determined by analytical
ultracentrifugation and gel filtration (not shown). For the enzyme to be efficient, dimerization
appears necessary, since a reaction catalyzed by monomeric PleD would be severely limited by
the macromolecular diffusion rate. Based on this reasoning, a simple mechanistic model of
activation and product inhibition can be proposed (Fig. 4). Phosphorylation at D53 of D1 would
induce repacking of the D1/D2 interface and reorientation of D1 with respect to D2. This in turn
will enhance dimer formation mediated by isologous D1 - D2 contacts across the interface. In
fact, the dimeric structure of non-activated PleD in the crystal may well resemble the active
dimer, though with a suboptimal interface. This view is supported by the lack of activity of N-
terminally His-tagged PleD (data not shown) which would be due to interference of the tag with
the interface (Fig. 1c). The low constitutive activity observed in vitro (10) would thus be due to a
small fraction of non-dissociated dimers. Consistent with this, the specific activity shows a
strong dependence on the enzyme concentration (unpublished data).
The large distance between the substrate binding sites of the crystal dimer (Fig. 1c) would not
permit catalysis. However, allowing for flexibility of the DGC domains relative to the stem (a
realistic assumption considering the small D2/DGC interface area of 690 Å2) a 'closed' dimer
conformation competent for catalysis can be readily modeled (schematically shown in Fig. 4) in
which a complete 2-fold symmetric active site is formed as observed for the DGC/DGC'' pair
(Fig. 2b). In the context of this 'activation by dimerization' model the observed allosteric product
inhibition can easily be explained (Fig. 4). Stabilization of the D2/DGC interface by product
binding to the I-site would simply prevent encounter of the substrate binding sites ('inhibition by
domain immobilization’).
The tight feedback regulation of PleD by product inhibition probably demonstrates the
importance of imposing an upper limit on the concentration of the second messenger c-diGMP. It
remains to be shown that inhibition indeed constitutes, as predicted by the model, an overriding
principle, i.e. that inhibition is independent of the phosphorylation state of the enzyme. The
structure of DGC provide the first insight into the molecular interactions of  c-diGMP with its
possible partners. The quest for downstream targets of this messenger that appears to be
ubiquitous in prokaryotes (6) has started.
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Table 1. Crystallographic data
Data collection Native SeMet
Peak Inflection Remote
Wavelength (Å) 0.97950 0.97950 0.97970 0.97700
Resolution (Å)
Highest shell (Å)
2.7
2.85 – 2.70
3.2
3.27 – 3.20
3.0
3.16 – 3.00
3.0
3.16 – 3.00
Space group P42212
a = b (Å)
c (Å)
135.9
169.2
134.9
168.1
Nr. of unique
reflections
42707 26249 32080 32140
Redundancy 5.7 (5.5) 4.1 (3.9) 4.8 (4.9) 4.6 (3.6)
I /  7.2 (1.9) 6.2 (2.1) 7.2 (1.8) 7.3 (1.1)
Completeness (%) 99.3 (98.7) 99.9 (100) 99.9 (100) 99.6 (97.6)
Anom. completeness
(%)
- 99.7 99.9 97.5
Rmerge (%) 8.3 (36) 10.5 (33) 9.4 (39) 11.0 (63)
Phasing
Resolution shell 13.12 7.69 5.98 5.06 4.47 3.72 3.46 3.16
Figure of merit 0.74 0.67 0.62 0.55 0.50 0.34 0.27 0.13
Mean figure of merit 0.39
Refinement
No of molecules in a.u. 2 Protein atoms 6883
Resolution (Å) 50.0 – 2.7 Water molecules 15
R / Rfree (%) 21.0 / 23.9 Ligand atoms 233
RMSD
            bond lengths a (Å)
            bond angles a (o)
0.008
1.2
Residues in
Ramachandran core (%)
92.8
Residues in disallowed
region (%)
0.0
Average B (Å2) 25.6
Rms B of bonded atoms (Å2)
main chain
side chain
1.13
2.42
Values in parentheses are for the highest resolution shell.
a RMSD from ideal stereochemistry.
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Legends to the Figures
Figure 1. Crystal structure of PleD. a, The monomer consists of three domains connected by
disordered linker peptides (light grey). Domains D1 (residues 2-140, red) and D2 (141-285,
yellow) show the CheY-like fold. D1 carries the phosphoacceptor D53. The catalytic DGC
domain (286-454) is shown in green. The GGEEF signature motif is located on the -hairpin
(blue) and constitutes part of the active site (A-site) to which a c-diGMP molecule is bound. Two
c-diGMP molecules are found at the D2/DGC interface (I-site). b, The D1(red)/D2(yellow)
interface as viewed along the quasi-two-fold. Compared to the view in panel a the structure has
been rotated by 900 approximately around the horizontal. Ionic residues in the interface and
residues implicated in activation (phosphoacceptor D53, K105, T83, F102) are shown. The trace
of the 4-4 loop and F101 of phosphorylated FixJ (magenta; PDB code 1d5w (23)) is shown
superimposed on D1. c, The two monomers of the asymmetric unit form a 2-fold dimer. The
view is related by a -60° rotation about the dimer (vertical) axis with respect to the view in a.
The c-diGMP molecules that are bound to sites A and A' cross-link to another dimer above (see
Fig. 2a).
Figure 2. Ligand binding to the active site of PleD. a, Dimers are packed head-to-head to form
222 tetramers. The view is rotated by 135° about the vertical axis with respect to Fig. 1c. The
dimers are held together by two c-diGMP ligands that are located on a local 2-fold axis of the
tetramer (the viewing direction), the ligand molecule in the back has been omitted for clarity. b,
Stereographic close-up view of a. The G368GEEF signature motif comprises residues important
for substrate binding (G368, G369 and E371) and catalysis (E370). The omit map of the ligand is
contoured at 4 . The side-chains of E370, E371, R300, K332, and D336 are partly disordered. c,
Complex of DGC with substrate GTP-Mg as modeled on the basis of the product complex shown
in panel b. The positions of the guanine, ribose and -phosphoryl moieties are the same as in the
product complex structure. The upper substrate, which has been shifted arbitrarily by about 2 Å
to the upper right, would be bound to another, 2-fold related DGC domain (not shown). The side-
chain conformations of E370 and K332 have been adjusted to bring the functional groups into
catalytically competent positions. The arrows indicate the nucleophilic attack of the 3’-oxygens
on the -phosphates. d, AC in complex with substrate analog ATP--S (light-blue, PDB code
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1cjk (25)), view corresponding to that in panel c. The C-trace corresponds to that part of the -
chain which is structurally homologous to DGC. The -chain, which provides specific
interactions with the adenine base, has been omitted for clarity.
Figure 3. Product binding to the allosteric inhibitory I-site. a, A close-up view of the two
mutually intercalated c-diGMP molecules (khaki and grey carbon atoms) bound at the D2
(yellow) - DGC (green) interface. The omit map of the ligand is contoured at 4 . b, The ligand
is tightly bound to both domains (carbons are colored in magenta (D2) and cyan (DGC)) by a
multitude of specific interactions including a recurrent arginine - guanine binding motif. Figures
were generated by DINO (33).
Figure 4. Mechanistic model of PleD regulation. The catalytic DGC domain (green) is tethered
via a flexible linker peptide to the D1/D2 stem. The DGC domain is postulated to be mobile with
respect to the stem as indicated by the curved broken arrow.  Top row: PleD is activated by
phosphorylation at the D1 domain, which induces dimerization mediated by the stems and allows
the two substrate binding sites (with bound GTP substrate in yellow) to approach each other and
to the condensation reaction (2 GTP -> c-diGMP + 2 PPi) to occur. Bottom row: Allosteric
product inhibition occurs by binding of (c-diGMP)2 to the I-site at the stem - DGC interface.
Whereby, the DGC domain is immobilized with respect to the stem and barred from approaching
its counterpart in the dimer.





 Diguanylate cyclase structure and mechanism  1
Supporting Online Material
Structural basis of activity and allosteric control of diguanylate
cyclase
Carmen Chan, Ralf Paul, Dietrich Samoray, Nicolas C. Amiot, Bernd Giese, Urs Jenal &
Tilman Schirmer
 Diguanylate cyclase structure and mechanism  2
Figure S1.
Common core structure shared by the DGC domain, the catalytic domain of AC and the palm
domain of DNA polymerase. a, Stereographic view of the superposition of DGC (green) on AC
(blue, PDB code 1cjk). 92 C were superimposed with an rmsd of 1.5 Å. The common core is
shown in a thicker line. b, Stereographic view of the superposition of DGC (green) on DNA
polymerase I (light blue, PDB code 1nk4). 63 C were  superimposed with an rmsd of 1.7 Å.
The common core here is different from the that in panel a in that DNA polymerase I lacks a 5
strand.
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Figure S2.
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Product inhibition of PleD at varying GTP concentrations as determined by thin layer
chromatography. Data refer to the initial velocity, i.e. they were acquired at time points before
the reaction slowed down due to product inhibition. The values represent the averages of 4
independent experiments for 10, 31.6, 100 and 316 μM GTP, and 2 independent experiments for
3.16 μM GTP, respectively. For all substrate concentrations roughly the same c-diGMP
concentration of 6 μM is required to attain 50% inhibition. Taking into account the enzyme
concentration of 5 μM, a Ki of about 0.5 μM corresponding to the bimolecular association
reaction: PleD + (c-diGMP)2 <-> PleD-(c-diGMP)2 can be obtained by numerical solution. This
assumes that c-diGMP is present as a dimer in solution.
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Pole development is coordinated with the Caulobacter crescentus cell cycle by two-component signaling
proteins. We show that an unusual response regulator, PleD, is required for polar differentiation and is
sequestered to the cell pole only when it is activated by phosphorylation. Dynamic localization of PleD to the
cell pole provides a mechanism to temporally and spatially control the signaling output of PleD during
development. Targeting of PleD to the cell pole is coupled to the activation of a C-terminal guanylate cyclase
domain, which catalyzes the synthesis of cyclic di-guanosine monophosphate. We propose that the local
action of this novel-type guanylate cyclase might constitute a general regulatory principle in bacterial growth
and development.
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During developmental transitions, localized changes of
cellular morphology are mediated by adaptation in levels
and arrangement of proteins. Temporal and spatial con-
trol often relies on the timed synthesis or activation of
transcriptional regulators and on the establishment of
gradients through the compartmentalization of signaling
complexes. Although the regulatory mechanisms of gene
expression are relatively well understood, it is often not
clear how morphogenetic changes are controlled and co-
ordinated locally. In prokaryotes, the major paradigm for
signal transduction is the two-component regulatory
system (Parkinson and Kofoid 1992). On signal input, the
first component, a sensor kinase, autophosphorylates on
a histidine residue. The second component, a soluble
response regulator, often functions as a transcriptional
regulator. Its phosphorylation by the cognate histidine
kinase on a conserved aspartate residue in the N-termi-
nal receiver domain usually results in increased DNA
binding affinity (Parkinson and Kofoid 1992). Here we
present evidence that a novel-type response regulator
acts at a distinct subcellular site where it contributes to
local changes in cell morphology through the production
of a novel signaling molecule.
The unicellular bacterium Caulobacter crescentus
goes through an obligate developmental transition that
allows it to switch between a sessile, adhesive, and a
motile, planktonic cell during its cell cycle. As a conse-
quence, cell poles are continuously remodeled during
cell differentiation to facilitate assembly and removal of
motility and surface adherence organelles at the right
time and in the correct order. Asymmetry is established
in the predivisional cell with a single flagellum, a che-
motaxis machinery, and pili being assembled at one pole,
whereas the opposite pole consists of a stalk and an ad-
hesive organelle, the holdfast (Fig. 1). As a result, divi-
sion generates two cell types with distinct properties: a
surface-attached stalked cell and a motile swarmer cell.
The swarmer progeny first differentiates into a stalked
cell before it initiates DNA replication and cell division.
During this transition the pili retract, flagella are re-
leased, and the adhesive organelles are synthesized at the
same pole. Here we investigate the function and regula-
tion of the PleD response regulator in C. crescentus polar
development. Cells that lack a functional PleD protein
are hypermotile, are unable to eject the flagellum, and
fail to synthesize a complete stalk structure (Hecht and
Newton 1995; Aldridge and Jenal 1999). In contrast, the
presence of a constitutively active mutant protein PleD*
results in elongated stalks and has a dominant negative
effect on motility (Aldridge et al. 2003). The PleD* pro-
tein contains four point mutations (Asn/Thr 120, Ala/
4Corresponding author.
E-MAIL urs.jenal@unibas.ch; FAX 41-61-267-2118.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/
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Thr 214, His/Pro 234, and Tyr/Asn 234) and retains its
activity even when its phosphoryl acceptor site Asp 53 is
modified, suggesting that this mutant form does not rely
on phosphorylation input by a cognate kinase (Aldridge
et al. 2003). In vivo phosphorylation experiments indi-
cate that the polar kinases DivJ and PleC are involved in
modulating the phosphorylation status of PleD. Whereas
PleD∼P is reduced to about 10% in cells lacking DivJ, it
is undetectable in a mutant lacking both DivJ and PleC
(Aldridge et al. 2003). DivJ and PleC are asymmetrically
positioned at opposite cell poles, with DivJ localizing to
the stalked pole coinciding with the requirement for ac-
tive PleD during cell differentiation (Fig. 1; Wheeler and
Shapiro 1999; Ohta and Newton 2003). Here we provide
evidence that DivJ and PleC directly interact with PleD
to modulate its phosphorylation state, suggesting that
together they are responsible for PleD phosphorylation
in vivo. We show that the PleD regulator dynamically
localizes to the differentiating stalked pole during the
cell cycle as a function of its phosphorylation state. Our
results indicate that only activated PleD is sequestered
to the stalked pole, providing a mechanism that spatially
restricts PleD activity to the emerging stalked pole,
where it coordinates polar morphogenesis.
PleD is a multidomain protein with two N-terminal
receiver modules arranged in tandem and a C-terminal
domain apparently serving as an output module (Hecht
and Newton 1995). This putative output domain, termed
“GGDEF” or “DUF1,” is widespread and highly con-
served in many bacterial species. Postulating a local ac-
tivity of PleD at one cell pole calls for a molecular
mechanism that converts the phosphorylation input into
a readout that affects downstream targets. We propose
that the PleD readout is the production of a cyclic
nucleotide, which acts as secondary messenger. In vitro
experiments with C. crescentus crude extracts and with
purified PleD protein show that PleD contains an intrin-
sic nucleotide cyclase activity, which converts two mol-
ecules of GTP into cyclic diguanylic acid (c-di-GMP).
Cyclase activity correlates with PleD activation by phos-
phorylation and requires an intact PleD C-terminal out-
put domain. This suggests that the GGDEF domain con-
stitutes a novel class of guanylate cyclases, which in
PleD is specifically activated in response to phosphory-
lation of the N-terminal receiver domain. Our findings,
together with the observation that more than 900
GGDEF proteins are reported in the nonredundant
SMART database (Schultz et al. 1998), implies that di-
guanylate cyclases are abundant in the bacterial king-
dom and that the diffusible molecule c-di-GMP might be
a common secondary messenger in prokaryotes.
Results
DivJ and PleC directly control PleD phosphorylation
Genetic data (Sommer and Newton 1991; Aldridge et al.
2003) and in vivo phosphorylation experiments (Aldridge
et al. 2003) established a role of the polar kinases DivJ
and PleC in PleD control. To test whether DivJ and PleC
directly modulate phosphorylation of PleD, in vitro
phosphorylation assays were carried out using purified
full-length PleD, fused to either a GST or a hexa-histi-
dine tag, and purified soluble catalytic domains of DivJ
(DivJ) and PleC (PleC). DivJ and PleC autophosphory-
late in the presence of ATP and Mg2+ (Fig. 2). The addi-
tion of GST-PleD to autophosphorylated DivJ and PleC
results in transfer of phosphate to PleD (Fig. 2A),
whereas the purified PleD protein is not phosphorylated
in the presence of ATP alone (data not shown). Auto-
phosphorylation of purified PleC is relatively inefficient
(Fig. 2A). Although this is in agreement with earlier find-
ings (Hecht et al. 1995), we find that the addition of
GST-PleD to the autophosphorylated soluble PleC ki-
nase fragment results in a rapid loss of PleC∼P, presum-
ably by transfer of the phosphoryl group to the response
regulator (Fig. 2A). The phosphotransfer from the kinases
to GST-PleD is incomplete, possibly because of interfer-
ence by the N-terminal GST tag. When using a PleD–
His6 fusion protein instead, efficient phosphotransfer
from DivJ and PleC is observed. The addition of PleD
but not PleDD53N (lacking the phosphoryl acceptor site)
to autophosphorylated DivJ or PleC results in an al-
most complete phosphotransfer to the response regulator
(Fig. 2B). Because both PleD–His6∼P and GST-PleD∼P
could barely be detected, we hypothesize that under
these conditions the stability of the phosphorylated form
of PleD is relatively low. This suggests that both DivJ
and PleC directly interact with the PleD response regu-
lator.
The PleD response regulator dynamically localizes
to the stalked pole during the cell cycle
Whereas the sensor kinases DivJ and PleC are mem-
brane-bound, the PleD response regulator is a soluble
cytoplasmic protein (Fig. 3A). However, the fact that
Figure 1. Dynamic localization of the PleC and DivJ sensor
protein kinases during the C. crescentus cell cycle. The posi-
tioning of PleC (circle) and DivJ (rectangle; Wheeler and Shapiro
1999) during the cell cycle are indicated. Polar organelles and
cell cycle stages are specified.
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DivJ and PleC are specifically localized in the cell (Fig. 1)
implies that information transfer from the sensor kinase
to PleD requires the physical presence of the response
regulator at the cell poles. In addition, the role of PleD in
controlling assembly and function of polar organelles
during development suggested that the PleD regulatory
output might be restricted to the cell pole. To test the
hypothesis that PleD might perform its regulatory func-
tion locally, we first analyzed the subcellular distribu-
tion of PleD during the C. crescentus cell cycle. A PleD–
GFP fusion was introduced into the pleD strain UJ284
on a low-copy number plasmid, and the analysis of mo-
tility and stalk formation of the resulting strain (UJ626)
confirmed that the PleD–GFP fusion protein was func-
tional (data not shown). The same fusion was also intro-
duced into the wild-type strain CB15N (UJ627), and im-
munoblot analysis with anti-PleD and anti-GFP antibod-
ies confirmed that in both strains the PleD–GFP fusion
was produced at similar levels to PleD wild-type and
excluded degradation of the fusion protein and the re-
lease of soluble GFP (data not shown). Analysis of strain
UJ627 by fluorescence microscopy revealed that in a
large fraction of stalked and predivisional cells, PleD–
GFP is concentrated at the stalked pole (Fig. 3B, Table 1).
From a total of 1000 cells counted, 36% had visible GFP
foci at the cell pole, whereas only 4% of the cells had
nonpolar foci. Localization of PleD–GFP in strains UJ626
and UJ627 was qualitatively and quantitatively indistin-
guishable (data not shown). Importantly, in all cases in
which the identity of the cell poles could be determined
Figure 3. PleD is a soluble protein that localizes to the stalked
pole of C. crescentus cells. (A) Immunoblot analysis of fraction-
ated cell extracts of C. crescentus CB15N wild-type with anti-
PleD, anti-FliF, and anti-ClpP antibodies. Cells of a logarithmi-
cally growing culture were lysed and soluble, and insoluble frac-
tions were separated as indicated in Materials and Methods.
Staining of the membrane-integral FliF and the soluble ClpP
protein demonstrates the quality of the cell fractionation. (P)
Insoluble pellet fraction; (S) soluble fraction. (B) PleD specifi-
cally localizes to the stalked pole. Phase contrast (PC) and fluo-
rescent images of wild-type CB15N strains producing PleD–GFP
from a low-copy number plasmid. The arrows indicate the polar
foci of PleD–GFP in the fluorescent images and the stalk struc-
tures visible by phase contrast. (C) PleD dynamically localizes
to the stalked pole during the C. crescentus cell cycle. Repre-
sentative time-lapse experiment on C. crescentus wild-type
cells producing PleD–GFP from a low-copy number plasmid.
Fluorescent images (top) and a schematic representation of the
cell cycle-dependent localization of PleD–GFP (bottom) are
shown. In young swarmer cells, PleD–GFP is uniformly distrib-
uted in the cytoplasm. As the cells progress through the cell
cycle and differentiate into stalked cells, PleD–GFP accumu-
lates at the old flagellated and emerging stalked pole coinciding
with flagellar ejection and stalk formation. PleD–GFP remains
at the stalked pole throughout the cell cycle and is randomly
dispersed in the newly formed swarmer cell. Only when the
swarmer cell differentiates into a stalked cell again does PleD–
GFP localize to the pole.
Figure 2. In vitro phosphotransfer between the protein kinases
DivJ and PleC and the response regulator PleD. DivJ and PleC
autophosphorylation in the presence of [-32P]ATP and subse-
quent phosphotransfer to PleD are shown. The bands corre-
sponding to the phosphorylated proteins are marked on the side.
(A) Assays contained 0.5 and 5 μg of the soluble kinase frag-
ments and 37.5 μg GST-PleD as indicated. (B) Assays contained
12.5 μg DivJ, 20 μg PleC, and 50 μg PleD-H6 and PleDD53NH6,
respectively, as indicated. In this experiment, DivJ and PleC
were preincubated with [-32P]ATP for 15 min before PleD or
PleDD53N were added to the reaction mix for an additional 5
min (PleC) or 10 min (DivJ), respectively.
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unequivocally by the presence of a visible polar stalk, the
GFP foci were associated with the stalked pole. This
strongly implied that the PleD–GFP protein specifically
localizes to the stalked pole and is absent from the flag-
ellated swarmer pole. This, in turn, suggested dynamic
behavior of the PleD protein during the C. crescentus
cell cycle. To resolve the dynamic spatial distribution of
PleD–GFP during the cell cycle, we performed time-
lapse fluorescence microscopy with isolated swarmer
cells of strain UJ627. Swarmer cells were grown directly
on a microscope slide coated with a thin layer of agar,
and progression though the cell cycle was visualized by
phase contrast microscopy (Fig. 3C). The PleD protein is
evenly distributed within C. crescentus swarmer cells,
but then concentrates at the emerging stalked pole dur-
ing the swarmer-to-stalked cell differentiation. With in-
creasing time, the signal at the stalked pole increases in
strength, whereas the pole opposite the stalk remains
free of PleD–GFP throughout the entire cell cycle (Fig.
3C). This results in an asymmetric PleD–GFP distribu-
tion throughout most of the cell cycle and, on division,
generates two different progeny cells: a swarmer cell
with a uniform distribution of PleD–GFP and a stalked
cell with an accumulation of PleD–GFP at the stalked
pole. Only after the newborn swarmer cell has under-
gone the morphological transition into a stalked cell
does PleD–GFP concentrate at this pole (Fig. 3C). The
new poles generated by cytokinesis remain free of PleD–
GFP protein.
Only activated PleD localizes to the pole
It is evident from the illustrations in Figure 3B and C
that even in stalked and predivisional cells only a frac-
tion of the PleD–GFP protein accumulates at the pole,
whereas the rest seems to be evenly distributed in the
cytoplasm. This is most evident from the observation
that few cells, which do not seem to express the pleD–
gfp copy, not only lack polar foci but also have a lower
cytoplasmic fluorescence signal (Fig. 3B, short arrows).
One possible explanation for this is that PleD exists in
two different forms that have different targeting proper-
ties. To test whether phosphorylation of PleD is required
for dynamic localization, we fused GFP to an inactive
PleD mutant form that lacks the aspartic acid phospho-
ryl acceptor residue at position 53 (Asp 53). Immunoblot
analysis confirmed that the resulting fusion protein
PleDD53N–GFP is stable and produced at wild-type levels
(data not shown). However, in contrast to PleD–GFP,
PleDD53N–GFP is homogenously distributed in all cells
and fails to accumulate at the stalked pole (Fig. 4A; Table
1), irrespective of the genetic background (data not
shown). PleD–GFP also fails to localize in a mutant
strain lacking both the DivJ and PleC kinases (Fig. 4B;
Table 1). In this mutant PleD phosphorylation is reduced
below detectable levels in vivo (Aldridge et al. 2003). A
partial loss of PleD localization to the stalked pole
was observed in mutants lacking either PleC or DivJ
(Table 1).
These data suggest that phosphorylation plays a criti-
cal role in sequestering PleD to the pole. To support this
and to distinguish between the possibilities that phos-
phorylation itself might constitute the targeting signal
or, alternatively, that PleD preferentially binds to the
cell pole in its active conformation, we analyzed the dy-
namic behavior of a constitutively active PleD mutant
protein, PleD*D53N. PleD*D53N is dominant over wild-
type PleD, but because it lacks the aspartic acid phos-
phoryl acceptor site at position 53, its activity is not
dependent on phosphorylation (Aldridge et al. 2003). As
shown in Figure 4C, PleD*D53N–GFP localizes almost
exclusively to the cell poles in both the wild-type and
the divJ pleC double mutant. The polar foci of
PleD*D53N–GFP are considerably stronger than the foci
observed for wild-type PleD–GFP, and the cytoplasmic
signal is significantly reduced. The fact that cellular lev-
els of the two fusion proteins are similar (data not
shown) suggests that a larger fraction of the activated
PleD protein is concentrated at the pole compared with
the wild-type PleD–GFP fusion. Pole selectivity of
PleD*D53N–GFP is similar to wild-type PleD in that the
protein has a strong preference for the stalked pole and is
absent from newly formed poles at division and from
flagellated swarmer poles (Fig. 4C; Table 1). Pole selec-
tivity of PleD*D53N–GFP is unaltered even in the ab-
sence of the stalked pole-specific kinase DivJ (Fig. 4C),
Table 1. Quantitative analysis of PleD-GFP localization in Caulobacter crescentus wild-type and mutant strains
Construct Strain (genotype)
% cells with
polar focia
% cells with
non-polar foci
Total cells
counted
PleD-GFP CB15N (wild type) 36 4 1000
PleDD53N-GFP CB15N (wild type) 0 0 500
PleD-GFP UJ506 (pleC) 22 12 396
PleD-GFP UJ998 (divJ) 13 22 494
PleD-GFP UJ1000 (pleC divJ) 0 0 500
PleD*D53N-GFP CB15N (wild type) 37 10 348
PleD*D53N-GFP UJ1000 (pleC divJ) 40 17 381
PleDGG368DE-GFP UJ284 (pleD) 44 6 617
aBased on the dynamic behavior of PleD-GFP during the cell cycle (Fig. 3), about two-thirds of the cells of a mixed population are
expected to show polar PleD-GFP foci. Whether this discrepancy is a biological property of the system or due to a technical property
of the experiment is not clear.
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indicating that DivJ contributes to PleD localization
mainly by activating the response regulator. Together,
these data are consistent with the idea that activated
PleD protein is specifically targeted to the emerging
stalked pole. The observation that a PleDGG368DE–GFP
fusion protein, which lacks an active C-terminal output
domain (see below), still localizes to the stalked pole
(Fig. 4D) suggests that an activated conformation of
PleD, rather than the PleD readout itself, is required for
polar sequestration of the regulator.
The PleD response regulator is a di-guanylate cyclase
The experiments described above suggest that PleD ac-
cumulates at the old pole of the cell only in its activated
state. Because genetic data indicated that PleD∼P is re-
quired for the differentiation of a flagellated into a
stalked pole (Hecht and Newton 1995; Aldridge et al.
2003), PleD could act locally at this subcellular site, co-
ordinating the developmental events involved in pole re-
modeling. However, what could be the output signal
generated by the activated PleD response regulator,
which in turn controls these downstream events? A re-
port has established a link between a multidomain pro-
tein family containing the GGDEF domain and the me-
tabolism of cyclic di-GMP (c-di-GMP), a compound dis-
covered as a cofactor of cellulose synthase in
Gluconacetobacter xylinum (Ross et al. 1991; Tal et al.
1998). To examine the possibility that the PleD output
domain harbors di-guanylate cyclase activity, we at-
tempted to biochemically assay its ability to convert
GTP into c-di-GMP. Although extracts of C. crescentus
wild-type strain CB15N and CB15N pleD showed no
activity (Fig. 5A), GTP was readily converted into a novel
nucleotide compound when extracts of a strain contain-
ing the pleD* or pleD*D53N alleles were used (Fig. 5A;
data not shown). To demonstrate that PleD was respon-
sible for this activity, PleD with a C-terminal His-tag
was overexpressed in Escherichia coli and purified to ho-
mogeneity. In the presence of purified PleD protein, GTP
rapidly disappeared and was replaced by a nucleotide
with a retardation factor (RF) value identical to the one
observed with crude extracts (Fig. 5B).
To confirm that the novel spot indeed corresponds to
the cyclic dimeric form of GMP, the reaction product of
PleD and GTP was analyzed by mass spectrometry. The
major peak resulting from the mass fingerprinting corre-
sponds to a molecular mass of 689, which exactly
matches the molecular weight of c-di-GMP (Fig. 5C). To
gather additional evidence for the proposed enzymatic
reaction, product inhibition was investigated. When
chemically synthesized c-di-GMP was added to the re-
action mix in a concentration range similar to the GTP
substrate, strong inhibition was observed (Fig. 6A). This
suggests that c-di-GMP effectively competes with GTP
for the binding site. To exclude the possibility that PleD
also possesses phosphodiesterase (PDE) activity and cata-
lyzes the cleavage of c-di-GMP into two GMP mono-
Figure 4. Dynamic localization of PleD to the stalked pole requires its activation by phosphorylation and is dependent on the polar
kinases DivJ and PleC. (A) A nonphosphorylatable PleD mutant is impaired in polar localization. Phase contrast (PC) and correspond-
ing fluorescent image of wild-type strain CB15N producing PleDD53N–GFP from a low-copy number plasmid. Bar: left panel, 2 μm. (B)
DivJ and PleC are required for the polar positioning of wild-type PleD–GFP. Phase contrast (PC) and corresponding fluorescent images
of wild-type and divJ pleC mutant strain producing PleD–GFP from a low-copy number plasmid. (C) DivJ and PleC are not required
for localization of the constitutive mutant PleD*D53N–GFP. Phase contrast (PC) and corresponding fluorescent images of wild-type and
divJ pleC mutant strain producing PleD*D53N–GFP from a low-copy number plasmid. (D) An active GGDEF output domain is not
required for localization of PleD. Phase contrast (PC) and corresponding fluorescent image of a pleD mutant strain producing
PleDGG368DE–GFP from a low-copy number plasmid. Filled arrows point to stalked poles in the phase contrast images (black) and to
polar PleD–GFP foci in the fluorescent images (white). Open arrows point to nonpolar PleD–GFP foci.
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mers, c-di-GMP concentration was measured quantita-
tively by HPLC after incubation with purified PleD–His6
protein for several hours. Neither a decrease of the c-di-
GMP concentration nor a conversion of c-di-GMP into
GMP or any other degradation product was observed dur-
ing a prolonged incubation period (Fig. 6B). The absence
of PDE activity is not caused by the loss of PleD enzyme
activity because the PleD sample used in this experi-
ment had a high di-guanylate cyclase (DGC) activity (Fig.
6B). Together, this is consistent with the view that the
PleD protein harbors a di-guanylate cyclase activity,
which specifically catalyzes the conversion of GTP into
the di-cyclic form of guanosine monophosphate, and that
this activity constitutes the signaling output of the PleD
response regulator.
The PleD nucleotide cyclases activity is GTP specific
Nucleotide cyclases have been described for both adeno-
sine and guanosine nucleotides (Domino et al. 1991;
Johnson and Salomon 1991). To investigate whether the
nucleotide cyclase activity of PleD is specific for GTP,
we measured the synthesis of radiolabeled [32P]c-di-GMP
from [32P]GTP (0.1 mM) on addition of nonlabeled
nucleotides (see Materials and Methods). As expected, an
excess of unlabeled GTP efficiently inhibits the forma-
tion of [32P]-labeled c-di-GMP (Fig. 6A). Similarly, deoxy-
GTP was able to effectively compete with radiolabeled
GTP, suggesting that GTP and deoxyGTP bind to PleD
with comparable affinities (Fig. 6A). In contrast, the ad-
dition of ATP had only a marginal effect on [32P]c-di-
GMP formation. Although the addition of 100 μM non-
labeled GTP reduced the formation of [32P]-labeled c-di-
GMP by about 50%, the activity was unchanged in the
presence of 100 and 500 μM ATP and dropped by only
10%–20% in the presence of a 10-fold higher concentra-
tion of ATP (Fig. 6A). This suggests that guanosine
nucleotides bind specifically to the PleD nucleotide
cyclases, whereas the affinity for ATP is significantly
lower. However, HPLC analysis showed that neither
ATP nor deoxyGTP were converted into their respective
dimeric forms (data not shown). In summary, the nucleo-
tide cyclase domain of PleD seems to specifically bind to
guanosine nucleotides, but only GTP serves as a sub-
strate for the formation of a dimeric product.
PleD-dependent synthesis of c-di-GMP is stimulated
by phosphorylation of the receiver domain
and requires an intact GGDEF output domain
The modular architecture of the PleD response regulator
suggests that the receiver domain or domains are in-
volved in information input and that the C-terminal
GGDEF domain constitutes the regulatory output of the
molecule (Parkinson and Kofoid 1992). To test whether
the guanylate cyclase activity is indeed localized in the
GGDEF domain, we determined the activity of wild-type
PleD with the activity of two mutant proteins with
amino acid changes in the highly conserved GGDEF sig-
Figure 5. PleD is a di-guanylate cyclase. (A) Cyclic-di-GMP is
produced by C. crescentus cell extracts. The soluble fraction of
total cell extracts of CB15N pleD (UJ284) or CB15N pleD
producing PleD* from a low-copy number plasmid were used to
assay for di-guanylate cyclase activity. Control reactions with-
out cell extracts are also shown. Samples were taken at 5, 10, 15,
20, and 30 min after addition of extracts and were analyzed on
thin-layer chromatography plates. (B) Cyclic-di-GMP is pro-
duced by purified PleD protein. PleD–His6 (50 μg) was tested for
di-guanylate cyclase activity, and the products of the enzymatic
reactions were analyzed for 30, 45, 60, and 300 sec (lanes 1–4)
after addition of purified PleD–His6, as indicated in A. (Lanes
5–8) Control reactions without PleD are also shown. (C) Analy-
sis of products synthesized by PleD in vitro. The reaction prod-
ucts of PleD (200 μg) and GTP (1 mM) were separated by HPLC
(cf. Fig. 6B). Peaks were collected and applied to mass spectrom-
etry analysis. The fragmentation pattern shown corresponds to
the main reaction product with a high-pressure liquid chroma-
tography retention time of 6.73 min. The main peak had a mo-
lecular mass of 689 (theoretical molecular weight of c-di-GMP:
688.4). Reisolation and analysis of the substance with the molecu-
lar mass of 689 resulted in an identical fragmentation pattern.
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nature motif. The mutant alleles pleD368–372 (lacking
the entire GGDEF motif) and pleDGG368DE (two highly
conserved Gly residues in GGDEF replaced by Asp and
Glu) failed to complement the pleD mutant phenotype,
even though their products were stably expressed in C.
crescentus (Aldridge and Jenal 1999). Consistent with
their functional deficiency in vivo, both mutant proteins
completely lack di-guanylate cyclase activity in vitro
(Fig. 7A). This is in line with the idea that the C-terminal
GGDEF domain represents the output domain of PleD
and is responsible for the enzymatic activity observed.
Because no phospho-donors for PleD were present in
the assays, our data indicate that activation of PleD by
phosphorylation is not strictly required for the in vitro
synthesis of c-di-GMP. This is supported by the fact that
the activity of the mutant protein PleDD53N, lacking the
phosphoryl acceptor side Asp 53, is comparable to wild-
type PleD (Fig. 7A,B). However, when purified DivJ ki-
nase was added to the reaction mix, the di-guanylate
cyclase activity of wild-type PleD was significantly
stimulated (Fig. 7A). This stimulation was not only de-
pendent on the presence of ATP but also required residue
Asp 53, as a DivJ-dependent increase of enzyme activity
was not observed for the PleDD53N mutant protein (Fig.
7A). Consistent with an increase of PleD enzyme activ-
ity on activation of the molecule by phosphorylation, we
found that the constitutively active mutant proteins
PleD*D53N and PleD* had a considerably higher specific
activity than unphosphorylated wild-type PleD (Fig. 7B).
This dramatic increase of the in vitro di-guanylate cy-
clase activity suggests that the dominant phenotypic ef-
fects of the pleD* and pleD*D53N alleles is caused by an
uncontrolled overproduction of c-di-GMP (Aldridge et al.
2003). The observation that PleD in the presence of DivJ
and ATP is by far less active than purified PleD* may be
the result of the modest efficiency of PleD phosphoryla-
tion in vitro (Fig. 2A). Although the molecular mecha-
nism of PleD activation remains to be elucidated, these
data clearly indicate that phosphorylation of the first re-
ceiver domain leads to an increased activity of the C-
terminal guanylate cyclase domain.
Discussion
Localization of signaling molecules is a conserved
mechanism for the establishment of cell polarity in both
prokaryotes and eukaryotes (Shapiro et al. 2002; Nelson
2003). In C. crescentus, cell polarity and the develop-
mental program are controlled by sensor histidine ki-
nases, which are asymmetrically positioned at the ends
of the cell (Shapiro et al. 2002). Here we present data
indicating that two of these polar kinases, DivJ and PleC,
control the activity and the dynamic localization of the
soluble response regulator PleD during the cell cycle.
The activated form of PleD, PleD∼P, possesses catalytic
guanylate cyclase activity and is specifically sequestered
to one pole of the cell, arguing that spatially confined
synthesis of a diffusible secondary messenger might con-
tribute to the temporal and spatial control of pole devel-
opment in this organism.
Time-lapse experiments with a PleD–GFP fusion re-
vealed a highly dynamic behavior and precise localiza-
tion mechanism for the PleD response regulator during
the C. crescentus cell cycle. PleD–GFP is randomly dis-
persed in the cytoplasm of swarmer cells but then local-
izes to the emerging stalked pole during cell differentia-
tion. This dynamic positioning coincides with the local-
ization of DivJ to the same pole (Wheeler and Shapiro
1999) and presumably precedes flagellar release and stalk
formation, both of which are dependent on activated
PleD (Hecht and Newton 1995; Aldridge and Jenal 1999).
We have presented several lines of evidence indicating
that activation of PleD by phosphorylation is critical for
polar targeting and that only the activated form of the
Figure 6. The PleD nucleotide cyclase activity is GTP-specific.
(A) GTP, deoxyGTP, and c-di-GMP, but not ATP, specifically
inhibit the PleD-dependent conversion of [32P]GTP into [32P]c-
di-GMP. The relative c-di-GMP formation corresponds to the
initial velocity determined for the enzymatic reactions. The
reaction mixtures routinely contained 25 μg PleD and 100 μM
GTP (see Materials and Methods) and were supplemented with
nonlabeled nucleotides, as indicated below the graph. (B) PleD
is a di-guanylate cyclase but lacks phosphodiesterase activity.
High-pressure liquid chromatography analyses of GTP and c-di-
GMP (left) and their reaction products with PleD (right) are
indicated. The reaction mixtures contained 100 μg PleD and
GTP and c-di-GMP at 200 μM each. Conversion of GTP into
c-di-GMP by PleD is shown in the top panel by the appearance
of a novel peak (arrow), which corresponds to chemically syn-
thesized c-di-GMP (panels in second row). Incubation of PleD
with chemically synthesized c-di-GMP for several hours did not
lead to the cleavage or disappearance of the cyclic substance.
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response regulator accumulates at the pole. Localization
experiments with PleD*D53N–GFP suggest that it is not
phosphorylation itself but, rather, an activated confor-
mation of the protein that provides the information for
polar localization. Two different mechanisms can be en-
visioned to explain the coupling between activity and
polar localization of PleD. PleD could auto-catalytically
control its own subcellular positioning, for instance, by
altering the nature of the cell pole. Alternatively, pole
recognition might be restricted to the activated form of
PleD. The observation that the inactive PleDD53N–GFP
fusion protein does not accumulate at the stalked pole in
the presence of a chromosomal pleD wild-type gene, and
the finding that GFP fused to PleDGG368DE, which is un-
able to generate c-diGMP, still sequesters to the pole in
a pleD mutant, favors the second mechanism. Prelimi-
nary evidence suggests that purified PleD is able to form
dimers, raising the possibility that activation and target-
ing might be a consequence of PleD dimerization. The
observed coupling between PleD activity and polar lo-
calization is reminiscent of the mechanism observed for
the single-domain response regulator DivK (Jacobs et al.
2001; Lam et al. 2003). However, although DivK∼P lo-
calizes to both the swarmer and the stalked pole, PleD∼P
shows no detectable affinity for the flagellated pole. The
affinity of DivK for the cell poles is also mediated
through the DivJ and PleC kinases, but in contrast to
PleD, which requires both kinases to be sequestered to
the stalked pole, DivK targeting to the poles is mediated
by DivJ, whereas PleC controls its release from the
swarmer pole late in the cell cycle (Jacobs et al. 2001).
Neither PleD–GFP nor the constitutive active form,
PleD*D53N–GFP, localize to the pole in swarmer cells,
irrespective of the presence or absence of PleC. This ar-
gues for a marker at the stalked pole that appears or is
unmasked during the swarmer-to-stalked cell transition
and is recognized by activated PleD. Such a marker has
already been postulated for the localization of DivJ
(Wheeler and Shapiro 1999), but its molecular identity
remains unknown.
Targeting of active PleD to the differentiating stalked
pole might serve to position the output domain of the
response regulator in close proximity to the machinery
that is responsible for the morphogenetic changes during
cell differentiation. PleD is a di-guanylate cyclase, which
on activation by phosphorylation, synthesizes c-di-GMP.
This low-molecular weight molecule was originally
identified as a positive allosteric effector of cellulose
synthase in G. xylinum and Agrobacterium tumefaciens
(Ross et al. 1987; Amikam and Benziman 1989). The con-
version of glucose moieties into cellulose polymers is
energetically costly for the cell, and it has been postu-
lated that the committing step is tightly regulated by
c-di-GMP to adjust the polymerization process to the
cell’s metabolism (Ross et al. 1991). The intracellular
concentration of c-di-GMP in G. xylinum seems to be
controlled by the opposing activities of DGCs and c-di-
GMP-specific PDEs (Ross et al. 1987). Tal and coworkers
were able to identify three operons in G. xylinum in-
volved in cellular turnover of c-di-GMP (Tal et al. 1998;
Chang et al. 2001). Each operon contains a pair of paralo-
gous genes termed pde and dgc, which code for multido-
main proteins with an N-terminal PAS/PAC domain
(Ponting and Aravind 1997), a central GGDEF (DUF1)
Figure 7. Activation of the PleD di-guanylate cyclase by phos-
phorylation and the requirement of an intact GGDEF output
domain. (A) Influence of phosphorylation and mutations in the
GGDEF domain on the PleD in vitro di-guanylate cyclase ac-
tivity. The enzymatic reactions contained 100 μM GTP and
were carried out with 25 μg of the following purified proteins:
PleD, PleDD53N, PleD368–372, and PleDGG368DE. DivJ (12.5 μg)
and ATP (200 μM) were added where indicated. The relative
c-di-GMP formation corresponds to the initial velocity mea-
sured for the enzymatic reactions. (B) Constitutive active forms
of PleD mimic the activated state of the di-guanylate cyclase.
The enzymatic reactions contained 200 μM GTP and were car-
ried out with 12.5 μg of the following purified proteins: PleD,
PleDD53N, PleD*D53N, and PleD*. The relative c-di-GMP forma-
tion corresponds to the initial velocity measured for the enzy-
matic reactions.
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domain, and a C-terminal EAL (DUF2) domain (Galperin
et al. 2001). Although genetic data suggested that a PleD
homolog in Rhizobium had DGC activity (Ausmees et
al. 2001), the following evidence presented in this work
strongly suggests that the GGDEF domain of PleD pos-
sesses DGC, but no PDE activity: First, in vitro synthesis
of c-di-GMP with C. crescentus cell extracts is depen-
dent on the presence of a constitutively active form of
PleD. Second, purified PleD protein is able to efficiently
convert GTP into a nucleotide species with a molecular
mass corresponding exactly to that expected for c-di-
GMP. Third, the DGC activity of purified PleD is depen-
dent on an intact GGDEF domain and the PleD cyclase
activity is specific for GTP. Fourth, purified PleD pos-
sesses no detectable PDE activity (in contrast, PDE ac-
tivity can readily be detected in C. crescentus whole-cell
extracts; data not shown). Fifth, the in vitro DGC activ-
ity of PleD is stimulated several fold by phosphorylation
through its cognate kinase DivJ. Sixth, the specific DGC
activity of a phosphorylation-independent form of PleD
was up to two orders of magnitude higher than that of
wild-type PleD. This dramatic increase of c-di-GMP syn-
thesis is consistent with the dominant phenotype of the
pleD* allele with respect both to motility and to stalk
formation (Aldridge et al. 2003). Taken together, these
results support the view that the GGDEF domain repre-
sents a novel signaling domain with a bona fide DGC
activity. This is in line with a recent structure prediction
(Pei and Grishin 2001), which shows an excellent corre-
spondence between GGDEF and the catalytic domain of
adenylate cyclases.
The GGDEF proteins constitute one of the largest
known families of orthologs with undefined function
and three-dimensional structure (Schultz et al. 1998; Ta-
tusov et al. 2001). Whereas proteins containing a GGDEF
domain are found in most bacterial species for which the
genome sequence is available, they are absent in archea
and eukaryotes. The analysis of the domain architecture
of GGDEF proteins listed in the nonredundant protein
databases reveals an intriguing pattern. The GGDEF do-
main seems to be highly “promiscuous,” as it is found
associated as a module with a multitude of different do-
mains. Intriguingly, all of these domains are known or
proposed to be involved in signal sensing in the
periplasm, the membrane, or the cytoplasm (Fig. 8). Al-
though the nature of the signals is unclear in most cases,
it has been well defined for others, like the PAS domain
or hemerythrin (Gong et al. 1998; Terwilliger 1998). We
propose that the GGDEF domains represent the output
of a complex bacterial signal transduction network,
which converts signals from different cellular compart-
ments into the production of a secondary messenger, c-
di-GMP (Fig. 8). The only two domains, which are often
found associated with GGDEF and do not seem to be
involved in signal sensing, are specialized metal-depen-
dent phosphohydrolases (HD-GYP) and EAL domains.
One could speculate that proteins containing both a
GGDEF and an HD-GYP or EAL domain might have op-
posing cyclase and hydrolase activities, which contrib-
ute to the cellular level of c-di-GMP (Chang et al. 2001).
The presence of a large number of potential DGCs in
single bacterial species (e.g., 39 in Vibrio cholerae) raises
the question of how the output specificity of parallel
signaling pathways might be achieved. Our finding that
C. crescentus polarized cells spatially restrict the distri-
bution of an active DGC to the site of morphogenetic
changes could offer an explanation for this dilemma.
Physical proximity between c-di-GMP synthesis and ac-
tion could very well be of general regulatory significance.
This is in agreement with the observation that in G.
Figure 8. The GGDEF domain is coupled in a modular fashion
with different sensory input or information transfer domains.
The domain composition of GGDEF proteins listed in the
SMART protein database (Schultz et al. 1998) is shown sche-
matically. Recognized or putative signal sensing domains are
indicated in rounded rectangles, the signal transfer domain (Rec)
is indicated as a polygon, and the GGDEF domain is indicated as
a rectangle. Connecting bars indicate the association of domains
found in a single protein. The broken line symbolizes informa-
tion transfer between sensor histidine kinases (e.g., DivJ) and
the receiver domain of their cognate response regulator (e.g.,
PleD). (Rec) Receiver domain of response regulators; (MASE)
membrane-associated sensor (MASE1 and MASE2; Nikolskaya
et al. 2003); (PBPb) high-affinity periplasmic solute-binding pro-
tein of ABC-type amino acid transport system; (CHASE) cycla-
ses/histidine kinases associated sensory exracellular (Anan-
tharaman and Aravind 2001; Mougel and Zhulin 2001; Zhulin
et al. 2003); (RXAG) permease component of ribose, xylose,
arabinose, galactoside ABC transporter; (PAS/C:PAS) Dro-
sophila period clock, aryl hydrocarbon receptor, and single-
minded proteins (putative signaling domain; Ponting and Ara-
vind 1997); (PAC) PAS C-terminal motif (Ponting and Aravind
1997); (MHYT) integral membrane sensor domain (Galperin et
al. 1999); (SBP-bac) bacterial extracellular solute binding pro-
tein; (SHK) Sensor histidine kinase; (CACHE) signaling domain
common to Ca2+ channels and chemotaxis receptors (Anan-
tharaman and Aravind 2000); (GAF) cGMP-specific and -stimu-
lated phosphodiesterases/adenylate cyclases (Anabaena)/FhlA
(E. coli; Galperin et al. 2001); (HE) Hemerythrin, oxygen-binding
protein (Stenkamp et al. 1978); (IQ) sequence motifs for
calmodulin recognition (Rhoads and Friedberg 1997); (PL) phos-
pholamban, small protein that regulates the affinity of the car-
diac sarcoplasmic reticulum Ca2+-ATPase for calcium (Smith et
al. 2001); (HAMP) Histidine kinases, adenylyl cyclases, methyl-
accepting proteins, phosphatases (Aravind and Ponting 1999);
(cNMP) cyclic nucleotide-monophosphate-binding domain.
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xylinum, most of the c-di-GMP present in the cell seems
to exist in a protein-associated rather than in a freely
diffusible form (Ross et al. 1991; Weinhouse et al. 1997).
An example for the compartmentalized production of a
secondary messenger has been presented recently by Kri-
ebel and collaborators, who showed that in Dictyo-
stelium discoideum, asymmetric cellular distribution of
adenylate cyclase is essential for cells to stream, possibly
by contributing to the local secretion of the chemoat-
tractant cAMP (Kriebel et al. 2003). Similarly, the obser-
vation that type VIII adenylate cyclase is enriched at
cell–cell borders of endothelial cells could explain how
localized changes in calcium-dependent cAMP concen-
trations regulate intercellular gap formation (Cioffi et al.
2002).
The finding that bacterial cells produce c-di-GMP as a
regulatory compound highlights an added layer of com-
plexity in bacterial signaling networks. What could be
the cellular functions controlled by these regulatory
mechanisms? Bacterial genetics has so far provided only
a limited number of functional analyses of GGDEF pro-
teins, but the results have revealed a recurring theme. In
all cases, GGDEF proteins seem to be involved in the
regulation of cell adhesion or cell surface colonization
(Ausmees et al. 1999; Romling et al. 2000; Gronewold
and Kaiser 2001; Boles and McCarter 2002; D’Argenio et
al. 2002; Spiers et al. 2002; Bomchil et al. 2003). An in-
teresting but so far poorly understood example is the
HmsT protein, which allows the colonization and block-
age of the flea foregut by Yersinia pestis and, as a result,
the effective transmission of the plague bacillus to the
mammal (Jones et al. 1999). A specific role for these
novel regulatory components in adhesive behavior of
bacterial cells could also help to explain why decades of
(planktonic) bacterial genetics did not lead to the iden-
tification of the GGDEF network, which had to await
the arrival of large-scale microbial genome analysis, bac-
terial cell biology, and an intensified scientific interest
in microbial surface colonization.
Materials and methods
Strains, plasmids, and media
Bacterial strains and plasmids used in this study are shown in
Table 2. C. crescentus strains were grown in complex peptone-
yeast extract or in minimal glucose media (Ely 1991). Cultures
ofC. crescentuswere synchronized by density gradient centrifu-
gation as described previously (Jenal and Shapiro 1996). For con-
jugal transfer into C. crescentus, E. coli strain S17-1 was used as
donor strain. E. coli strains were grown in Luria Broth (LB) me-
dia supplemented with antibiotics for selection, where neces-
sary. The exact procedure of strain and plasmid construction
(Table 2) is available on request.
Purification of PleD, PleC, and Div
E. coli cells carrying the respective expression plasmid were
grown in LB medium with ampicillin (100 μg/mL), and expres-
sion was induced by adding either arabinose (final concentration
of 0.2%) or IPTG (final concentration of 0.4 mM). After harvest-
ing by centrifugation, the cells were resuspended in TN-buffer
(50 mM Tris-HCl at pH 8.0, 500 mM NaCl, 1 mM -mercapto-
ethanol), lysed by passage through a French press cell, and the
suspension was clarified by centrifugation. The supernatant was
loaded onto Ni-NTA affinity resin (Qiagen), washed with TN-
buffer, and eluted with an imidazol-gradient. All PleD fusion
proteins and the DivJ fragment remained soluble and were pu-
rified in native form on Ni-NTA affinity resin (Qiagen) or Glu-
tathione-agarose (Clontech), whereas the PleC fragment was
solubilized from inclusion bodies in guanidine hydrochloride
and renatured after purification as described previously (Hecht
et al. 1995). Protein preparations were examined for purity by
SDS-PAGE. Fractions containing pure protein were pooled and
dialyzed. C. crescentus cell extracts were prepared after harvest-
ing cells by centrifugation and resuspension in TN-buffer. Cells
were lysed by passage through a French press cell, and the ex-
tract was clarified by centrifugation. Soluble and insoluble pro-
tein fractions were separated by a high-spin centrifugation step
(100,000 × g, 1 h; Jenal et al. 1994).
Enzymatic assays
Di-guanylate cyclase assays were adapted from procedures de-
scribed previously (Ross et al. 1987). The reaction mixtures with
purified PleD protein or Caulobacter cell extracts contained 75
mM Tris-HCl at pH 7.8, 250 mM NaCl, 25m M KCl, 10 mM
MgCl2 in 50 μL volume and were started by the addition of a
mixture of 0.1 mM GTP [-32P]GTP (Amersham Biosciences;
0.01 μCi/μL). To calculate the initial velocity of product forma-
tion, aliquots were withdrawn at regular time intervals and the
reaction was stopped with an equal volume of 50 mM EDTA.
Reaction products (2.5 μL) were separated on polyethyl-
eneimine-cellulose plates (Macherey-Nagel) in 1.5 M KH2PO4
(pH 3.65). Plates were exposed to a phosphor-imager screen, and
the intensity of the various radioactive species was calculated
by quantifying the intensities of the relevant spots using the
imageQuant software (Molecular Dynamics). Measurements
were always restricted to the linear range of product formation.
Reaction mixtures for HPLC analyses were incubated 90 min at
25°C and terminated by heating to 95°C.
In vitro phosphorylation assays were adapted from a method
described previously (Hecht et al. 1995). The proteins were in-
cubated at 25°C for 20 min in phosphorylation buffer (50 mM
Tris-HCl at pH 7.8, 25 mM NaCl, 25 mM KCl, 5 mM MgCl2)
containing 5 μCi [-32P]ATP (Amersham Biosciences). The re-
actions were stopped by adding one-third volume SDS-PAGE
sample buffer (250 mM Tris-HCl at pH 6.8, 40% glycerol, 8%
SDS, 2.4 M -mercaptoethanol, 0.06% bromophenol blue, 40
mM EDTA), and 32P-labeled proteins were separated by electro-
phoresis on 10% SDS-PAGE gels followed by autoradiography.
Synthesis and analysis of c-di-GMP
c-di-GMP was chemically synthesized as described by Ross and
coworkers (Ross et al. 1990) and was purified by semipreparative
reverse phase high-pressure liquid chromatography. Merck Li-
chrospher RP18e was used at 37°C with a 0.01 M triethylam-
monium carbonate buffer pH 7 containing 7.5% of methanol as
mobile phase. A flow rate of 5 mL/min was used on a Hewlett
Packard 1050 series system with ultrviolet detection at 252 nm.
Synthetic c-di-GMP was used in comparative HPLC runs to
characterize the enzymatic assay products. The conditions de-
scribed above were used with a flow rate of 1 mL/min on a
Waters Alliance 2690 separative module connected to a Waters
2487 ultroviolet detector. The retention time of c-di-GMP
ranges between 6 and 7 min.
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Both synthetic and enzymatic c-di-GMP were also analyzed
by mass spectrometry. ESI mass spectrometry was conducted on
a Brucker Daltonics Esquire 3000 plus instrument.
Microscopy and photography
For fluorescence imaging, C. crescentus strains were grown in
peptone-yeast extract media and placed on a microscope slide
that was layered with a pad of peptone-yeast extract containing
1% agarose. The slide was placed on a microscope stage at room
temperature (∼22°C). Samples were observed on an Olympus
AX70 microscope through a phase contrast 100× objective with
a Hamamatsu C4742-95 digital camera. Images were taken and
processed with Improvision Openlab and with Adobe Photo-
shop software.
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Table 2. Strains and plasmids
Strain Relevant genotype or description Reference or source
Caulobacter crescentus
CB15N Synchronizable variant strain of CB15 Evinger and Agabian 1977
UJ284 CB15N pleD Aldridge et al. 2003
UJ417 CB15N and plasmid pPA41 Aldridge et al. 2003
UJ506 CB15N pleC Aldridge et al. 2003
UJ626 UJ284 and plasmid pPA53-4 This study
UJ627 CB15N and plasmid pPA53-4 This study
UJ998 CB15N divJ Aldridge et al. 2003
UJ1000 CB15N pleC Aldridge et al. 2003
UJ1168 CB15N and plasmid pPA114-47 Aldridge et al. 2003
UJ1169 UJ284 and plasmid pPA114-47 Aldridge et al. 2003
UJ1420 UJ1000 and plasmid pPA53-4 This study
UJ1466 UJ998 and plasmid pPA53-4 This study
UJ1875 UJ506 and plasmid pPA534 This study
UJ1909 CB15N and plasmid pSW6 This study
UJ1910 UJ284 and plasmid pSW7 This study
UJ2222 UJ506 and plasmid pSW7 This study
UJ2223 UJ998 and plasmid pSW7 This study
UJ2224 UJ1000 and plasmid pSW7 This study
UJ2262 UJ284 and plasmid pSW8 This study
Escherichia coli
DH10B F−mcrA (mrr− hsd RMS− mcrBC) 80dlacZM15 lacX74 endA1 recA1
deoR (ara, leu)7697 araD139 galU galK nupG rpsL thi pro hsdR− hsd+
recA RP4-2-TcMu-Tn7
Simon et al. 1983
BL21 (DE3) E. coliB F− dcm ompT hsdS(rB−mB−) Stratagene
pLysS gal (DE3) [pLysS CAMr]
BL21-CodonPlus E. coli B F− ompT hsdS(rB− mB−) dcm+ Stratagene
(DE3)-RIL Tetr gal l (DE3) endA Hte [argU ileY leuW Camr]
Plasmid Relevant genotype or description Reference or source
pMR20 TetR low copy number vector Roberts et al. 1996
pBAD AmpR expression plasmid Invitrogen
pGEX4T3 AmpR vector for creation of GFP-fusion proteins Amersham Biotech
pEGFP-N1 AmpR expression plasmid Clontech
pET11 AmpR expression plasmid Stratagene
pPA53-4 pMR20; pleD-GFP under the control of divK promoter This study
pSW6 pMR20; pleDD53N-GFP under the control of divK promoter This study
pSW7 pMR20; pleD*D53N-GFP under the control of divK promoter This study
pSW8 pMR20; pleDGG368DE-GFP under the control of divK promoter This study
pPA69 pGEX4T3; pleD, N-terminal GST-tag This study
pRP49 pBAD; pleC, N-terminal His6 tag This study
pRP63 pBAD; divJ, N-terminal His6 tag This study
pCC2 pET11; pleD, C-terminal His6 tag This study
pRP87 pET11; pleDD53N, C-terminal His6 tag This study
pRP88 pET11; pleD368-372, C-terminal His6 tag This study
pRP89 pET11; pleD*, C-terminal His6 tag This study
pRP90 pET11; pleD*D53N, C-terminal His6 tag This study
pRP91 pET11; pleDGG368DE, C-terminal His6 tag This study
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